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CHAPTER 1: INTRODUCTION 
 
 
1.1 MICROENCAPSULATION 
 
Microencapsulation is a coating technology based on solid small particles, drops of liquids, or 
gaseous components, with protective membranes – microparticle walls. These particles are 
known as microparticles. [1] 
 
Microparticles are tiny particles with diameters in the range of nanometres or millimetres which 
consist of core materials and covering membranes. The most important feature of microparticles 
is their little size, providing large effective surface or interface area. Depending on the selection 
of the covering materials and the core substances, microparticles can be endowed  with a wide 
range of functions.  
 
Covering materials are generally chosen to highlight microencapsulation effects. Therefore, the 
synthetic and natural polymers are used to produce microparticles, as well as lipids and 
inorganic materials. [2] 
 
Due to the development and specialisation of microencapsulation technologies and 
applications, microencapsulation products differ in structure and terminology (Table 1). [1] 
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Table 1. Terminology of microencapsulation products [1] 
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There are several reasons and interesting advantages to use microencapsulation, which are as 
follows: 
 
1. Controlled release of encapsulation active agents. 
2. Protection of the encapsulated materials against oxidation or deactivation due to reaction 
in the environment. 
3. Masking of odour and/or taste of encapsulating materials. 
4. Isolation of encapsulating materials from undesirable phenomena. 
5. Easy handling, specially the powder-like materials. [2] 
 
1.2 TECHNIQUES OF MICROENCAPSULATION 
 
The main interest of microencapsulation consists of separating the active principle from its 
environment through the occlusion in the cavity of microparticles surrounded by a polymer. 
 
Microencapsulation techniques are mainly based on the emulsion of the active principle in a 
solution of polymer used to surround the droplets formed. The “solidification” of the particles is 
obtained by modifying the continuous medium of solution, either changing physical-chemical 
parameters, or by incorporating a chemical agent. 
 
There are different types of emulsions depending on the composition and morphology of the 
dispersed phase and continuous phase. Two groups  are known basically: 
 
1. Emulsions where water is the internal dispersed phase and the continuous phase is oil, 
are termed water-in-oil emulsions (W/O). 
 
2. Emulsions where oil is the dispersed phase and the continuous phase is water, are 
known as oil-in-water emulsions (O/W). 
 
More complex systems where one emulsifier is further dispersed into another continuous phase 
are called double or multiple emulsions (W/O/W or O/W/O emulsions) (Figure 1). [3] 
 
 
Figure 1. Possible sequence of events leading to the final formation of an O/W emulsion via a transient (W/O/W) 
emulsion, when hydrophilic surfactant is initially located in the oil phase. [3] 
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Various techniques are available for the encapsulation of core materials. The choice of the 
appropriate technique depends on the core material properties, the involved manufacturing 
conditions and the user requirements of the final product. The physical nature of the core 
substance to be encapsulated, will determine the technique to be used. In general terms, 
methods are divided into three main types (see different types of microencapsulation 
techniques listed in Table 2). [1,4-6] 
 
1. Chemical methods. The membrane of the capsule is directly formed by the 
polycondensation of two reactive monomers surrounding the dispersed core material.  
You can get the same effect with a previous dissolution, with two immiscible liquids but 
soluble in the same phase. 
 
2. Physico-chemical methods. These processes are based on the control of the 
solubility and precipitation conditions of the polymers under the influence of several 
factors that tend to reduce the solvation on the solvent. 
 
3. Physico-mechanical methods. These methods are similar to the coating techniques 
in general. 
 
Table 2. Different techniques used for microencapsulation. [4] 
Chemical processes Physico-chemical processes Physico-mechanical process 
Interfacial polymerization Coacervation and phase separation Spray drying and congealing 
In situ polymerization Sol-gel encapsulation Fluid bed coating 
Poly condensation Supercritical CO2 assisted microencapsulation Pan coating 
  Solvent evaporation 
 
1.3 APPLICATIONS OF MICROENCAPSULATION 
 
The introduction of microencapsulation techniques for industrial purposes was at the end of the 
1950s to produce pressure sensitive copying papers with hydrophobic solutions of leuco dyes 
encapsulated (Fanger, 1974).  
 
Since then, the microencapsulation has been constantly improved, modified and adapted for a 
variety of purposes and applications. As a result, it has become a relevant example of a 
knowledge-intensive and dynamic technology (Boh and Kardos, 2003), characterised by a rapid 
growth of patent applications, reflecting industrial research and development, as well as an 
increase of the number of new scientific articles, deriving from the basic research (Figure 2). 
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Figure 2. Growth of new patent documents and scientific articles on microencapsulation. [1] 
 
Apart from the graphic and printing industries, microencapsulation has been vastly used for 
pharmaceutical and medical purposes in cosmetic and food products, agricultural formulations, 
in chemical and construction materials industries, biotechnology, photography, electronics, and 
waste treatment. However, their introduction in the textile industry is pretty new.  
 
The microcapsule composition for textile purposes will depend on the required effect. 
Sophisticated shell materials and technologies have already been developed and an extremely 
wide variety of functionalities can now be achieved through microencapsulation. [1,7] 
 
1.4 TEXTILE INDUSTRY 
 
The textile industry has been slow to react to the possibilities of microencapsulation, although 
by the beginning of the 1990s a few commercial applications were appearing with many more at 
the research and development stage (Nelson, 1991).  
 
The microencapsulation technology applied on textiles was firstly used in the early 1980s by the 
US National Aeronautics and Space Administration (NASA) with the aim of managing the 
thermal barrier properties of garments, especially in space suits. They encapsulated phase-
change materials (PCMs) with the aim of reducing the impact of extreme variations in 
temperature during space missions by astronauts. 
 
As the industry moves into the 21st century the number of commercial applications of 
microencapsulation in the textile industry keeps on growing, particularly in Western Europe, 
Japan and North America. The decision of the most developed countries is to introduce into 
fabrics new properties with added value, specially medical textiles and technical textiles.[8]  
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Textile manufacturers show increasing interest in the application for durable fragrances in 
textiles, as well as in skin softeners. Other potential applications include insect repellents, 
cosmetics, dyes, antimicrobials, phase change materials, fire retardants, counterfeiting, 
polychromic and thermochromic effects, in specific medical applications and antibiotics. [7] 
 
The methods for applying microparticles on fabrics are basically two: either they can be 
incorporated directly into the fiber during the spinning process, or they can be added at the 
finishing process (Figure 3).  
 
 
Figure 3. PCM microcapsules incorporated directly into the fibers. PCM microcapsules applied on textile by a 
finishing process. [9] 
  
The encapsulation process allows the active compound to be integrated in textile finishing, by 
textile impregnation (Pad-dry technique) by exhaust bath, or directly incorporated in different 
artificial fibres (spinning). The microparticles will remain effective as long as the coating or fibres 
remain intact. [9-11] 
 
All common coating processes, such as knife over roll, knife over air, or screen printing, can be 
adapted to apply microcapsules to fabric. The method for manufacturing coating composition 
has been widely described in technical literature. Nevertheless, few papers published in 
technical literature give account of the formulation of coating, finishing of fabrics, and they 
neither offer a waste  evaluation of their characteristics, such as thermal and durability 
properties. However, the choice of the process influences the microencapsulated fabric 
behaviour and the efficiency of the system tissue-microparticles [9-12]. 
 
1.5 MODELLING OF DRUG RELEASE 
 
The science of drug release may be described as the application of chemical and biological 
principles to control the in vivo temporal and spatial location of drug molecules for clinical 
benefit. When drugs are delivered (oral or jet injection delivery), only a very small portion of the 
dose actually hits the relevant receptors or sites of action, and a considerable part of the dose is 
actually wasted because it is taken up into the “wrong” tissue, removed from the “right” tissue 
too quickly, or destroyed on the way before its reception . [13-15] 
 
The design and implementation of systems for controlled drug dosage and management 
systems located in the activity of a given drug is currently one of the most important aspects in 
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the development of new ways of drug delivery [16]. The main objective of the controlled release 
is simple, it consists on getting the right amount of active agent, at the right time and in the right 
place. This release method is commonly used to extend the therapeutic dosage and to remove 
or reduce the concentrations exceeding the therapeutic requirements [17]. 
 
Drug delivery is becoming an extremely demanding science. The reasons are essentially 
threefold:  
 
1. The emergence of the more challenging low molecular weight molecules and 
biomacromolecules with poor aqueous solubility, poor tissue permeation, or with both. 
 
2. The increased use of biological materials with poorly understood physical properties or 
questionable shelf life issues. 
 
3. When determining the portion of the precise dose it hat to be directed to the specific aim. 
This way toxic side effects would become less frequent, thus improving the therapeutic 
index.  
 
The emerging areas of tissue engineering or tissue reconstruction have harnessed the 
properties of the polymers as drug delivery systems. These matrix systems effectively hold up 
the diffusion of active agents, trapping them within a three-dimensional network of polymer 
chains. Therefore, their mechanical properties have to be taken into account in the fabrication 
process of these systems. Specifically, there should be a good match between tissue and 
polymer properties, being a main requirement to achieve the final aim of the system [13]. 
 
1.5.1 POLYMERS IN CONTROLLED DRUG RELEASE 
 
The introduction of the controlled release from polymers happened on the 1960s through the 
employment of silicone rubber (Folkman and Long, 1964) and polyethylene (Desai et al., 1965) 
with the aim to improve the effectiveness of drug therapy. But it is necessary to go further in its 
research, because the lack of degradability in these systems implies the requirement of 
eventual surgical removal and restricts their applicability. In the 1970s, biodegradable polymers 
were suggested as appropriate drug delivery materials circumventing the requirement of 
removal (Jalil and Nixon, 1990).  
 
The idea of polymer microcapsules as delivery systems was reported at early 60s (Chang, 
1964) and degradation was incorporated by Mason et al. (1976) through the employment of a 
degradable polymer coating, the topic was reviewed by Marty and Oppenheim (1977).  
 
Recent literature shows that biodegradable systems of microencapsulation can be employed for 
sustained drug release at desirable doses, by implantation and without surgical procedures. 
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Biocompatibility can be achieved by the use of natural polymers such as cellulose, chitin, and 
chitosan or using polymers made from naturally occurring monomers such as lactic and glycolic 
acids. However, polymers derived from synthetic monomers also show excellent delivery 
properties. The wide range of polymers used in controlled release applications based on 
backbone compositions is shown in Table 3. [18-20] 
 
Table 3. Summary of Polymer Structures based on backbone composition. [19] 
Backbone 
Structure 
Examples Notes 
C-C 
 
 
Zero-order temporal control achieved by diffusion from 
matrices. 
Tetanus toxoid released by pulsatile kinetics. 
Prolonged pseudo-first order release of acetoaminophen in 
gastrointestinal tract. 
 
 
Biocompatibility improved by albumin grafting to surface. 
Ophthalmic drug delivery applications. 
Accurel® used to release agents active in vapour state. 
Vinyl-based 
C-C 
 
Membrane devices formulated to release volatile agents into air 
and non-volatile agents into aqueous solutions. 
 
Water-soluble copolymer of vinyl alcohol and vinyl acetate is 
formed by hydrolyzing poly(vinyl acetate). 
Surface stabilizer in microsphere formulation. 
Bioadhesive hydrogels. 
Vinyl-based 
C-C  
 
Employed as rate controlling membrane in Ocusert®. 
Drug permeability tailored by ratio of vinyl acetate present. 
Used in magnetically controlled temporal release, ultrasound-
stimulated release, subcutaneous implant for cancer pain relief, 
and chemotherapeutic agents. 
 
 
Produced by controlled oxidation of PVA. 
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Table 3. Continued [19] 
Backbone 
Structure 
Examples Notes 
  
Bioadhesive polymer. 
Hydrogels of PAA reversibly swell as function of pH. 
 
PAA-based hydrogel loosely cross-linked with divinyl glycol. 
Mucoadhesive properties allow temporal and distribution 
control. 
Vinyl-
based  
C-C 
 
Plasma expander used as polymer-drug conjugate for 
distribution control. 
Enzyme cleavable side chains employed to target release at 
colon. Hydrolytically degradable hydrogels produced by cross-
linking with N,O-dimethacryloyl hydroxylamine linker. 
Component of photosensitive delivery system. 
 
Pronounced negative thermosensivity. 
Used in stimuli sensitive systems. 
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Table 3. Continued [19] 
Backbone 
Structure 
Examples Notes 
 
 
Employed as surgical adhesive due to polymerization in water at 
room temperature. 
Controlled drug release applications reported in polymer-drug 
conjugate and topical applications. 
Bone cements with hydrophicility tailored to facilitate protein 
release. 
C-O 
 
Also termed poly(ethylene oxide) (PEO). 
Used as diffusion-limited tablet formulation, cross-linked hydrogels, 
and polymer-drug conjugates. 
Employed as a component of block copolymer systems. 
C-O, 
C=O 
 
Copolymer: 
 
Poly(lactic acid-co-glycolic acid) 
(PLGA) 
 
 
Biosynthetic poly(ester) often employed as copolymer with 
hydroxyvalerate monomer. 
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Table 3. Continued [19] 
Backbone 
Structure 
Examples Notes 
C-N, 
C=O 
 
 
 
C-N, 
C=O 
 
Hydrolyzable polymer with hydrophilic and hydrophobic 
segments. Potential for diffusion controlled drug release. 
 
Complexes with DNA to form conjugates for gene therapy. 
C-N, 
C-O, 
C=O 
 
Hard and soft segment polymers containing PEG for temporal 
controlled release.  
Azo-containing polymers used to control site of polymer-drug 
conjugate degradation. Anti-infectious biomaterials containing 
antibiotics. 
 
Azo bond degraded by bacteria in colon thereby generating 
colon-specific delivery of chemotherapeutic and other drugs. 
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Table 3. Continued [19] 
Backbone 
Structure 
Examples Notes 
Silicon-based  
Si-O 
 
Temporal controlled release of rifampicin from shunt. Bone 
infections treated with crosslinked matrix. 
Phosphorus-
based 
P=N, P-O 
 
Amino acid side chains generate flexible materials that degrade 
to amino acid, phosphate and ammonia poly[bis(glycine ethyl 
ester)phosphazene]. PEG-modified nanoparticles for site-
specific drug delivery. 
 
 
The most attractive and commonly used biodegradable polymers are polyesters such as 
poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA) and poly(ε-caprolactone) (PCL) 
(Table 3). These materials are commercially available in different compositions and molecular 
weights, allowing the control of the polymer degradation. 
 
The term degradation designates the process of polymer chain cleavage which leads to a loss 
in molecular weight (inducing to the subsequent erosion of the material). For biodegradable 
polymers two different erosion mechanisms can be suggested: homogeneous or bulk erosion, 
and heterogeneous or surface erosion. The difference between both is that, in the case of the 
bulk erosion, degradation is observed all over their cross-section because the penetration of 
water into the polymer bulk is faster than degradation of polymer. However, in surface eroding 
polymers, the degradation is faster than the penetration of water into the bulk. As a 
consequence, these polymers erode mainly from their surface. But normally, for most polymers, 
erosion follows both mechanisms.  
 
The erosion mechanism has consequences for the mechanism of drug release which has been 
classified into diffusion, swelling and erosion-controlled. A biodegradable polymer device might 
release the active agent by all three mechanisms and the fastest mechanism dominates. In the 
case of biodegradable polyesters, based on monomers connected to each other by ester bonds, 
degradation starts after penetration of water into the device. The breakage of ester bonds 
occurs randomly via hydrolytic ester cleavage and leads to the subsequent erosion of the 
device. The hydrolysis rate is influenced by molecular weight, copolymer ratio, polydispersity 
and crystallinity, and all these factors can be used to control drug release. For example, poly(ε-
caprolactone), which is a highly hydrophobic and crystalline polyester, degrades very slowly 
compared to amorphous less hydrophobic PLGA. [19] 
 
Depending on these variables, the degradation time varies from several weeks up to years and 
allows the release of drugs over this time period. However, the achievement of controlled drug 
release from polyester-based delivery systems is difficult because these polymers undergo bulk 
erosion which changes the polymer matrix and influences drug release. As a consequence, 
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drug release is controlled by swelling, drug diffusion and polymer erosion, which is not straight 
forward to predict [19-23]. 
 
1.5.2 ACTIVE COMPOUNDS 
 
The active compounds that have been tested in this project are: caffeine, ibuprofen and gallic 
acid. Caffeine and gallic acid are cosmetic compounds that have functions as anti-cellulite and 
antioxidant, respectively. And Ibuprofen as an  anti-inflammatory pharmaceutical compound. 
 
1.5.2.1 CAFFEINE 
 
Caffeine, C8H10N4O2 is a natural alkaloid appear in more than 60 species of plants. It is part of 
the daily diet contained in drinks such as coffee or tea, chocolate and some soft drinks. It could 
be considered one of the most widely consumed stimulant substances and it is socially 
accepted worldwide. 
 Caffeine is an odourless, colourless and bitter powder or white, long and silky needles, which 
easily agglomerate and shape fluffy and light masses. It is very soluble in boiling water, in which 
crystallizes with a water molecule (in water at 25 ºC is 16 mg/mL). 
 
Friedrich Ferdinand Runge extracted it from the coffee in 1819 and from the tea in 1827, but its 
chemical structure was not described until 1875 by E. Fischer. Caffeine (1,3,7-trimethylxanthine) 
and other methylxanthine alkaloids (Figure 4), as theobromine (3,7-dimethylxanthine) and 
theophylline (1,3-dimethylxanthine), come from the group of xanthines, which ,at the same time, 
come from purines. They are pharmacologically related to psychostimulants. Methylxanthines 
are common ingredients used in cellulite products, such as, caffeine, aminophylline, 
theophylline, etc. and are used because of their suggested effect on adipocyte lipolysis via 
inhibition of phosphodiesterase, and increasing cyclic adenosine monophosphate (AMP) levels 
[14,24,25]. 
 
 
Figure 4. Metabolites of Caffeine. [25] 
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1.5.2.2 IBUPROFEN 
 
Ibuprofen (C13H18O2) (Figure 5) was derived from propionic acid by the research of Boots Group 
during the 1960's. It was discovered by Andrew RM Dunlop with the colleagues Stewart Adams, 
John Nicholson, Jeff Wilson and Colin Burrows and was patented in 1961. The drug was 
launched as a treatment for rheumatoid arthritis in the UK in 1969, and in the United States in 
1974. 
 
 
Figure 5. Chemical structure of Ibuprofen. 
 
It is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve the symptoms of arthritis, 
fever, as an analgesic (pain reliever), especially where there is an inflammatory component, and 
dysmenorrhea. Ibuprofen is known to have an antiplatelet effect, though it is relatively mild and 
somewhat short-lived when compared with aspirin or other better-known antiplatelet drugs. In 
general, ibuprofen also acts as a vasoconstrictor, having been shown to constrict coronary 
arteries and some other blood vessels mainly because it inhibits the vasodilating prostacyclin 
produced by cyclooxygenase 2 enzymes. Ibuprofen is poorly soluble in water, its solubility at 
25°C in water is 0.14 mg/mL, however, it is much more soluble in solutions alcohol / water [26]. 
 
1.5.2.3 GALLIC ACID 
 
Gallic acid is an important component of iron gall ink, the standard European writing and 
drawing ink from the 12th to 19th century. Pliny the Elder (23-79 AD) described his experiments 
with it and wrote that it was used to produce dyes. It was discovered by French chemist and 
pharmacist Henri Braconnot (1780–1855) in 1818 and studied by French chemist Théophile-
Jules Pelouze (1807–1867). 
 
Gallic acid is an organic acid polyphenolic acid also known as 3,4,5-trihydroxybenzoic, found in 
a wide variety of plants. Its chemical formula is C6H2(OH)3COOH (Figure 6). It is a white 
crystalline powder or pale. It is soluble in acetone, ethyl acetate, alcohol, slightly soluble in cold 
water and insoluble in benzene or chloroform. Its solubility in water at 25 °C is 11.50 mg/mL. 
 
 
Figure 6. Chemical structure of gallic acid. 
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Gallic acid is found both in free form or as part of tannins. Salts and esters of gallic acid are 
called gallates. Gallic acid is obtained by hydrolysis of tannic acid with sulfuric acid or enzymes. 
  
It has astringent, antiseptic and antioxidant properties. It helps to protect the cells against 
oxidative damage. It is used to treat diabetes and also for some other treatments such as 
psoriasis and external haemorrhoids containing this active agent [27]. 
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1.5.3 RELEASE MECHANISMS 
 
The release of the encapsulated agent can be achieved by several methods, according to 
three types of systems (Figure 7): [16,20] 
 
 
Figure 7. Systems of controlled drug release from a polymeric matrix. A) Systems of controlled release of bioactive 
agent inner core, B) monolithic controlled release system, C) Monolithic controlled release system by swelling, D) 
bioerodible system, E) controlled release system with side chains. [18] 
 
1. Diffusion of active agents through polymers. 
 
The release behaviour of active agents is the result of the phenomenon of diffusion in 
the polymer through the molecules network and mass transfer restrictions in the 
interphase polymer/liquid. Thus, the modification or the design of a controlled release 
system requires prior knowledge of the mechanism of diffusion of the solute through the 
polymeric material . 
 
2. Controlled dosage by physical mechanisms. 
 
Polymeric systems of drug release can be classified according to the way that drug 
molecules have been incorporated to the matrix. In the case of systems with physical 
bonds between the polymer and the active agent, depending on the mechanism of action, 
the systems can be controlled by diffusion, either in reservoirs (membranes), in matrices 
(monolithic) or controlled by the solvent (controlled by swelling or osmotic systems).  
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2.1. Systems controlled by diffusion. 
 
The amount of active compound that reaches a particular area is controlled by the 
phenomenon of diffusion, it could be directly through the molecular structure of the 
polymer or through macro/micropores. However, the most common one is a 
combination of both mechanisms. 
 
a) Systems with reservoir or systems with inner core that contains the drug. 
This consists of a core of the active agent surrounded by a homogeneous, non-
porous and thin membrane. The active compound is contained within a polymeric 
coating, which can swell or not in the biological medium where is applied.  
 
b) Matrices or monolithic devices. 
In these systems the active compound is uniformly distributed in a support of 
solid polymer. Drug can be dissolved in the polymeric matrix or dispersed, 
depending on if its solubility is greater than the solubility limit.  
 
2.2. Systems controlled by the solvent. 
 
These are polymeric matrices or systems with reservoir where the release is 
controlled by the penetration of a solvent, via osmosis or swelling. 
 
a) Systems controlled by swelling. 
These are monolithic systems in which the active compound is dissolved or 
dispersed in a support of hydrophilic polymer, cross-linked or not, which swells 
without dissolving when it is in contact with an aqueous medium. These polymeric 
systems are named hydrogels and have achieved great interest, at least 
theoretically, because they can achieve a constant rate of release.   
 
b) Osmotic systems. 
These are systems with a drug core surrounded by a polymeric membrane that is 
selective to the pass of water. The membrane allows water molecules to pass but 
it does not allow drugs to get through. These devices are like pressurized 
chambers containing aqueous solutions of the drug, this pressure is relieved by 
the flow of the solution out of the delivery device.  
 
3. Dosage controlled in a chemical way. 
 
Such method where the dosage is controlled by chemical means, the release of the active 
compound is produced by a chemical mechanism, which  can be either a hydrolytic or 
enzymatic attack to a weak bond, or by ionization or protonation. 
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3.1. Bioerodible systems. 
 
The active compound is dispersed into a polymeric material which gets eroded as 
time passes, this allows the drug release. In the specific case of the surgical suture 
(one of the most important applications), this method does not require surgical 
removal, since the biodegradable polymers are gradually absorbed by the organism. 
However, the resulting products may be toxic, immunogenic or carcinogenic. 
 
3.2. Systems with side chains. 
 
The drug molecule is chemically bonded by a polymeric chain and it is released by 
hydrolytic or enzymatic rupture.  
 
1.5.4 MODELS OF DRUG RELEASE 
 
There are many devices providing several mechanisms to control drug release; mechanisms 
such as polymer swelling, drug dissolution, drug diffusion or combinations of them. 
 
The physicochemical characteristics and the geometry of each device determine the resulting 
governing processes. As for  the mathematical modelling of the  microencapsulation systems 
release, one must identify the most important transport phenomenon for the investigated device 
and leave other processes aside, otherwise the mathematical model becomes too complex to 
be used. [28] 
 
The kinetic models of drug release in biological medium, are generally governed by zero order 
or first order. The following table shows the kinetic models of drug release (Table 4) [29]. 
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Table 4. Kinetic models of Drug Release. 
% Q: Percentage of dissolved drug; F: Fraction of released drug; α: Parameter  that defines the process time; β: 
parameter that defines the shape of the matrix.  [29] 
MODEL EQUATION APPLICATION 
Baker and Lonsdale 3/2 [1 – (1 – F)
2/3
] – F = 
kb1t 
Describe the drug release 
from spherical matrices. 
Fisrt order % Q = 100 (1 – e
–kt
) The amount of drug released 
depends on the diffusion and/or 
dissolution. 
Higuchi % Q = kH · t
0.5
 It is a release model 
controlled by diffusion from 
homogeneous matrices and 
granular matrices. 
Hixson-Crowell (Root cubic Law) 1 – (1 – F)
1/3 
= khc · t Kinetic model for dissolution of 
powder; is used to describe the 
release from  erodible  
isometric matrices (eg, spheres 
and cubes). 
Jorgensen and Christensen model F = [1 – (1 – (1 - n)k(t –
t0)
1/1-n
)] 
Multiparticles systems 
(individual particles, assembly 
particles and tablets). 
Combination between Higuchi and zero 
order models 
% Q = k0·t + kH·t
0,5
 Indicative of controlled 
release by diffusion and 
membrane that acts as a barrier 
for itself. 
Equation of Peppas and Korsenmeyer 
(Power Law) 
Mt/ M0= k · t
n
 
 
Polymeric systems with 
swelling, n depends on the 
geometry of the system and its 
value is indicative of the release 
mechanism. 
Weibull % Q = 100 [1 – e
–(t-to/β)α
] Describes exponential curves 
and sigmoidal forms. 
Zero Order % Q = k0 ·t Constant release rate; erodible 
systems with constant surface 
area and systems with 
membranes that control the 
diffusion with constant 
concentration gradient over the 
membrane. 
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1.5.4.1 THEORETICAL MECHANISMS OF DRUG RELEASE 
 
There is relevant coherence between current results and the assorted model release curves in 
some portion of the release curve, but there often significant deviations. Release of core 
material from a non-erodible microcapsule can be observed in several ways. Figure 8 shows 
four theoretical curves (A, B, C, and D) which describe four types of release behaviour. All 
curves are plotted as percent of drug released versus time. 
 
 
Figure 8. Theoretical release curves expected for different types of non erodible delivery systems. A, Membrane 
reservoir-type free of lag time and burst effects; B, same as A, with burst effects; C, matrix or monolithic sphere with 
square root time-release; D, system with first-order release. [30] 
 
In Figure 8, curve A represents the release behaviour of a perfect, non-erodible, spherical 
microcapsule which releases the encapsulated material by steady-state diffusion through a 
coating of uniform thickness. The rate of release remains constant as long as the internal and 
external concentrations of core material and the concentration gradient through the membrane 
are constant. If a finite time is needed to establish the initial, constant concentration gradient in 
the capsule wall membrane then there is a time lag in core material release. Curve A displays a 
system with no time lag. If some of the encapsulated material migrates through the 
microcapsule membrane during storage, a burst effect occurs, as represented by Curve B. If the 
microcapsule acts as an inert matrix particle in which core material is dispersed (a 
microsphere), the Higuchi model is valid up to 60% release (equation (3)). In this case, a plot of 
percent drug released versus square-root time is linear, as shown by Curve C in Figure 8. First-
order release is represented by Curve D. The curve is linear if log percent core material left in 
the capsule is plotted versus time. [30] 
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1.5.4.2 POWER LAW 
 
Several kinetic equations have been used to study drug release for different systems (Table 4). 
Thus, the Power Law (1) is used to measure the coupled effects of Fickian diffusion and 
viscoelastic relaxation in polymer systems, including both processes, 
 
nt tk
M
M


  (1) 
 
where Mt amount of drug released at time t, M∞ the maximal amount of the released drug at 
infinite time (equilibrium), k is the rate constant of drug release, n is  a release exponent 
depends on the system geometry and its value is indicative of the release mechanism of the 
active principle. 
 
It is clear from Eq. (1) that when the exponent n takes a value of 1.0, the drug release rate is not 
linked to  time. This case corresponds to zero-order release kinetics. For slabs, the mechanism 
that creates the zero-order release is known among polymer scientists as case-II transport. 
Here the relaxation process of the macromolecules occurring upon water imbibition into the 
system is the rate-controlling step. Water acts as a plasticizer and decreases the glass 
transition temperature of the polymer. Once the T equals the temperature of the system, the 
polymer chains undergo the transfer from the glassy to the rubbery state, with increasing 
mobility of the macromolecules and volume expansion. 
 
Thus, Eq. (1) has two distinct physical realistic meanings in the two special cases of n=0.5 
(indicating diffusion-controlled drug release) and n=1.0 (indicating swelling-controlled drug 
release). Values of n between 0.5 and 1.0 can be regarded as an indicator for the superposition 
of both phenomena (anomalous transport). It has to be kept in mind that the two extreme values 
for the exponent n, 0.5 and 1.0, are only valid for slab geometry. For spheres and cylinders 
different values have been derived, as listed in Table 5 [28,31-41]. 
 
Table 5. Drug delivery models based on the parameter n. 
Exponent n    
Plane surface Cylinder Sphere Drug Delivery Systems 
0,5 0,45 0,43 Fickian Diffusion Mechanism 
0,5 < n < 1,0 0,45 < n < 0,89 0,43 < n < 0,85 Anomalous Diffusion 
1,0 0,89 0,85 Non-Fickian Diffusion Mechanism 
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1.5.4.3 HIGUCHI EQUATION 
 
Higuchi probably published the most famous and most often used mathematical equation to 
describe the release rate of drugs from matrix systems. It was initially valid only for planar 
matrix, but it was later modified and extended to consider different geometries and matrix 
characteristics. The classical Higuchi equation  was derived under pseudo-steady state 
assumptions and generally cannot be applied to real controlled release systems. 
 
An important advantage of these equations is their simplicity. However, when applying them to 
controlled drug delivery systems, the assumptions of the Higuchi derivation should carefully be 
kept in mind: [31-41] 
 
1. The initial drug concentration in the system is much higher than the solubility of the drug. 
This assumption is very important, because it provides the basis for the justification of 
the applied pseudosteady state approach. 
2. Mathematical analysis is based on one-dimensional diffusion. Thus, edge effects must 
be negligible. 
3. The suspended drug is in a fine state such that the particles are much smaller in 
diameter than the thickness of the system. 
4. Swelling or dissolution of the polymer carrier is negligible. 
5. The diffusivity of the drug is constant. 
6. Perfect sink conditions are maintained. 
 
This equation can be expressed as: 
 
tK
M
Mt 
   (2) 
 
1.5.4.4 KORSENMEYER-PEPPAS EQUATION APPROXIMATION 
 
In addition, a proportionality between the fractional amount of drug released and the square root 
of time can as well be derived from an exact solution of Fick’s second Law. So the diffusion of 
the active compound can be studied as a plane surface for short times of liberation, where D is 
the diffusion coefficient of drug release, and δ is the thickness of thin films under perfect sink 
conditions, it can be expressed as follows [28,42-47]: 
 
tK
Dt
M
M
/
t 








21
2
4   (3) 
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Thus, a proportionality between the fraction of drug released and the square root of time can 
also be based on these physical circumstances which are substantially different from those 
studied by Higuchi from the derivation of his classical equation.  
 
1.6 TRANSDERMAL DRUG RELEASE 
 
The transdermal drug release is a viable administration route for powerful, low-molecular weight 
therapeutic agents, which has to be precise in their control of drug distribution.  This strategy is 
specially recommended for many drugs that are difficult to be taken since they must be 
delivered slowly over a prolonged period to have a beneficial effect. However, there is still 
necessary to research in this field. For instance, the drug release modelling of biodegradable 
polymeric systems by encapsulation technology in textiles has not progressed much yet, due to 
its high complexity. 
 
Skin drug delivery can be divided into topical and transdermal. In a topical administration, the 
drug is meant to act at skin level, this is indicated for the treatment of skin diseases such as 
follicle-related disorders (for example, acne and alopecias). And the aim of transdermal 
administration is getting a systemic release, and in this case the skin acts as a barrier and not 
as a target. It is logic that the topical administration shows far less problems than the 
transdermal one for the use of drug delivery system. However, transdermal administration has 
several interesting advantages over other systemic administration routes such as: 
 
a) The reduction of first-pass drug degradation as the liver is initially bypassed. 
b) The reduction of over dosage peaks that can appear in oral administration. 
c) The existence of variable delivery conditions, typical of the gastrointestinal tract. 
 
Transdermal administration also can take advantage of chemical and physical strategies that 
can improve skin permeability and allow to drug penetration [47-54]. Specifically, the 
transdermal drug delivery is a good viable administration route for powerful, low-molecular 
weight therapeutic agents which either can or cannot withstand the hostile environment of the 
gastrointestinal tract are subject to considerable first-pass metabolism by the liver [55]. 
Regardless of the necessity or not of physical-chemical enhancing, for a reliable and effective 
designing of transdermal delivery systems it is fundamental prerequisite the knowledge of skin 
structure and its properties [58].  
 
The human skin is composed of three layers (Figure 9), the outer layer is the epidermis. This is 
put in contact with the dermis by the so-called dermo-epidermic junction (as permeable area). 
The dermis is constituted by a connective tissue layer of mesenchymal origin. Finally, the inner 
layer is represented by the hypodermis, mainly constituted by connective tissue. The different 
layers of the skin are crossed by nerve endings and blood vessels. Additionally, hair follicles and 
glands, non uniformly distributed throughout the skin, are present. The total human skin weight 
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is more than 3 kg and the total surface is of 1.5–2 m2. The peripheral blood flow through the skin 
in the extremities and torsum is 0.3 mL/h/cm3 . The fluxes through the skin cheeks, front, 
fingers, foot–sole, or palms are somewhat higher. The total surface area of the intracutaneous 
blood vessels, available for the direct passage of drugs into the systemic circulation, amounts to 
100%–200% of the skin area [55]. 
 
For that reason, the drug release to the skin surface and its transport to the systemic circulation 
are studied as a multistep process which involves:   
 
a) dissolution within and release from the drug formulation,  
b) partitioning into the skin’s outermost layer, the stratum corneum (SC),  
c) diffusion through the SC, principally via a lipidic intercellular pathway, (i.e., the rate-
limiting step for most compounds),  
d) partitioning from the SC into the aqueous viable epidermis,  
e) diffusion through the viable epidermis and into the upper dermis, and  
f) uptake into the local capillary network and eventually the systemic circulation (Figure 9). 
 
Figure 9. Schematic representation of the transport processes involved in drug release from the formulation up to its 
uptake through the dermal capillaries. [55] 
 
Therefore, an ideal drug candidate would have sufficient lipophilicity to partition into the SC, but 
also sufficient hydrophilicity to enable the second partitioning step into the viable epidermis and 
eventually the systemic circulation. 
 
A transdermal drug release is a formulation or device (for example, a transdermal patch) that 
maintains the blood concentration of the drug for therapeutic purposes. It should ensure that 
drug levels neither fall below the minimum effective concentration nor exceed the minimum toxic 
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dose [55]. 
 
1.6.1 ANIMAL MODEL OF SKIN DELIVERY – PIG 
 
Detailed information about skin absorption and percutaneous permeation is of utmost relevance 
for skin pharmacological and toxicological research or other products. 
 
It is important to progress /go forward in these fields, since he availability of alternative methods 
to human experimentation is a current need. In vitro methods, using human or animal skin, can 
meet the purpose. However, sometimes without a reliable in vivo animal model, definitive 
conclusions are difficult to be reached. Thus, animal models have been widely considered. Pig 
model is one of particular interest. The common anatomical and physiological characteristics 
between man and pig indicate that pig skin represents a reliable model to study percutaneous 
permeation in man. 
 
Pigs, like men, have a median body size, large enough to collect multiple samples (body fluids, 
biopsies) and, at the same time, it is not too large to be conveniently handled in standard 
laboratory animal facilities. Another important similarity is that the skin of both is only sparsely 
covered with hair. Therefore, it is possible to select pig strains with different amounts of hair. 
Man and pig skins are both characterized by a sparse hair coat and a thick epidermis, which, by  
parameters of tissue turnover time and the characterization of keratinous proteins are 
comparable. Additionally, swine SC contains protein fractions grossly similar to human and 
presents a filament density and areas of cell overlapping comparable as well. The epidermal–
dermal junction is also similar in the pig and man. Dermis is comparable between man and pig 
where it is characterized by a well differentiated papillary body and a large content of elastic 
tissue. Moreover, the structure of collagen fibres and fibre bundles in the dermis of pig, 
generally corresponded to those observed in human skin, including the thickness of collagen 
fibrils. Finally, biochemical similarities were also observed studying glycosphingolipids and 
ceramides in human and pig epidermis as well as the enzyme patterns. 
 
But, some differences have been observed with regard to the amount of vessels which are more 
abundant in man than in pig, and also differences have been revealed in skin glands. The pig 
has only apocrine glands however, human have mostly eccrine sweat over the body surface.  
 
Percutaneous absorption in man varies depending on the area of the body on which the 
chemical resides as well as on the age and sex. Most of the percutaneous permeation studies 
conducted in pigs were performed on their back, the ear, the flank, or the abdomen. The 
selection of a specific skin site of the pig, when matching it to the human skin, determines the 
result of the test.. In vivo studies involving classified chemical  agents and stimulant agent 
showed that the back skin of weanling pigs were closely approximated to human forearm skin 
with regard to its resistance to permeation. 
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Also permeation tests substantially confirm the similarities. For instance, in vitro skin permeation 
to water revealed that human and porcine skins were similar, as well as other compounds. 
Anatomical and biochemical analysis and permeation tests definitely confirm the similarities 
between pig and man and therefore, the possibility to use the pig as a transdermal model 
[56,57]. 
 
1.6.2 IN VITRO TECHNIQUES 
 
An experimental apparatus (Franz diffusion Cells) aimed to measure skin permeability as an in 
vitro technique was proposed in mid-1970s by Franz. Simply. Franz Cell is a double-walled 
beaker characterized by a top donor chamber separated from the receiver chamber by skin. 
While thermostatic fluid flows inside the beaker double wall (constant temperature), sampling 
receiver takes place from the sampling port (Figure 10). Skin permeability is evaluated on the 
basis of drug concentration increase in the receiver environment. In vivo tests are usually 
conducted on human, rodent, and pig skin, which are the closest to human skin. Monkey skin is 
also used [58-62]. 
 
 
Figure 10. Schematic representation of Franz Diffusion Cell. [57] 
  
1.6.3 DRUG PERMEATION THROUGH MEMBRANES 
 
Historically speaking, the first mathematical model of drug permeation phenomenon through 
skin is the one proposed by Higuchi. Then, many other authors developed excellent research 
studies on this topic, finding several models based on the changes on active principle 
concentrations.  
 
These models can be  divided into two main groups: empirical and mechanistic models. 
Although mechanistic models should be further used as they can provide very useful 
information about the relative importance of several phenomena concurring in the determination 
of skin permeability, empirical ones can overcome inaccuracies of mechanistic models (due to 
uncertainties) providing better predictions from the practical point of view.  
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Mechanistic models are  divided into two categories: Analysis based on simple diffusion models 
(Fick's diffusion law , Quantitative structure-activity relationship (QSAR) methods) and Analysis 
based on heterogeneous diffusion models. Empirical analysis of skin permeation of drugs  is 
based on molecular structures such as a Neural network modelling to predict of skin 
permeability [63-69]. 
 
Complex situations may happen in the drug release. They can be summarized in four simple 
conditions concerning release properties of the formulation : 
 
a) Formulation can match drug dissolution. 
b) Formulation can show drug dispersion  in a liquid phase [70]. 
c) A polymeric matrix containing the drug in a dissolved or an undissolved form. 
d) Drug solution reservoir separated from the skin by a matrix. 
 
1.6.3.1 DRUG DISSOLUTION 
 
When  formulation consists of a well-stirred drug solution,  skin acts as a unique barrier 
characterized by proper ,constant diffusion (Dskin) and partition (Kskin) coefficients. In that way 
drug transport can be approached according to Fick's second law considering the diffusion in 
only in one direction [71] 
 
 (4) 
 
where t is time, X is the abscissa, and Cskin (t,X) is drug concentration inside the skin. Assuming 
that initial drug concentration in the solution Cd0 is constant and that drug concentration in 
X=hskin (skin thickness) is always zero, equation (4) must be solved with the following initial and 
boundary conditions: 
 
initial: 
  (5) 
boundary: 
 
 (6) 
 
where equation (5) states that the skin is initially drug free, while equation (6) states the 
partitioning conditions at the formulation/skin interface (left equation) and sink conditions in the 
receiver environment (right equation). Equation (5) holds in the presence of a wide solution 
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volume, while equation (6) holds in the presence of a wide receiver volume. Equation (7) 
analytical solution reads 
 
 (7) 
 
Mt as the drug amount permeated at time t and S is the permeation area. This equation can be 
used as a model both in vitro and in vivo experiments, even if the assumption of zero drug 
concentration in X=hskin (Figure 11) is more reasonable for in vivo conditions, as systemic drug 
concentration is lowered by drug remove or metabolization. 
 
 
Figure 11. Schematic representation of human skin and most important geometric characteristics [63]. 
 
On the contrary, the assumption of pure one-dimension diffusion is much more reasonable in 
vitro set up than in in vivo experiments. Dskin is the skin effective diffusion coefficient accounting 
for skin heterogeneity (follicles, sweat gland, SC, epidermis, dermis). Interestingly, equation (8), 
for very long periods of time, can be designated as 
 
 (8) 
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Consequently, drug flux J (mass/(surface × time)) is given by 
 
  (9) 
 
where Pskin is skin permeability. Michaels et al. [70] (equation (9)) assuming that skin resistance 
is substantially due to SC, developed a simple model that can also account for permeation of 
dissociating compounds. They assume that SC is made up of parallel array of thin plates 
(constituted by proteins) regularly dispersed in a lipid homogeneous continuous matrix (Figure 
11). As a result, drug diffusion behaves according to two different mechanisms: (a) solely 
through the continuous, tortuous lipid matrix, or (b) alternatively crossing the continuous and 
dispersed phase. Thus, J will be the sum of both contributions (Ja and Jb) and the problem shifts 
on their evaluation which, in turn, implies the determination of the corresponding permeability Pa 
and Pb. The plates are assumed as rectangles characterized by length λ and thickness Ƭ and 
that they are equidistantly separated by nearest neighbours by an interstitial channel of 
thickness δ (Figure 11), hskin=n(δ+ Ƭ) (n=layers number) while the thickness of lipidic and plate 
phases will be hL=nδ and hP=nƬ, respectively. Thus, Pb can be evaluated assuming that the 
diffusive resistance of a layered membrane is given by the sum of the resistances belonging to 
each layer. 
 
 (10) 
 
Pa is estimated considering that the surface fraction (according to the diffusion direction) 
belonging to the lipid phase is 2β / α and that the effective path length through the lipid channels 
is 1 + (α + β) / 2 (1 + β). Consequently, Pa is 
 
 (11) 
 
Finally, model can be expressed as follows: 
 
 (12) 
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1.6.3.2 DRUG DISPERSION IN A LIQUID PHASE 
 
Coceani et al. [70] studied permeation of drug molecule. This consists of a liquid phase 
containing dispersed drug with a shape of equal spherical particles of initial radius R0. The 
model requires the solution, in one dimension, of Fick’s second law inside the trilaminate made 
up by stratum corneum, dermis–epidermis and stagnant layer, provided that the initial and 
boundary conditions appropriate are considered. Fick’s second law for stratum corneum, 
dermis–epidermis and stagnant layer reads, respectively [70,72,73]: 
 
 (13) 
 (14) 
 (15) 
 
where Dsc, Dde, Dss, Csc, Cde, and Css are, respectively, the drug effective diffusion coefficient 
and concentration in the SC, in the dermis–epidermis and in the stagnant layer. Equation (13) 
through equation (15) must accomplish the following boundary conditions (Figure 11): 
 
 (16) 
 (17) 
 (18) 
 (19) 
 (20) 
 
and the following initial conditions: 
 
 (21) 
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where Vd and Vr are the donor and receiver environment volumes, respectively, Kt is the 
dissolution rate constant, and Cd and Cr are drug concentration in the donor and receiver 
compartment. Respectively, Cd0 and M0 are the starting drug concentration in the donor 
compartment and the starting amount of undissolved drug in the donor compartment. Cs is drug 
solubility in the fluid filling the donor compartment, S is the permeation area, and Kp1, Kp2, Kp3, 
and Kp4 are the partition coefficients.  
 
Equation (16) shows the drug mass balance made up on the donor compartment: the first right-
hand side term takes into account powder dissolution, whereas the second one takes into 
account the mass flux that leave from the donor through the SC.  
 
Equation (17) and equation (18) impose, respectively, that it makes no difference whether 
accumulation occurs at the SC/dermis–epidermis interface (X=hsc) or at the dermis–
epidermis/stagnant layer interface (X = hsc + hde).  
 
Equation (19) states that the increase in concentration of the receiver compartment depends on 
drug flux exiting from the stagnant layer.  
 
Finally, equation (20) shows interfaces partitioning conditions while equation (21) states that, at 
the beginning, skin and receiver are drug free, while donor compartment contains a drug 
solution (initial concentration Cd0) and an amount M0 of undissolved drug. Particles dissolution 
constant Kt  is supposed to be time dependent, because particle radius decreases upon 
dissolution (Kt = 4πR
2 kd/Vd).  
 
As a result, once Kd (intrinsic drug dissolution constant) is known, Kt evaluation gives the 
knowledge of particle radius R reduction. For this purpose, A drug mass balance is created with 
the amount that reaches the skin, the donor and receiver compartments:  
  
 (22) 
 
where M is the drug amount not yet dissolved at time t. Bearing in mind the Hixon–Crowell 
equation: 
 
 (23) 
 
it is possible to calculate R reduction and, thus, Kt reduction. Obviously, when the dissolution 
phenomenon implies a considerable variation of the particle radius, the effects of Kt decrease 
are more evident. In this case, the solid surface will be strongly reduced and, accordingly, the 
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drug flux feeding the donor compartment will decreased. Thus, the importance of Kt reduction 
should be more relevant for few big particles than for many small particles, the total particles 
mass remains the same.  
Coceani et al. apply this model to study acyclovir permeation through male hairless rat skin at 
37ºC. In particular, they studied (Franz Diffusion cell apparatus) acyclovir permeation through 
the full skin and the dermis–epidermis layer after removing SC. [70] 
 
Guy and Hadgraft [55,60] developed a mathematical model in order to investigate the effect of 
the variation of thickness during drug release through the skin. Accordingly, the experimental 
permeation data are fitted by the following equation, suitable to describe drug permeation 
through a thin membrane:  
 
 (24) 
 
where Mt is the total amount of drug that passes through the layers of skin, Ls is  stratum 
corneum thickness and L0 the formulation thickness, during period t. Ds is the diffusion 
coefficient of the drug through the different skin layers and K is a partition coefficient between 
skin layer and drug formulation (typically K= concentration in skin layer/concentration in 
vehicle). 
 
1.6.3.3 POLYMERIC MATRIX CONTAINING DRUG 
 
Fernandes et al. [74,75] proposes a very interesting analytical solution to the problem of skin 
(thought as a unique membrane) permeation when formulation is represented by a matrix 
containing dissolved drug. Taking this into account, , their model consists in the following 
equations: 
 
 
 (25) 
 (26) 
 
where Cf(X) and Cskin(X) represent, respectively, drug concentrations in the formulation and the 
skin, while Df and Dskin are drug diffusion coefficients in the formulation and the skin, 
respectively. These equations are solved under the following initial and boundary conditions 
(see Figure 11): 
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initial conditions: 
 
 (27) 
boundary conditions: 
 
 (28) 
 (29) 
 (30) 
 (31) 
 
Although, initially, matrix (formulation) is uniformly loaded by the drug (concentration Cf0) 
(Equation (27)), skin is drug free.  
 
Equation (28) imposes the existence of a drug impermeable wall on the matrix back while 
equation (29) excludes drug accumulation at the matrix/skin interface. Finally, Equation (30) 
imposes partitioning conditions at the matrix/skin interface and Equation (31) fixes to zero drug 
concentration in the blood circulation. 
 
Model analytical solution reads 
 
 (32) 
 (33) 
 (34) 
 (35) 
 (36) 
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Where Den is the diffusion corresponding to the enhancer and eigen-values λi are given by the 
solution of 
 
(37) 
 
 
1.6.3.4 DRUG SOLUTION RESERVOIR 
 
The last configuration considered shows that the formulation is based on a drug solution 
reservoir separated from the skin by a matrix. Again, assuming that the skin as a one-layer 
membrane, mass transport in the matrix and in the skin is ruled by equation (25) and equation 
(26), respectively. 
It obviously applies to different initial and boundary conditions: 
 
initial conditions: 
 
 (38) 
 (39) 
 
boundary conditions: 
 
 (40) 
 (41) 
 (42) 
 (43) 
 
where S is the surface area available for permeation, Cres is the drug concentration in the 
reservoir, Cres0 is its initial value, 
fr
pk  and 
sf
pk  are matrix/reservoir and skin/matrix partition 
coefficients while Vres is the reservoir solution volume. Equation (39) implicitly assumes that, at 
test time, a drug equilibrium partitioning is fully established between the solution and the matrix 
whereas Equation (40) states that Cres reduction speed is equal to the drug flow crossing matrix 
surface in X=0. 
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It is worth mentioning that, to render skin permeation mathematical modelling closer to in vivo 
conditions, the boundary condition set in X=hskin should be modified. Indeed, if at an initial stage 
drug concentration can be set equal to zero, and it is also required to take the drug 
accumulation in the blood and drug released from the blood into account. As a consequence, 
the new boundary condition reads 
 
 (44) 
 (45) 
 
where Sskin is the area available for permeation, Vb and Cb are, respectively, blood volume and 
drug concentration in blood, ke is the drug elimination constant while 
sb
pk  is the skin/blood drug 
partition coefficient. Equation (45) simply affirms that Cb variation depends on drug flow crossing 
the skin and on drug elimination (here supposed, for the sake of simplicity, a first-order kinetics 
process) [76,77]. 
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2.1 ABSTRACT 
 
Mathematical drug release modelling of biodegradable polymeric systems by 
microencapsulation technology in textiles has not progressed much yet, because it is generally 
too complex. The release of a therapeutic agent from a formulation applied to the skin surface 
and its transport to the systemic circulation has a multistep process.  
 
The transdermal drug released is a feasible administration route for powerful, low-molecular 
weight therapeutic agents, which has to be accurate in their control of drug distribution. 
Moreover, many drugs are difficult to handle because they must be delivered slowly over a 
prolonged period to have a beneficial effect.  
 
In the present work, several examples of practical applications of mathematical models, 
developed through experimental drug release data, are given. For those involved in the design 
and development of biodegradable drug delivery systems, it will be useful to choose the generic 
mathematical model for several specific drug release problems. This transport model is based 
on the appropriate solution to Fick's second law of diffusion and can be used to explain drug 
release kinetics into this complex biological membrane. 
 
Keywords: Microencapsulation; Active compound; Biodegradable polymers; Drug release; 
Mathematic model; Smart Textiles; 
 
2.2 OBJECTIVES OF THE THESIS 
 
Current technology of microencapsulation has enabled the production of biofunctional textiles. 
These textiles are able to release drugs or cosmetics to the skin. This technology is based on 
empirical procedure which is limited to high added-value applications, such as the ones in 
medicine field. A quantitative analysis based on physico-chemical principles could allow the 
generation of new technologies. 
 
The main objective of this study is to create smart textiles which allow a controlled drug release 
for any active compound/substance. Such objective will allow the control of the textiles drug 
release in such a way that the active compound is released in the right quantity, at the right time 
and at the right place.  
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The steps to be followed in order to get to the  objective are as per below: 
 
1. Handling and characterization of microspheres. 
2. Impregnation of microspheres on textile substrate 
3. Analysis of drug release. 
4. Find and check a Mass Transport Model through the skin. 
2.3 EXPERIMENTAL STRUCTURE 
 
The experimental structure is adapted to the project steps. These steps are summarized in the 
Figure 12. 
 
Microspheres containing active principles were prepared using a solvent evaporation procedure 
with poly(vinyl alcohol) as surfactant in the external aqueous phase. Several biodegradable 
microspheres of biocompatible polymers, taken as delivery systems for active agent, have been 
studied.  
 
Polymers were PLGA (Poly(lactide-co-glycolide)) and PCL (poly(ε-caprolactone)). The active 
compounds chosen were cosmetics and drugs, such as gallic acid, caffeine and ibuprofen. The 
microspheres obtained were characterized by the measure of encapsulation efficiency. The 
surface morphology and chemical structure of the micro particles were investigated using 
scanning electron microscopy (SEM) and  Fourier transform infrared spectroscopy (FT-IR). 
Nanosizer was used for particle size distribution. 
 
The application of the microspheres in the fabrics was carried out using Pad-Dry technique, 
since it is a simple and efficient technology and its working conditions are harmless to the 
system. 
 
The drug release system was analyzed, through samples of the treated fibre (cotton, polyamide, 
acrylic and polyester) in order to study the drug delivery behaviour in different media, deionized 
water and physiological saline (T=37ºC).  
 
The skin penetration profile by in vitro technique for different active principles was determined 
using pigskin. The release experiments are performed resorting to the Franz Diffusion cells 
apparatus (Lara-Spiral, Courtenon, France) consisting of two thermostatic chambers, the upper 
donor and the lower receptor chamber, divided by a skin biopsy. 
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Figure 12. Scheme of the experimental structure of the project. 
 
2.4 MATERIALS 
 
2.4.1 BIOCOMPATIBLE POLYMERS AND ACTIVE AGENTS 
 
The most important materials used to prepare microspheres were the ones from polymeric 
matrix, PLGA (Poly(lactide-co-glycolide)) with a copolymer ratio (lactic acid/glycolic acid) of 
75/25 and a molecular mass (Mw) range of 5,000-15,000 from Aldrich and PCL (poly(ε-
caprolactone)) with a molecular mass (Mn) of 60,000 from Aldrich. The active compounds used 
were Ibuprofen in powder with a molecular mass (Mr) of 206.28, supplied by Sigma-Aldrich; 
Caffeine anhydrous in powder with (Mr) 194.20 from Fluka; Gallic acid in powder with (Mn) 
170.12 from Sigma-Aldrich. As dispersant material, PVA (Poly(vinyl alcohol)), 87-89% 
hydrolyzed was used,  with a (Mw) range of 31,000-50,000 from Aldrich and finally, the  solvent 
dichloromethane stabilized with 20 ppm of amylene, supplied by Panreac.  
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2.4.2 TEXTILE SUBSTRATES 
 
The standard textile substrates woven fabrics used were: Cotton fabric (CO) (Style 400, ISO 
105 - F02) Polyamide fabric (PA) (Style 361, ISO 105-F03), Polyester fabric (PET) (Style 777, 
ISO 105-F04), and Acrylic fabric (PAC) (Style 864, ISO 105-F05) from Test Fabrics Inc (USA). 
 
2.4.3 SKIN PERMEATION 
 
The type of skin used to obtain a mass transport model through the skin by in vitro technique 
was pig skin. It was obtained from the unboiled back of domestic pigs (Landrace Large White 
race). The treated and dermatomed pigskin discs were supplied by a research group 
(Biophysics of Lipids and Interphases group) of IQAC-CSIC. The OECD Guidelines and the 
opinion of the Scientific Committee on Cosmetic Products and Non-Food Products (SCCNFP) 
were closely a considerable reference in the present study. phosphate-buffered saline at pH 7.4 
supplied by Sigma in distilled water (containing 0.9% NaCl, 0.02% KCl and 0.8% phosphate 
buffer) was used as receptor fluid.,. 
All chemicals used were of analytical grade. 
 
2.5 EXPERIMENTAL METHODS AND TECHNIQUES 
 
The methods or techniques used in the present work follow the structure according to its 
experimental steps. 
 
2.5.1 PREPARATION OF MICROSPHERES 
 
All the microspheres were performed by a double emulsion (w1/o/w2 type in the case of caffeine 
encapsulation, but of o1/o2/w type for ibuprofen and gallic acid encapsulation) using the 
conventional solvent evaporation method.  
 
Briefly, the polymer (PLGA or PCL) and the active principle (caffeine or ibuprofen or gallic acid) 
were separately dissolved in methylene chloride and either in water (in the case of caffeine) or 
in isopropylic alcohol (for ibuprofen) or in monalcol (for gallic acid), respectively.  
 
The simple emulsion (w1/o or o1/o2) was generated by mechanical agitation (Ultra-turrax T25, 
Figure 13; Table 6) for several minutes. Afterwards, this simple emulsion was added to a 
continuous phase, constituted of 150 ml aqueous solution of PVA (dispersant) (2% w/w) and 
emulsified for several minutes resulting in a double emulsion (w1/o/w2 or o1/o2/w). The mixture 
was maintained under constant agitation until the total evaporation of the solvent and the 
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consequent microsphere formation. The method used was carried out at 4ºC in the case of 
caffeine, but for ibuprofen and gallic acid it was carried out at room temperature. [16,17,22,75-
81] 
 
ULTRATURRAX T25 (Figure 13; Table 6) as a homogenizer is ideal to stir volumes from 1-
2000mL (H2O) in such applications as homogenizing wastewater samples, dispersion tasks 
under vacuum, or sample preparation in medical diagnostics. Stainless steel or plastic 
homogenizing tools can be used. Stirrer features a digital display, step less speed adjustment, 
and overload protection. Meets IP 20 protection class according to DIN EN 60529. 
 
 
Figure 13. T-25 Digital Ultraturrax IKA ® 
 
Table 6. Specifications of ULTRATURRAX T25 
MANUFACTURER IKA 
MODEL T25 
POWER 500 W 
SPEED RANGE 3500-24000 rpm 
SAMPLE VOLUME 1-2000 mL 
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2.5.2 CHARACTERIZATION OF MICROSPHERES 
 
For the characterization of the obtained microspheres, 4 tests were done: Scanning Electron 
Microscopy (SEM), Encapsulation Efficiency, Fourier Transform Infrared Spectroscopy (FTIR) 
and Particle Size Distribution [7]. 
 
2.5.2.1 SCANNING ELECTRON MICROSCOPY (SEM) 
 
The treated fabrics were analyzed by SEM (model JSM-5610, JEOL, Tokyo, Japan; Figure 14; 
Table 7). The SEM analysis was performed on cotton fabric with microspheres and void 
microspheres for each substance. 
 
 
Figure 14. Scanning Electron Microscope (JEOL, JSM-5610) 
 
Table 7. Specifications of Scanning Electron Microscope 
MANUFACTURER JEOL 
MODEL JSM-5610 
RESOLUTIONS (SEI) 3.0 nm guaranteed 
MAGNIFICATION x 18 
IMAGE MODE SEI*, BEI* 
PROBE CURRENT 1 pA to 1 µA 
MODE High Vacuum 
(*SEI: Secondary electron image; *BEI: Backscattered electron image) 
 
The scanning electron microscope is based on the interaction between an electron beam and 
the surface of a given solid material. The result is a high-resolution image of the surface 
topography of the material that can be analyzed using image analysis tools. To handle  non-
conductive samples, as in this case, there is sputtering equipment (Figure 15) to lay thin layers 
of gold on the surface of the samples, making them electrically conductive and enabling their 
visualization using the microscope. 
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Figure 15. Sputtering equipment 
 
2.5.2.2 ENCAPSULATION EFFICIENCY 
 
Encapsulation efficiency of active compounds in microspheres was detected indirectly in the 
liquid phase by UV/Vis Spectrophotometer (Shimadzu UV-2401 PC) after centrifugation (Figure 
16; Table 8) of dissolution for several minutes [82,83]. The ratio of amount of active agent 
entrapped in the dispersion was calculated by the following equation: 
 
100


t
dt
C
CC
(%)EE  (46) 
 
where Ct is the theoretical concentration of microencapsulated drug, Cd is the drug 
concentration that remains in the bath solution, therefore the amount of drug that has not been 
microencapsulated. 
 
  
Figure 16. Centrifuge and UV/Vis Spectrophotometer 
 
Table 8. Specifications of UV/Vis Spectrophotometer 
MANUFACTURER Shimadzu 
WAVELENGHT RANGE 190 to 900 nm 
MONOCHROMATOR 
SYSTEM 
Single monochromator with a high-performance blazed holographic grating in the 
aberration corrected Czemy-Tumer mounting 
RESOLUTION 0.1 nm 
LIGHT SOURCE 50 W halogen lamp (2,000 hours life) and D2 lamp (500 hours life) 
SOFTWARE 
SPECIFICATIONS 
Personal Spectroscopy Software (standard) Spectrum, Quantitative, Time Course 
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2.5.2.3 FOURIER TRANSFORM INFRARED SPECTROSCOPY (FTIR) 
 
A Fourier-transform infrared spectrometer FTIR (Avatar System 320; Figure 17; Table 9) was 
used to identify the chemical structure of the formulation of microspheres which were prepared 
by grinding the powder sample with KBr (wave-numbers 500-4000 cm-1, at a resolution of 4 
cm-1 and collected for 20 scans). Moreover, it allows the detection of interactions between 
active agents and polymers, as well as, the  determination of the changes on original polymers 
and the settlement of  microspheres as matrix. 
 
 
Figure 17. FTIR Spectrometer Avatar System 320. 
 
Table 9. Specifications of FTIR spectrometer 
MANUFACTURER Nicolet 
SPECTROMETER Avatar System 320 
SOURCE IR 
DETECTOR DTGS KBr 
BEAMSPLITTER KBr 
SAMPLE SPACING 2.0000 
DIGITIZER BITS 20 
MIRROR VELOCITY 0.6329 
APERTURE 100.00 
 
 
2.5.2.4 PARTICLE SIZE DISTRIBUTION 
 
Particle size distribution of microspheres was carried out at Malvern Nanosizer (Model Nano-ZS 
Series, Malvern; Figure 18; Table 10). Microspheres samples were introduced into a DTS1060C 
– Clear disposable zeta cell and water was used as a dispersant at 25ºC. The results were 
reported as an intensity size distribution. 
 
 
Figure 18. Zetasizer Nano ZS. 
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Table 10. Specifications of Nanosizer (Size range and Zeta Potential analysis) 
MANUFACTURER Malvern 
MODEL Zetasizer Nano-ZS 
SIZE RANGE 
(NANO S AND NANO ZS) 
SIZE RANGE MAXIMUM (Diameter) 0.3 mm-10 microns 
MINIMUM SAMPLE VOLUME 12 µL 
CONCENTRATION-MINIMUM 0.1 mg/ mL 15 KDa protein, 0.1 ppm of 60 nm polystyrene latex 
CONCENTRATION-MAXIMUM 40% w/v 
MEASUREMENT ANGLES 12.8º and 175º (Nano ZS) 
ZETA POTENTIAL 
(NANO Z, ZS AND NANO ZS90) 
SIZE RANGE SUITABLE FOR 
MEASUREMENT (Diameter) 
Minimum 3.8 mm, maximum 100 microns 
ZETA POTENTIAL RANGE No effective limitations 
MAXIMUM SAMPLE 
CONCENTRATION 
40% w/v 
MAXIMUM 
SAMPLE CONDUCTIVITY 
300 mS/cm 
CONDUCTIVITY ACCURACY ± 10% 
 
 
2.5.3 IMPREGNATION OF MICROSPHERES ON TEXTILE SUBSTRATE 
 
The application of microcapsules onto the fabrics was carried out by impregnation process 
using a Pad-Dry (Figure 19) technique of 30 cm width (ERNST BENZ AG KLD-HT and 
KTF/m250) and followed by a process of drying at room temperature, with the padding 
pressure, to obtain a pick-up of 805%, from the microencapsulation formulations. The treated 
fabric samples were finally conditioned at 202ºC and 655% relative humidity for 24 hours 
before weighting and proceeding to other experiments [9-12]. 
 
 
Figure 19. Pad-Dry technique. 
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2.5.4 ANALYSIS OF DRUG RELEASE 
 
To analyze  kinetic release of active compounds, samples of 1 g of the treated fabric were 
submerged into the thermostatized vessels which were filled with deionized water and 
physiological saline at infinite bath conditions at a temperature of 37ºC (Figure 20). This 
analysis aims to study the environmental effects on the drug release systems, for instance the 
effect of saline medium (physiological saline), simulating the skin’s sweat. The amount of active 
principle realised to the bath was determined by UV/Vis Spectrophotometer at different periods 
of time. The results will show the degree of fixation and retention capabilities of the 
microencapsulated compounds when they are in contact with water and sweat. 
 
 
Figure 20. Analysis of Drug Release in a thermostated water bath. 
 
2.5.5 OBTAINING A MASS TRANSPORT MODEL THROUGH THE SKIN 
 
The in vitro technique used was an experimental apparatus (Franz Diffusion Cells) aimed to 
measure skin permeability [32]. The in vitro studies are carried out with pig skin on Franz static 
diffusion cells (3 mL, 1.86 cm²) (Figure 21 and 22) in order to know the evolution of the amount 
of the principle present in each of the different skin compartments (SC, epidermis and dermis) 
as well as in the receptor fluid, as a function of time (percutaneous absorption essay) 
[14,15,48,70,84]. 
  
Figure 21. Franz Cells (3 mL, 1.86 cm², Lara-Spiral, Courtenon, France).  
Franz Cells in a thermostated water bath. 
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Figure 22. Schematic diagram indicating the different permeation experiments performed on release and skin 
penetration of ibuprofen. 
 
The skin is dermatomed to a thickness of 700 µm ± 50 µm (Dermatome GA630, Aesculap, 
Germany). A punch is used to obtain skin discs1 (2.5 cm inner diameter) which fit into the cell.  
 
A magnetic stirring bar is introduced in the lower part of the cell and it is filled with a receptor 
fluid through the lateral inlet of the cell. The receptor fluid is usually phosphate-buffered saline at 
pH 7.4 in distilled water. The penetration cells are placed in a thermostated water bath assuring 
a skin surface temperature at 32ºC while being subjected to magnetic stirring. 
 
The integrity of the skin samples is evaluated by measuring the transepidermal water loss 
(TEWL) with a Tewameter TM210 (Courage & Khazaka; Figure 23; Table 11). A minimum of 6 
diffusion cells with the corresponding skin samples of at least three donors are used for each 
experimental assay. Each sample of treated fabric is applied on the skin. 
  
 
Figure 23. Tewameter TM 210. 
 
                                                 
1
 The treated and dermatomed pig skin discs were supplied by research group of IQAC-CSIC. 
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Table 11. Specifications of Tewameter. 
MANUFACTURER Courage & Khazaka 
MODEL TM 210 
DIMENSIONS Hollow cylinder 2 cm, ∅  1 cm 
Probe 15.3 cm 
RESOLUTION Humidity ± 0.01 % RH 
Temperature ± 0.01 °C 
WATERLOSS ± 0.5 g/hm² for RH ≥ 30 %; 
± 1.0  g/hm² for RH ≤ 30 % 
TEMPERATURE ± 0.5 °C 
 
 
At the end of the period of exposure, the skin surface is washed by a specific procedure: first 
with water or sodium lauryl ether sulfate solution and then twice with water; a cotton swab is 
used to dry the skin. Moreover, 8 stripping are carried out on the surface horny layers of stratum 
corneum with adhesive tapes (D-Squame, Cuderm Corporation, Dallas, USA) applied under 
controlled pressure. The epidermis is pulled apart from the dermis after heating the skin at 80ºC 
for a few seconds (Figure 24). From the dermis, the skin which has been in contact with textile 
and the Franz cell has been separated and has considered as a surplus sample to be analyzed.  
 
 
Figure 24. Separation of skin layers. 
 
The active principles present in the different samples analyzed (receptor fluids, washing 
solutions, SC on tapes, epidermis and dermis) were extracted and diluted with an appropriate 
solvent. After one night of contact with the solvent, all samples were stirred during 30 min at 
room temperature and the dermis, epidermis and stratum corneum samples were sonicated for 
15 min. After sonication the  samples were filtrated on Nylon filter (0.45 µm, Cameo N, 
Scharlab, Spain), and then the concentration of the solutions were determined by HPLC (Figure 
25; Table 12). 
 
 
Figure 25. HPLC (VWR-Hitachi equipment (L-2400 UV/Vis detector)). 
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Table 12. Specifications of HPLC (VWR-Hitachi equipment (L-2400 UV/Vis detector)). 
MANUFACTURER VWR-Hitachi Elite LaChrom 
DETECTOR L-2400 UV/Vis 
PUMPING SYSTEM L-2130 
INJECTION SYSTEM L-2200 Autosampler 
SOFTWARE D-6000 Interfase 
COLUMN LiChrocart 250-4/LiChrosorb RP-18 (5µm) 
 
 
The kinetic study through cotton fabric samples with PCL-microspheres (ibuprofen) applied onto 
the skin was obtained and was analyzed with corresponding kinetic models (Chapter 1. (1.6.3)). 
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CHAPTER 3: PREPARATION OF MICROSPHERES AND THEIR CHARACTERIZATION 
 
 
3.1 PREPARATION OF MICROSPHERES 
 
The conditions of each of the processes corresponding to preparation of PLGA-microspheres 
with caffeine, PCL-microspheres with ibuprofen and PCL-microspheres with gallic acid, are 
shown in the following tables [16-18,22,53,75-81]. 
 
3.1.1 PLGA-MICROSPHERES WITH CAFFEINE 
 
The preparation of caffeine microspheres were obtained by solvent evaporation method 
resulting a double emulsion w1/o/w2. PLGA-microspheres without active compound were 
obtained by the same procedure and with the same experimental conditions the PLGA-
microspheres with the active compound [78]. 
 
The types of materials and their amounts are shown in Table 13. And the experimental 
conditions to obtain these are shown in Table 14. 
 
Table 13. Type of materials and their amounts. 
POLYMER  PLGA (Poly(lactide-co-glycolide)) 250 mg 
ACTIVE COMPOUND CAFFEINE 83,2 mg 
DISPERSANT PVA (Poly(vinyl alcohol)) 3.06 g 
SOLVENT OF POLYMER (o) DCM (Dichloromethane) 10 mL 
SOLVENT OF ACTIVE COMPOUND (w1) Distilled water 10 mL 
SOLVENT OF DISPERSANT (w2) Distilled water 150 mL 
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Table 14. Experimental conditions of preparation of caffeine PLGA-microspheres. 
TYPE OF EMULSION w1/o/w2     
RATIO (PLGA:CAFFEINE)  
3:1 
    
      PARAMETERS 
 
SOLUTIONS 
 
T (ºC) 
 
STIRRER 
 
SPEED (rpm) 
 
Addition time 
 
Stirring 
Time 
ACTIVE COMPOUND (w1)  
4 
 
Magnetic 
 
700 
 
- 
 
15 min 
POLYMER (o) 4 Magnetic 370 - 10 min 
DISPERSANT (W2) Room Magnetic 1,100 - 2 h 
W1/O emulsion 4 Ultra-turrax T25 24,000 7 min 15 min 
W1/O/ W2 emulsion 4 Ultra-turrax T25 24,000 8 min 10 min 
(Solvent evaporation) Room Magnetic 400 - 8 h 
 
3.1.2 PCL-MICROSPHERES WITH IBUPROFEN 
 
Ibuprofen PCL-microspheres were prepared by solvent evaporation method resulting a double 
emulsion o1/o2/w. PCL-microspheres without active compound were also  obtained by the same 
procedure. The differences respect to PLGA-microspheres with caffeine, apart from using a 
different polymer (PCL), another solvent was also used to dissolve the active compound. The 
reason of such changes is basically that the ibuprofen is partially soluble in water and therefore, 
an organic solvent (2-propanol) had to be used [81]. 
 
The types of materials and their amounts are shown in Table 15. And conditions followed  to 
obtain these microspheres are shown in Table 16.  
 
Table 15. Type of materials and their amounts. 
POLYMER  PCL (poly(ε-caprolactone)) 250 mg 
ACTIVE COMPOUND IBUPROFEN 250 mg 
DISPERSANT PVA (Poly(vinyl alcohol)) 3.06 g 
SOLVENT OF POLYMER (o) DCM (Dichloromethane) 10 mL 
SOLVENT OF ACTIVE COMPOUND (w1) 2-PROPANOL 10 mL 
SOLVENT OF DISPERSANT (w2) Distilled water 150 mL 
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Table 16. Experimental conditions of preparation of ibuprofen PCL-microspheres. 
TYPE OF EMULSION o1/o2/w     
RATIO (PCL:IBUPROFEN)  
1:1 
    
      PARAMETERS 
 
SOLUTIONS 
 
T (ºC) 
 
STIRRER 
 
SPEED (rpm) 
 
Addition time 
 
Stirring 
Time 
ACTIVE COMPOUND (w1)  
4 
 
Magnetic 
 
300 
 
- 
 
15 min 
POLYMER (o) 4 Magnetic 370 - 1h 30min 
DISPERSANT (W2) Room Magnetic 1,100 - 2 h 
W1/O emulsion Room Ultra-turrax T25 24,000 11 min 5 min 
W1/O/ W2 emulsion Room Ultra-turrax T25 24,000 14 min 11 min 
(Solvent evaporation) Room Magnetic 500 - 20 h 
 
3.1.3 PCL-MICROSPHERES WITH GALLIC ACID 
 
The preparation of gallic acid PCL-microspheres was made by the solvent evaporation method 
resulting a double emulsion o1/o2/w as in the case of PCL-microspheres with ibuprofen. 
Therefore, the void PCL-microspheres were obtained by the same procedure. However, in this 
case, the solvent of agent compound used, was another one since the solubility of gallic acid in 
water was not as good as in monalcol. 
 
The types of materials and their amounts are shown in Table 17. And the experimental 
conditions  to obtain them are shown in Table 18. 
 
Table 17. Materials and their amounts. 
POLYMER  PCL (poly(ε-caprolactone)) 250 mg 
ACTIVE COMPOUND GALLIC ACID 250 mg 
DISPERSANT PVA (Poly(vinyl alcohol)) 3.06 g 
SOLVENT OF POLYMER (o) DCM (Dichloromethane) 10 mL 
SOLVENT OF ACTIVE COMPOUND (w1) Monalcol 25 mL 
SOLVENT OF DISPERSANT (w2) Distilled water 150 mL 
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Table 18. Experimental conditions of preparation of gallic acid PCL-microspheres. 
TYPE OF EMULSION o1/o2/w     
RATIO (PCL:GALLIC ACID)  
1:1 
    
      PARAMETERS 
 
SOLUTIONS 
 
T (ºC) 
 
STIRRER 
 
SPEED (rpm) 
 
Addition time 
 
Stirring 
Time 
ACTIVE COMPOUND (w1)  
4 
 
Magnetic 
 
300 
 
- 
 
15 min 
POLYMER (o) 4 Magnetic 370 - 1h 30min 
DISPERSANT (W2) Room Magnetic 1,100 - 2 h 
W1/O emulsion Room Ultra-turrax T25 24,000 30 min 10 min 
W1/O/ W2 emulsion Room Ultra-turrax T25 24,000 10 min 10 min 
(Solvent evaporation) Room Magnetic 400 - 20 h 
 
3.2 CHARACTERIZATION OF MICROSPHERES 
 
The conditions of each process corresponding to characterization of microspheres are shown 
below. These conditions were the same for all types of microspheres.  
 
3.2.1 SCANNING ELECTRON MICROSCOPY (SEM) 
 
The morphology of microspheres was investigated using a SEM and the conditions of Scanning 
Electron Microscopy are shown in the following Table 19. 
 
Table 19. Conditions of the Scanning Electron Microscopy. 
SAMPLE DIMENSIONS 2 x 1 cm
2
 
COATING Gold 
INTENSITY 30 Ma 
WORKING DISTANCE 60 mm 
PRESSURE 0.005 mbar 
TIME 130 s 
 
3.2.2 ENCAPSULATION EFFICIENCY 
 
Encapsulation efficiency was studied to know the ratio of amount of active compound entrapped 
in the dispersion. The experimental conditions of encapsulation efficiency determination of 
microspheres are shown in the following tables. Table 20 shows the conditions of the 
centrifugation process and Table 21 shows the conditions of UV/Vis Spectrophotometer. 
 
Table 20. Conditions of centrifugation process. 
SAMPLE VOLUME (mL) 2 
SPEED (rpm) 1,000 
CENTRIFUGATION TIME (min) 30 
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Table 21. Conditions of UV/Vis Spectrophotometer. 
ACTIVE  
COMPOUNDS 
 
PARAMETERS 
 
CAFFEINE 
 
IBUPROFEN 
 
GALLIC ACID 
CELL QUARTZ QUARTZ QUARTZ 
LIGHTPATH (mm) 10 10 10 
λ WAVELENGTH (nm) 273 263 269 
 
3.2.3 FOURIER TRANSFORM INFRARED SPECTROSCOPY (FTIR) 
 
FTIR was used to identify the chemical structure of the formulation of microspheres and to 
detect interactions between active agents and polymers and also, to determinate the changes 
on original polymers and forming microspheres as matrix. The conditions of Fourier Transform 
Infrared Spectroscopy are shown in the following Table 23. 
 
Table 23. Conditions of the Fourier Transform Infrared Spectroscopy. 
TABLET KBr 
SAMPLE CONCENTRATION  
(ACTIVE COMPOUND/KBr) 
 
1 % (w/w) 
WAVENUMBERS 500 - 4,000 cm-
1
 
RESOLUTION 4 cm-
1
 
CO-ADDING 20 scans 
 
3.2.4 PARTICLE SIZE DISTRIBUTION 
 
The conditions of Nanosizer to determine the particle size distribution are shown in the following 
Table 24. 
 
Table 24. Conditions of Nanosizer. 
MATERIAL MANAGER LIPOSOME 
DISPERSANT WATER 
CELL DTS 1060C – 
Clear disposable zeta cell 
T (ºC) 25 
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3.3 RESULTS AND DISCUSSION 
 
The results corresponding to each of the types of microspheres (caffeine, ibuprofen and gallic 
acid) are shown below. 
 
3.3.1 SEM – PLGA-MICROSPHERES WITH CAFFEINE 
 
The fabrics with caffeine PLGA-microspheres have been analyzed by SEM and the SEM 
micrographs are shown below.  
 
 
(a)                                                            (b) 
 
(c)                                                           (d) 
Figure 26. Scanning electron micrographs of PLGA-microspheres on cotton fabric. (a) PLGA-microspheres with 
caffeine (x50) (b) PLGA-microspheres with caffeine (x150). (c) cross-sectional picture of caffeine PLGA-microsphere 
(x600). (d) PLGA-microspheres without caffeine (x500). 
 
SEM micrographs of PLGA-microspheres with caffeine and void PLGA-microspheres confirmed  
what has been obtained. The adhesion between fabrics and PLGA-microspheres is given, since 
polyvinyl alcohol (PVA) acts as binder [84] between fabrics and PLGA-microspheres. Both of 
them have a spherical shape with a smooth surface due to PVA. Cross-sectional picture of 
caffeine (c)  is a good result to demonstrate that internally the PLGA-microspheres are all highly 
porous. 
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3.3.2 SEM – PCL-MICROSPHERES WITH IBUPROFEN 
 
Fabrics with ibuprofen PCL-microspheres have been analyzed by SEM and the SEM 
micrographs are shown below. 
 
 
(a)     (b) 
Figure 27. Scanning electron micrographs of PCL-microspheres on cotton fabric. (a) PCL-microspheres with 
ibuprofen (x400). (b) PCL-microspheres without ibuprofen (x500). 
 
It can be observed that the PCL-microspheres have been obtained and both maintain the same 
characteristics. These two micrographs (Figure 27) show that PCL-microspheres with a 
spherical shape smooth surface have been formed, composed of PVA, but internally are porous 
(although it is not appreciated in these micrographs). The surfaces layer of PVA acts as a binder 
[85] between PCL-microspheres and fabric. The way they are bonded as can be seen in the 
pictures. 
 
3.3.3 SEM-PCL MICROSPHERES WITH GALLIC ACID 
 
Cotton fabrics with gallic acid PCL-microspheres have been analyzed by SEM and the SEM 
micrographs are shown below. 
 
 
(a)     (b) 
Figure 28. Scanning electron micrographs of PCL-microspheres on cotton fabric. (a) microspheres with gallic acid 
(x400). (b) PCL-microspheres without gallic acid (x500). 
 
Both micrographs (Figure 28) show that PCL-microspheres have been formed with a spherical 
shape and smooth surface, composed of a PVA layer, but they are probably internally porous. 
PVA also acts as a binder [85] between PCL-microspheres and fabric and is clearly appreciated 
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in the picture (a).  
 
3.3.4 ENCAPSULATION EFFICIENCY – PLGA-MICROSPHERES WITH CAFFEINE 
 
Table 25 shows the caffeine encapsulation efficiencies. Three repetitions were carried out and 
the overall average was about 28% [86]. 
 
Table 25. Encapsulation efficiency of the caffeine PLGA-microspheres. 
Sample Encapsulation efficiency (%) 
1 27.97 
2 27.89 
3 27.97 
 
Encapsulation efficiencies achieved are remarkably low, and there is no literature to compare 
them with other encapsulation efficiencies and to establish whether the methodology followed is 
optimal or not. Therefore, further studies are needed to achieve stabilization of the caffeine in 
the polymer matrix, because of the greater affinity of this with the medium than with the polymer. 
 
3.3.5 ENCAPSULATION – PCL-MICROSPHERES WITH IBUPROFEN 
 
Table 26 shows ibuprofen encapsulation efficiencies, three repetitions were carried out and the 
overall average was about 84%. 
 
Table 26. Encapsulation efficiency of the ibuprofen PCL-microspheres. 
Sample Encapsulation efficiency (%) 
1 88.02 
2 82.32 
3 82.17 
 
According to the literature [87], the efficiency obtained is too high as shown in the results. Thus, 
it might ensure us that the designed method for preparation of ibuprofen PCL-microspheres is 
very efficient. 
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3.3.6 ENCAPSULATION EFFICIENCY – PCL-MICROSPHERES WITH GALLIC ACID 
 
Table 27 shows the gallic acid encapsulation efficiencies, three repetitions were carried out and 
the overall average was about 31%  [86]. 
 
Table 27. Encapsulation efficiency of the gallic acid PCL-microspheres. 
Sample Encapsulation efficiency (%) 
1 31.79 
2 33.83 
3 27.50 
 
The results show low efficiencies of encapsulation, but there are no references of similar studies  
on active compounds. Therefore, it not possible to assure whether the results are good or not. 
 
3.3.7  FTIR – PLGA-MICROSPHERES WITH CAFFEINE 
 
The results corresponding to FTIR analysis are shown below. Discussion will be based on two 
types of FTIR spectrum, the first one (Figure 29) is the comparison between polymer and void 
PLGA-microspheres, and the second one (Figure 30) is the comparison between PLGA-
microspheres with caffeine and caffeine. 
 
 
Figure 29.  FTIR spectrum of (a) PLGA polymer and (b) PLGA-microspheres without caffeine. 
 
Figure 29 shows the FTIR spectrum of (a) PLGA polymer and (b) PLGA-microspheres without 
caffeine. Several structural differences are obvious both characteristic frequencies movements 
of the components as defined in the characteristic peaks [88-90]. The frequencies between 
3550 and 3200 cm-1 are linked to the stretching O-H from the intermolecular and intramolecular 
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hydrogen bonds of PVA (dispersant of the microspheres) [91]. The vibrational band observed 
between 2840 and 3000 cm-1 refers to the stretching C-H from alkyl groups. The frequency of 
1758.54 cm-1 belonging to the strain carbonyl group (C=O stretching) is part of PLGA. It  has 
suffered a displacement and an increase in the bandwidth of the frequency (1736.53 cm-1) in the 
spectrum of PLGA-microspheres without caffeine. This movement is due to the presence of PVA 
in the PLGA-microspheres. Polymeric chain has also been modified. Similarly, the frequencies 
of the methyl group (1456.10 cm-1) of PLGA moves and increases the bandwidth in the 
frequency of 1438.86 cm-1 for PLGA-microspheres without caffeine. Also,   it is shown the 
minimum frequency shift of 1090.64 cm-1 (C-O-C asymmetric stretching) and 1272.84 cm-1 (C-
H) belonging to the PLGA regarding frequencies of 1092.54 cm-1 (C-O-C asymmetric stretching) 
and 1273.84 cm-1 (C-H) PLGA-microspheres without caffeine. Finally, the frequency of 1420.30 
cm-1 (C-H deformation caused by the link -O-CH2) of PLGA in the spectrum of the PLGA-
microspheres without caffeine has disappeared.  
 
These structural changes suggest that the PLGA polymer, which comes from a linear chain 
turns to a polymeric matrix form. 
 
 
Figure 30.  FTIR spectrum of (a) caffeine PLGA-microspheres and (b) caffeine. 
 
Figure 30 shows the FTIR spectrum of (a) caffeine PLGA-microspheres and (b) caffeine [92,93]. 
Comparing the spectrum of caffeine to caffeine PLGA-microspheres encapsulated in PLGA, 
many structural differences represented by the displacements of the characteristic frequencies 
of the components can be seen. In the frequencies between 3550 and 3200 cm-1, the signal 
produced by stretching O-H of PVA is again observed [91]. And also vibrational band between 
2840 and 3000 cm-1 is linked to the stretching C-H of PVA [91]. In the frequency of 1701.53 cm-
1, belonging to the tension of the carbonyl group (C=O stretching) as part of caffeine, there is a 
movement and an increased bandwidth of the frequency (1736.28 cm-1) in the spectrum PLGA-
microspheres containing caffeine. This influence is due to the presence of the polymer and PVA 
CHAPTER 3:  
PREPARATION OF MICROSPHERES AND THEIR CHARACTERIZATION 
67 
 
[91], because both have this bond in their structures. Another peak to note is 1661.58 cm-1 (C=N 
stretching) in the spectrum of caffeine. This  is very significant on the PLGA-microspheres with 
caffeine when there is no signal in the polymer or void PLGA-microspheres in this frequency 
(Figure 24). Moreover, the latter suffers a slight shift to a frequency of 1654.67 cm-1. These 
changes could be possibly assigned to an interaction between the oxygen atoms of carbonyl 
groups of the polymer and/or PVA and nitrogen atom from the caffeine molecule. Other 
important frequencies that are part from the structure of caffeine and, as in previous case, are 
identified the peaks corresponding to displacements, such as: CH3 asymmetric stretching 
(1456.4 cm-1, 1431. 23 cm-1 and 1359.64 cm-1), the C-N stretching (1286.53 cm-1) and cyclic 
C=N tension (1550.29 cm-1). 
 
3.3.8 FTIR – PCL-MICROSPHERES WITH IBUPROFEN 
 
Results corresponding to FTIR analysis are shown. There are two types of spectrum. The first 
one (Figure 31) shows the comparison between polymer and void PCL-microspheres, and the 
second one (Figure 32) corresponds to the comparison between ibuprofen and the PCL-
microspheres with ibuprofen. 
 
 
Figure 31. FTIR spectrum of (a) PCL-microspheres without ibuprofen and (b) PCL polymer. 
 
Figure 31 shows the FTIR spectrum of (a) PCL-microspheres without ibuprofen and (b) PCL 
polymer [94-95]. When comparing both spectrums, many structural differences can be seen in 
frequencies of the vibrational/rotational movements. The frequencies between 3550 and 3200 
cm-1 are belonging to the stretching O-H from the intermolecular and intramolecular hydrogen 
bonds of PVA (dispersant of the microspheres) [91]. The vibrational band observed between 
2840 and 3000 cm-1 refers to the stretching C-H from PVA alkyl groups . These peaks are also 
in the polymer PCLFrequency of 1728,16 cm-1, belongs to the tension of the carbonyl group 
(C=O stretching) as a part of the polymer and PVA. There is also a displacement corresponding 
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to an asymmetric movement, COC stretching, in the frequency of 1266,02 cm-1. These 
movements that occur during the process, are crucial to justify optimal formation of the PCL-
microspheres. PCL polymer has  changed from a linear chain to a polymeric matrix form. 
 
 
Figure 32.  FTIR spectrum of (a) PCL-microspheres with ibuprofen and (b) ibuprofen. 
 
Figure 32 shows the FTIR spectrum of (a) PCL-microspheres with ibuprofen and (b) ibuprofen 
[96-97]. As shown in the image of the different spectra, several characteristic frequencies that 
conform the spectral identify of the active compound disappear. The most important bonds in 
the ibuprofen molecule are the following ones: COOH (C=O stretching in the frequency of  
1231,19 cm-1 corresponding to C=O stretching (COOH) and O-H bending) and CH3 and the 
aromatic group in frequency of 1421,36 cm-1 (CH3 asymmetric bend). The spectrum of PCL-
microspheres with the active agent show the presence of PVA like in the previous Figure 31. 
Frequencies between 3550 and 3200 cm-1, show once again the signal produced by stretching 
O-H of PVA [91]. Moreover, the vibrational band between 2840 and 3000 cm-1 belongs to the 
stretching C-H of PVA [91]. In the frequency of 1720.39 cm-1, which belongs to the tension of the 
carbonyl group (C=O stretching) as part of ibuprofen, there is a movement and an increased 
bandwidth of the frequency (1736.28 cm-1) in the spectrum PCL-microspheres containing 
caffeine. This influence is due to the polymer and PVA [91], because both have this bond in their 
structures. This means that the PCL-microspheres spectrum is the addition between the active 
compound and the polymer, and, as a result, it is shown that ibuprofen is encapsulated in the 
polymer cores. It is important to consider that the ibuprofen has stearic hindrance, as it belongs 
to an aromatic group (range from 950 to 1006 cm-1). This can affect in the absorption signals of 
the molecule. For that reason, the signals corresponding to CH3 movements are not much 
representative in the spectrum, with a frequency of 1421,36 cm-1 (CH3 asymmetric bend). These 
specific peaks observed in the spectrum of PCL-microspheres characterize the ibuprofen being 
encapsulated. Therefore, the possible interaction between polymer (C=O stretching, 1732,04 
cm-1) and active compound (COOH, 1231,19 cm-1) could be by hydrogen bonds. 
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3.3.9 FTIR – PCL-MICROSPHERES WITH GALLIC ACID 
 
The results corresponding to FTIR analysis are shown below. There are two types of FTIR 
spectrum, the first one (Figure 33) is the comparison between polymer and void PCL-
microspheres, and the second one (Figure 34) is the comparison between gallic acid, void PCL-
microspheres and PCL-microspheres with gallic acid. 
 
 
Figure 33. FTIR spectrum of (a) PCL-microspheres without gallic acid and (b) PCL polymer. 
 
Figure 33 shows the FTIR spectrum of (a) PCL-microspheres without gallic acid and (b) PCL 
polymer [94-95]. It can be observed that the structure between both is almost the same, but  
there are some differences to be considered. It should be specially noted the movement of the 
groups C=O stretching (1728,37 cm-1), CH2 stretching (2865,46 cm
-1), symmetric CH3 stretching 
(1366,95 cm-1) and COC stretching (1243.76 cm-1, 1191.61 cm-1, 1107,16 cm-1) of PCL in regard 
to void PCL-microspheres. In the case of C=O stretching appears the same as the previous 
cases, because the presence of PVA is demonstrated. The characteristic frequencies of PVA 
are between 3550 and 3200 cm-1 belonging to the stretching O-H from the intermolecular and 
intramolecular hydrogen bonds and the vibrational band observed between 2840 and 3000 cm-1 
belonging to the stretching C-H from alkyl groups of PVA, these peaks also belong to the 
polymer PCL [91]. These movements show that the polymer changes from a linear structure to a 
closed spherical structure. 
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Figure 34.  FTIR spectrum of (a) PCL-microspheres with gallic acid, (b) gallic acid. 
 
Figure 34 shows the FTIR spectrum of (a) gallic acid PCL-microspheres and (b) gallic acid [98-
99]. As shown in the spectra, there are some differences between the PCL-microspheres and 
the active compound The most important bonds in the molecule of gallic acid are OH, COOH 
and the aromatic compound. The movements corresponding to these bonds are shown in the 
spectrum of PCL-microspheres. To be precise, in the frequency of 1700,97 cm-1 corresponding 
to carbonyl stretching (C=O),  the C=C stretching (1611,65 cm-1) and the CH2 stretching 
(1541,75 cm-1). Moreover, there is another important frequency corresponding to the ring 
vibration (1029,13 cm-1) which is hidden in the case of PCL-microspheres. The frequency 
belonging to C=O stretching is also from PVA [91], therefore, the presence of PVA is shown 
again in the spectrum of PCL-microspheres with gallic acid. In the OH range of frequencies 
between 3550 and 3200 cm-1 (corresponding to PVA [91]), there are some modifications in the 
spectrum of PCL-microspheres  with gallic acid in regard to void system. That modification 
suggests that the incorporation of gallic acid into the system add different –OH groups linked to 
aromatic ring (that fact can be seen in b)) to the general spectrum of the void PCL-
microspheres.  
 
These spectral changes demonstrate that the gallic acid may be inside of PCL-microspheres 
(as a consequence of these movements). Therefore it can be confirmed that there is a possible 
interaction between gallic acid and the polymeric matrix. Regarding to the molecular structure of 
these components, the interaction could be between OH bonds of gallic acid and C=O bonds of 
the polymer. 
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3.3.10 PARTICLE SIZE DISTRIBUTION – PLGA-MICROSPHERES WITH CAFFEINE 
 
The particle size distribution by intensity of PLGA-microspheres is shown in the following Figure 
35.  
 
 
Figure 35. Size distribution by intensity of caffeine PLGA-microspheres. 
 
Figure 35, shows three different intensities belonging to caffeine PLGA-microspheres. The most 
important of them is about 87.5% intensity and the average particle diameter is 159.1 nm. 
These results show that the PLGA-microspheres are less than 1 μm, which implies that PLGA- 
nanospheres are not achieved, instead of microspheres. 
 
The polydispersity value (0.925) is almost 1,  stating that there are many PLGA-microspheres 
with similar sizes. The PDI values range from 0 to 1 and higher values, indicates a less 
homogeneous particles size distribution. Therefore, the results indicate that microparticles which 
have been generated  have homogeneity in size distribution. 
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3.3.11 PARTICLE SIZE DISTRIBUTION – PCL-MICROSPHERES WITH IBUPROFEN 
 
The particle size distribution by intensity of PCL-microspheres is shown in the following Figure 
36. 
 
 
Figure 36. Size distribution by intensity of ibuprofen PCL-microspheres. 
 
The average particle diameter is 846.9 nm and so, the microparticles can be considered as 
PCL-microspheres, since they are about 1 µm. 
 
The polydispersity value is about 1.000 that means there are many PCL-microspheres with 
similar sizes, but with lower homogeneity than PLGA-microspheres with caffeine. 
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3.3.12 PARTICLE SIZE DISTRIBUTION – PCL-MICROSPHERES WITH GALLIC ACID 
 
The particle size distribution by intensity of PCL-microspheres is shown in the following Figure 
37. 
 
 
Figure 37. Size distribution by intensity of gallic acid PCL-microspheres. 
 
 
The average particle diameter is 851.9 nm and so, the microparticles can be considered as 
PCL-microspheres, because are about 1 µm. The polydispersity value is about 0.815, The 
results in this case indicate higher homogeneity in particle size distribution than in the other 
cases. 
 
3.4 CONCLUSIONS 
 
It has been shown that the microencapsulation of caffeine, ibuprofen and gallic acid  is possible. 
Furthermore, in the case of ibuprofen encapsulation high level of efficiency has been achieved 
compared to the literature [86]. Good results of efficiency corresponding to the encapsulation of 
caffeine and gallic acid have been obtained. Taking  into account that there is no much literature 
on this subject it might be a great progress in terms of technology. 
 
Frequencies movements from FTIR spectroscopy could give an idea of the possible interaction 
between PLGA - microspheres and caffeine (nitrogen bond), PCL – microspheres and ibuprofen 
(hydrogen bond), PCL – microspheres and gallic acid (hydrogen bond).  
 
SEM results show that all microspheres have a spherical shape and there are internally porous 
with external PVA layer, and this, moreover acts as a binder between fabric and the 
microspheres.  
 
The particle size distribution results show that all dispersions are homogeneous solutions with 
particle size average of 159.1 nm (PLGA-microspheres with caffeine), 846.9 nm (PCL-
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microspheres with ibuprofen) and 851.9 nm (PCL-microspheres with gallic acid). Therefore, 
these results show that ones are nanoparticles and the other are microparticles. 
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CHAPTER 4: IMPREGNATION OF MICROSPHERES ON TEXTILE SUBSTRATE 
 
 
4.1 PAD-DRY TECHNIQUE 
 
Microspheres were applied using Pad-Dry technique. The conditions required for this procedure 
are shown in the table below. These are the same for all types of microspheres. 
 
Table 28. Conditions of textile impregnation process. 
FINISHING CONDITIONS  
SUBSTRATE Fabric Cotton/Polyamide/Acrylic/Polyester 
FABRIC DIMENSIONS 25 x 40 cm
2
 
LIQUOR RATIO 3 – 5 L/Kg 
PICK-UP 80-90% 
DRYING CONDITIONS Room temperature 
 
4.2 RESULTS AND DISCUSSION 
 
The results belonging to % by weight (dry) of various treated fabrics significantly differ to the 
ones with the % permeation in the different solutions of microspheres. Results are shown below. 
 
4.2.1 PAD-DRY TECHNIQUE – PLGA-MICROSPHERES WITH CAFFEINE 
  
The results of the finishing process (pad-dry) corresponding to the application of the solution of 
caffeine PLGA-microspheres are shown in the following Table 29. 
 
Table 29. Results of the finishing process of several textile fabrics. 
Textile % Pick-up*  
 
% o.w.f.* 
 Dry product applied 
CO 83.37 2.37 
PA 80.94 1.75 
PAC 82.49 1.98 
PET 81.21 1.26 
* %pick-up, the theoretical percentage of product after impregnation; and % o.w.f. (over weight of fibres) of product 
applied, calculated by weight difference between dry non-treated textile and dry textile after Pad-Dry process. 
 
These results show that the fabrics absorb the solution of PLGA-microspheres, but the o.w.f 
values are very low, which means that the amount of PLGA-microspheres on the fabrics is not 
really high. There might be two main reasons explaining this behavior: either the low efficiency 
in the preparation process of PLGA-microspheres or the affinity of the system. 
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The most important characteristic parameters controlling the affinity of the fabrics with other 
components is zeta potential. Zeta potential is not a constant value for textiles, but it gives 
information about the nature and dissociation of functional groups, hydrophilicity or 
hydrophobicity of the fibre surface, as well as the ions or water sorption. Zeta potential plays an 
important role in the electrical characterization of textiles in wet processing. In general, specific 
adsorption of ions or dissociation of surface groups in aqueous solution results in a surface 
charge. Fibre surface charge depends on the molecular and supramolecular structure and 
swelling capacity, as well as on ionogenity, structure and concentration of adsorbate. Wet 
treatments change the fibre surface charge as well as zeta potential and adsorption ability [100]. 
 
According to the existing literature on this subject [99] (Table 30), zeta potentials for the 
standard fabrics at pH 10 are all different and due to the different chemical and structural 
composition of the textile materials. In Table 30, it different values of zeta potential according to 
standard fabrics, taken from the literature available [100] and also the zeta potential value of 
PLGA-microspheres (measured values from nanosizer) are shown. 
 
Table 30. Zeta potential values of the standard fabrics [100] and measured zeta potential value of PLGA-
microspheres with caffeine. 
Textile ξ- potential (mV)  
CO -24.50  
PA -42.00  
PAC -55.50  
PET -69.00  
PLGA-microspheres with 
caffeine 
-17.30  
 
 
Polyester fabric displayed the most negative zeta potential (–69.00 mV). Zeta potential is higher 
in hydrophobic fabrics than hydrophilic fabrics, due to the hydration capacity. Cotton fabric has 
the lowest zeta potential (–24.50 mV). These fibres are negatively charged due to the presence 
of hydroxy and carboxy groups. The functional groups influence the zeta potential, but fibre’s 
swelling has also an important role. Interfibrillar swelling enlarges the surface area, and causes 
the shift of the shear plane into the liquid phase lowering the zeta potential. Polyamide has 
numerous carboxylate groups and also a large number of other chargeable groups, including 
nitrogen-containing groups;  all these groups result in a high zeta potential (-42.00 mV). The 
zeta potential of acrylic lies between the values for polyester and polyamide at –55.50 mV. As 
hydrophobic acrylic fabric has a high zeta potential, the presence of sulphonate groups in this 
fabric influences on the absorbability of polyelectrolyte [100]. 
 
Results show that he PLGA-microspheres have a low zeta potential if they are compared to 
fabrics. Thus, the affinity between them according to this parameter should decrease when zeta 
potential value of the fabrics is high. Therefore, the measured values of o.w.f are  the ones 
expected: the value of o.w.f in cotton fabrics is the highest value obtained respect to other sort 
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of fabrics. For this reason, it is important to consider another important parameter: the chemical 
structure of polymer. Although, the behavior of the PLGA-microspheres containing PVA on its 
surface with the fabrics will be more affected by the chemical structure than the polymer matrix. 
The PLGA polymer has an amorphous structure and less hydrophobic than the PCL, therefore, 
results show that the affinity with the fabrics increases when their hydrophilicity is higher [20-23]. 
 
4.2.2 PAD-DRY TECHNIQUE – PCL-MICROSPHERES WITH IBUPROFEN 
 
The results of the finishing process (pad-dry) corresponding to the application of the solution of 
ibuprofen PCL-microspheres are shown in the following Table 31. 
 
Table 31. Results of the finishing process of several textile fabrics. 
Textile % Pick-up* 
 
% o.w.f.* 
Dry product applied 
CO 76.13 4.30 
PA 80.20 4.36 
PAC 81.79 4.64 
PET 77.65 5.65 
* %pick-up, the theoretical percentage of product after impregnation; and % o.w.f. (over weight of fibres) of product 
applied, calculated by weight difference between dry non-treated textile and dry textile after Pad-Dry process. 
 
Results differ depending on the fabric being treated, due to fabric affinity with the PCL-
microspheres, like in the previous case. However, the tendency is the opposite respect to the 
previous case, since the polyester has given the highest value.  For this reason, in the following 
table (Table 32) the zeta potential values of the standard fabrics, as previously observed, and 
the zeta potential of ibuprofen PCL-microspheres are shown.   
 
Table 32. Zeta potential values of the standard fabrics [100] and measured zeta potential value of PCL-microspheres 
with ibuprofen. 
Textile 
ξ- potential 
(mV) 
 
CO -24.50  
PA -42.00  
PAC -55.50  
PET -69.00  
PCL-microspheres with 
ibuprofen 
-3.380  
 
 
Results show, that PCL-microspheres with ibuprofen have a really low zeta potential respect to 
the fabrics. Thus, the affinity between them, according to this parameter should be similar in all 
cases, because the zeta potential differences are relevant. the value of o.w.f in polyester fabric 
is the highest, therefore, respect to previous studies with PLGA-microspheres with caffeine, the 
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same effects can be shown in this case. Since, the PCL polymer has a crystalline structure and 
it is highly hydrophobic, the affinity with polyester fabric is higher than with the rest of fabrics 
[20-23]. 
 
4.2.3  PAD-DRY TECHNIQUE – PCL-MICROSPHERES WITH GALLIC ACID 
 
The results of the finishing process (pad-dry) corresponding to the application of the solution of 
gallic acid PCL-microspheres are shown in the following Table 33. 
 
Table 33. Results of the finishing process of several textile fabrics. 
Textile % Pick-up* 
 
% o.w.f.* 
Dry product applied 
CO 82.52 1.51 
PA 79.84 1.55 
PAC 83.52 1.72 
PET 83.19 2.51 
* %pick-up, the theoretical percentage of product after impregnation; and % o.w.f. (over weight of fibres) of product 
applied, calculated by weight difference between dry non-treated textile and dry textile after Pad-Dry process. 
 
It can be observed that the impregnation (dry) value of the cotton fabric is the lowest of while 
polyester fabric has the highest value. The most important factors (such as the efficiencies and 
the affinities of the fabric with the PCL-microspheres) are the same as in previous cases, 
 
The tendency of o.w.f is really similar to the previous case (PCL-microspheres with ibuprofen). 
The different values of zeta potential belonging to standard fabrics again [100] and PCL-
microspheres with gallic acid  are shown in Table 34.  
  
Table 34. Zeta potential values of the standard fabrics [100] and measured zeta potential value of PCL-microspheres 
with gallic acid. 
Textile 
ξ- potential 
(mV) 
 
CO -24.50  
PA -42.00  
PAC -55.50  
PET -69.00  
PCL-microspheres with 
gallic acid 
-7.450  
 
Results show that the PCL-microspheres with gallic acid have a really low zeta potential respect 
to the fabrics, but in this case, they are a little bit higher than the PCL-microspheres with 
ibuprofen. Thus, the same conclusion as in  the previous case can be reached, namely, the 
affinity between them according to this parameter should be similar in all cases  since the 
differences of zeta potential are high. And, for the same reason, as in the case of PCL-
microspheres with ibuprofen, the effect of the chemical structure is important, since the 
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tendency is really similar between each other. For this reason, the PCL-microspheres in both 
cases have higher affinity with polyester fabric than the rest [20-23]. 
 
It can be seen that due to they are complex systems, it cannot be demonstrated that the zeta 
potential is the most important effect in these systems. 
 
4.3 CONCLUSIONS 
 
The results in the case of the PLGA-microspheres with caffeine are opposite to the results from 
the test on  gallic acid and ibuprofen, therefore it can be demonstrated that the most important 
factor is the affinity between fabrics and microspheres, Both PLGA and PCL are polyesters, but 
they have different chemical structures [20-23]. Besides that, the zeta potential [100] which 
depends also on the chemical structure is one important parameter to consider regarding to the 
affinity of the system . PCL is a crystalline polymer and highly hydrophobic, however the PLGA 
polymer is amorphous and less hydrophobic than PCL. According to that, zeta potential values 
in the case of PCL-microspheres are smaller  than PLGA-microspheres. For this reason, PLGA-
microspheres  have higher affinity with cotton fabric than with the rest, and on the contrary, 
PCL-microspheres have more affinity with polyester, since PCL is more hydrophobic than 
PLGA. 
 
There are small differences between PCL-microspheres with ibuprofen and the ones of gallic 
acid. However, zeta potential values for both are quite different. Affinity in the case of PCL-
microspheres with ibuprofen is higher than the PCL-microspheres with gallic acid due to the 
difference of the zeta potential values between fabrics and microspheres. 
CHAPTER 5: 
ANALYSIS OF DRUG RELEASE 
80 
 
CHAPTER 5: ANALYSIS OF DRUG RELEASE 
 
 
5.1 DRUG RELEASE ESSAY 
 
Drug release essay consists on submerging the treated fabrics into thermostatized vessels filled 
with deionized water or physiological saline at semi-infinite bath conditions at a temperature of 
37ºC. (Described in Chapter 2. (2.5.4.)). 
 
The experimental conditions of Drug Release are shown below. These are the same for all type 
of microspheres. 
 
Table 35. Conditions of Drug Release essay. 
WEIGHT SAMPLE (g) 1 
VOLUME OF MEDIUM (mL) 100 
MEDIUM TYPES DEIONIZED WATER OR  
PHYSIOLOGICAL SALINE 
T (ºC) 37 
BATH CONDITIONS SEMI-INFINITE 
 
5.2 RESULTS AND DISCUSSION 
 
Experimental results are treated following two different types of modification approaches: 
phenomenological models based on Theoretical Mechanisms of Drug Release and quantitative 
following Semi-empirical Equations, in order to know the mechanism of drug release for each 
kind of system (Tables 36, 37 and 38). 
 
5.3 THEORETICAL MECHANISMS OF DRUG RELEASE 
 
Results corresponding to the mechanisms of Drug Release for different systems according to 
Figure 8 are shown below. 
 
5.3.1 THEORETICAL MECHANISMS – PLGA-MICROSPHERES WITH CAFFEINE 
 
From the results shown in the following graphics (Figures 38 - 41), the caffeine release from 
PLGA-microspheres of all treated fabric samples (CO, PA, PAC and PET) seems to be 
characterized by a bimodal behavior [101-102]. Because, there are two clear stages in the rate 
of delivering. The first one is very quick and afterwards, there is a very slow increase on bath 
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concentration. 
 
 
Figure 38. Kinetic release of PLGA-microspheres with caffeine applied onto cotton fabric at 37ºC according the 
experimental medium. Mt (g caffeine/ g fabric). 
 
 
 
Figure 39. Kinetic release of PLGA-microspheres with caffeine applied onto polyamide fabric at 37ºC according the 
experimental medium. Mt (g caffeine/ g fabric). 
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Figure 40. Kinetic release of PLGA-microspheres with caffeine applied onto acrylic fabric at 37ºC according the 
experimental medium. Mt (g caffeine/ g fabric). 
 
 
 
Figure 41. Kinetic release of PLGA-microspheres with caffeine applied onto polyester fabric at 37ºC according the 
experimental medium. Mt (g caffeine/ g fabric). 
 
Comparison of different kinetic profiles from the theoretical curves (A, B, C and D) is illustrated 
in Figure 8. The behavior of the different fabrics, regardless the media is similar to the 
theoretical curve B/D. This bimodal kinetic profile could be explained by a burst effect and a part 
of the drug entrapped in the polymeric matrix, which requires a longer time for degradation. 
 
It can be seen that the amount of caffeine released is lower in physiological saline solution than 
in deionized water for all fabrics. Therefore, the influence of the medium is really important. In 
the case of physiological saline medium, saline ions can interact with the system showing 
different behaviors [20]. The release of caffeine may be inhibited due to interactions between 
the system (caffeine, PLGA-microspheres and fabrics) and ions of physiological saline, as a 
result, the percentage of caffeine released is lower than in the deionized water medium. 
Moreover, the solubility of caffeine is 16 mg/mL, and therefore, this active agent will be more 
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stable in water than in saline medium.  
 
According to the polymer, PLGA degrades fast and in saline medium its degradation increases. 
For this reason, the burst effect is big and the amount of caffeine released is low over time in all 
cases [20, 23]. 
 
5.3.2 THEORETICAL MECHANISMS – PCL-MICROSPHERES WITH IBUPROFEN 
 
The ibuprofen release from PCL-microspheres of all treated fabric samples (CO, PA, PAC and 
PET) is also characterized by a bimodal behavior depending on the type of fabric as shown in 
following figures. 
 
 
Figure 42. Kinetic release of PCL-microspheres with ibuprofen applied onto cotton fabric at 37ºC according the 
experimental medium. Mt (g ibuprofen/ g fabric). 
 
 
 
Figure 43. Kinetic release of PCL-microspheres with ibuprofen applied onto polyamide fabric at 37ºC according the 
experimental medium. Mt (g ibuprofen/ g fabric). 
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Figure 44. Kinetic release of PCL-microspheres with ibuprofen applied onto acrylic fabric at 37ºC according the 
experimental medium. Mt (g ibuprofen/ g fabric). 
 
 
 
Figure 45. Kinetic release of PCL-microspheres with ibuprofen applied onto polyester fabric at 37ºC according the 
experimental medium. Mt (g ibuprofen / g fabric). 
 
When comparing these results to the caffeine results, there is an inverse effect. In the case of 
Ibuprofen, the amount of active compound released is higher in physiological saline solution 
than in deionized water for all the fabrics except for cotton. The behaviour of the fabrics in water 
medium is similar to the theoretical curve D and in saline medium is like theoretical curve 
between B/C. Although in general terms  there is always a burst effect, but is even more evident 
in the case of the physiological saline medium, since the saline medium accelerates the 
polymer degradation [20]. 
 
Polyamide and cotton have a behaviour that suggest two curves on the same curve in the 
physiological medium and in cotton. Such phenomena is also observed in the deionized water. 
Probably it is due to changes on surface potential because cotton and polyamide have different 
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superficial characteristics and liquid absorption percentages. In the case of cotton, the 
absorption of water is higher compared to other fabrics, moreover its zeta potential is about -
24.50 mV, the lowest one. For these reasons, the behaviour of the caffeine released from cotton 
in both media is similar. However, in the physiological saline medium the ibuprofen released is 
slower than in water. This can be for the affinity of the ibuprofen, because both the zeta potential 
of PCL-microspheres with ibuprofen (-3.38 mV) and  the zeta potential of the cotton and 
polyamide, -24.50 mV and -42.00 mV respectively have high differences between each other. 
Therefore, it seems that the ions from saline medium can interact with the system and inhibit the 
release of ibuprofen [20], which leads to a release system in two steps.  
 
In the case of polyamide, it does not happen the same phenomena in deionized water. This is 
due to the different fabric features. The surface of polyamide fabric is more chargeable the 
cotton fabric’s one, thus it seems that the physiological saline medium interacts [20] more than 
the one with deionized water due to the saline ions. Water can produce the solvation 
phenomena to the chargeable surface, which, at the same time,  can avoid ibuprofen release. 
Moreover, since  this active agent is partially soluble in water, it can behave with further stability 
inside the system than in water medium. 
 
In the cases of acrylic and polyester fabrics, the amount of active agent released is lower than 
the other ones. The influence of the different characteristics of fabrics and PCL-microspheres 
with ibuprofen are obvious: when the value of zeta potential increases, the amount of released 
ibuprofen goes down. The zeta potential of both fabrics is higher, therefore the inhibition effect 
of saline ions increases. In the case of polyester fabric, the behaviour is similar in both media, 
because this sort of fabric has a high zeta potential and consequently it is the most hydrophobic 
and thus less absorbed. There is a difference between the media in this case:  the burst effect is 
slower in water than in saline medium. This effect is observed in all type of fabrics. As previously 
noted, ibuprofen is partially soluble in water, and this implies a bigger delay of ibuprofen release 
in water. 
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5.3.3 THEORETICAL MECHANISMS – PCL-MICROSPHERES WITH GALLIC ACID 
 
The results of gallic acid release from PCL-microspheres of all treated fabric samples (CO, PA, 
PAC and PET) are shown in the following figures. 
 
 
Figure 46. Kinetic release of PCL-microspheres with gallic acid applied onto cotton fabric at 37ºC according the 
experimental medium. Mt (g gallic acid/ g fabric). 
 
According to Figure 8, cotton fabric behaviours in water or saline medium are similar to the 
theoretical curve B due to an important burst effect. Respect to caffeine case, it can be seen the 
same tendency but with a contrary effect. Since, the gallic acid release is higher in physiological 
saline than in water. The solubility of gallic acid in water is really lower (11.50 mg/mL) than 
caffeine, but higher than ibuprofen. And also, this active agent has 3 hydroxil groups and 1 
carboxyl group that can interact more with water (solvation phenomena). For those reasons,  
release is higher in saline medium than in water.  
 
 
Figure 47. Kinetic release of PCL-microspheres with gallic acid applied onto polyamide fabric at 37ºC according the 
experimental medium. Mt (g gallic acid/ g fabric). 
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The results in this case show that gallic acid behavior is really different in each medium. The 
release in water is close to theoretical curve B, but in physiological saline it is close to curve D. 
The influence of saline medium is evident, since due to the low solubility of gallic acid, it is more 
stable in a medium saline. Moreover, the type of the fabric is important, because polyamide has 
a chargeable surface allowing a solvation phenomena of water and giving a gradual increase of 
the gallic acid released over time. 
 
 
Figure 48. Kinetic release of gallic acid microspheres applied onto acrylic fabric at 37ºC according the experimental 
medium. Mt (g gallic acid/ g fabric). 
 
 
 
Figure 49. Kinetic release of PCL-microspheres with gallic acid applied onto polyester fabric at 37ºC according the 
experimental medium. Mt (g gallic acid/ g fabric). 
 
These fabrics (acrylic and polyester)show similar behaviours, because both have similar 
features. In both media, the theoretical model is between the types B and D. Burst effect can be 
observed again and it is more evident in the physiological saline than in water. As previously 
developed, the solubility of gallic acid in water is low and also its chemical structure, and 
therefore the release will be slower in water than in physiological saline. The amount of gallic 
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acid released in the physiological saline, from acrylic and polyester fabrics, is lower than in the 
rest of fabrics. Therefore, the influence of the medium [19] in the system  can be shown  : both 
fabrics have a high zeta potential value and the saline ions can have easily interacted with them 
or with PCL-microspheres. As a result, the release of the active compound  can be inhibited 
over time. 
 
5.4 POWER LAW 
 
The results corresponding to Power Law Equation (1) for different systems are shown below. 
 
5.4.1 POWER LAW – PLGA-MICROSPHERES WITH CAFFEINE 
 
It has been taken under consideration the two steps described in the discussion of graphics, just 
for that reason, it would be assumed that the fabrics have two behaviors and were treated in 
two steps, short times (K1) (Table 36) and long times (K2) (Table 37). Using Eq. (1), the value of 
the exponent n, indicative of kind of mass transport mechanism was calculated.  
 
Table 36. Estimated parameters, short times (K1) and n values obtained from fitting drug release experimental data to 
Power Law (Eq. (1)). 
Fabric 
type 
T 
(ºC) 
Classification 
(Figure 5) 
Experimental 
medium 
K1 n1 R
2 Drug Delivery 
System 
CO 
37 B/D Deionized water 0.4676 0.2273 0.9741 Fickian diffusion 
37 B/D Physiological saline 0.2371 0.4909 0.9139 Fickian diffusion 
PA 
37 B/D Deionized water 0.5981 0.0881 0.8912 Fickian diffusion 
37 B/D Physiological saline 0.4826 0.0913 0.9848 Fickian diffusion 
PAC 
37 B/D Deionized water 0.5064 0.2588 0.8934 Fickian diffusion 
37 B/D Physiological saline 0.1467 0.6825 0.9439 
Anomalous 
diffusion 
PET 
37 B/D Deionized water 0.6786 0.0265 0.9220 Fickian diffusion 
37 B/D Physiological saline 0.3929 0.1070 0.9398 Fickian diffusion 
 
From experimental results, K1 values are, higher in deionized water than in physiological saline 
solution for all samples checked, except for polyamide fabric (similar values in both media). It 
happens the same with n, although in the opposite  direction happens. Nevertheless, most of 
the samples prepared, except for PAC, show Fickian diffusion mechanism, as it was expected 
(Table 36) [28,31-41]. 
 
It can also be demonstrated the influence of saline solution [20], since this can interact and 
change the release behaviour in all cases. 
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Table 37. Estimated parameters, long times (K2) and n values obtained from fitting drug release experimental data to 
Power Law (Eq. (1)). 
Fabric 
type 
T 
(ºC) 
Classification 
(Figure 8) 
Experimental 
medium 
K2 n2 R
2
 
Drug 
Delivery 
System 
CO 
37 B/D Deionized water 0,7276 0,0382 0.9255 
Fickian 
diffusion 
37 B/D 
Physiological 
saline 
0,5487 0,0620 0.9356 
Fickian 
diffusion 
PA 
37 B/D Deionized water  0,6979 0,0390 0.9118 
Fickian 
diffusion 
37 B/D 
Physiological 
saline 
- - 0.8901 - 
PAC 
37 B/D Deionized water 0,8270 0,0142 0.8949 
Fickian 
diffusion 
37 B/D 
Physiological 
saline 
0,4953 0,0642 0.9201 
Anomalous 
diffusion 
PET 
37 B/D Deionized water - - 0.9303 - 
37 B/D 
Physiological 
saline 
0,1902 0,4714 0.9290 
Fickian 
diffusion 
 
Some of the systems checked don’t allow finding these second constants, as PA in physiological 
saline solution and PET in deionized water. In cotton and acrylic, the results show the same 
tendency observed in K1, while constants obtained in deionized water are higher than the ones 
in physiological saline solution. The values of n also follow the same tendency observed in early 
stages of delivery process and they are  higher in physiological saline solution than in deionized 
water. 
 
In the two stages of  the delivery process, the values of K and n follow a similar behaviour when 
treated with of PLGA-microspheres with caffeine.   
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5.4.2 POWER LAW – PCL-MICROSPHERES WITH IBUPROFEN 
 
The value of the exponent n (indicative of mass transport mechanism) was calculated using Eq. 
(1), and the results are shown below (Table 38). 
 
Table 38. Estimated parameters, (K) and n values obtained from fitting drug release experimental data to Power Law 
(Eq. (1)). 
 
 
According to correlation coefficients obtained for all fabrics, it can be deduced that ibuprofen 
release from PCL-microspheres could be explained using power law models in only one stage. 
 
The results from cotton and polyamide show that K values are higher in physiological saline 
than in water. However, in the case of polyester and acrylic fabrics, the values are the contrary: 
higher in water than in saline medium. That fact could be attributed to a possible surface 
potential equilibrium, because cotton and polyamide have better absorption  than acrylic and 
polyester fabrics. It can be shown that burst effect is more important when the surface is 
charged by electrolytes from the saline medium than when water molecules are the only ones 
being absorbed. Therefore, this means that the influence of the chemical structure of ibuprofen 
is also important, since ibuprofen shows better stability in physiological saline than in water due 
to its low solubility in water (0.14 mg/mL). 
 
Fabric type 
T 
(ºC) 
Classification 
(Figure 8) 
Experimental 
medium 
K n R
2
 Drug Delivery System 
CO 
37 D Deionized water 0,0860 0,2948 0.9077 Fickian diffusion 
37 B 
Physiological 
saline 0,3313 0,1288 
0.9272 Fickian diffusion 
PA 
37 D Deionized water  0,0567 0,3805 0.9568 Fickian diffusion 
37 B/C 
Physiological 
saline 0,3159 0,1368 
0.9619 Fickian diffusion 
PAC 
37 D Deionized water 2,9424 0,3109 0.9272 Fickian diffusion 
37 B/C 
Physiological 
saline 0,3734 0,1258 
0.9614 Fickian diffusion 
PET 
37 D Deionized water 2,8987 0,3034 0.9299 Fickian diffusion 
37 B/C 
Physiological 
saline 0,3474 0,1335 
0.9862 Fickian diffusion 
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5.4.3 POWER LAW – PCL-MICROSPHERES WITH GALLIC ACID 
 
The analyzed fabrics have two different behaviors and were treated in two steps, like in the 
caffeine case, short times (K1) (Table 39) and long times (K2) (Table 40). Using Eq. (1), the value 
of the exponent n, indicative of mass transport mechanism was calculated. 
 
Table 39. Estimated parameters, short times (K1) and n values obtained from fitting drug release experimental data to 
Power Law (Eq. (1)). 
Fabric type T (ºC) 
Classification 
(Figure 8) 
Experimental 
medium 
K1 n1 R
2
 
Drug 
Delivery 
System 
CO 
37 B Deionized water 0.3186 0.3017 0.9182 
Fickian 
diffusion 
37 B 
Physiological 
saline 
0.6394 0.1392 0.9788 
Fickian 
diffusion 
PA 
37 B Deionized water 0.1378 0.4431 0.9629 
Fickian 
diffusion 
37 D 
Physiological 
saline 
0.4453 0.1771 0.9726 
Fickian 
diffusion 
PAC 
37 B/D Deionized water 0.1368 0.5100 0.9778 
Fickian 
diffusion 
37 B/D 
Physiological 
saline 
0.3428 0.3877 0.9033 
Fickian 
diffusion 
PET 
37 B/D Deionized water 0.4141 0.2220 0.8511 
Fickian 
diffusion 
37 B/D 
Physiological 
saline 
0.4068 0.3126 0.9691 
Fickian 
diffusion 
 
 
Release mechanisms of gallic acid from PCL-microspheres in all samples was governed by 
Fickian diffusion, as shown in Table 39. 
 
As it happens in with caffeine trial, when fitting this mathematical model to the experimental 
results obtained, delivery data must be spread into two different stages: short times (more 
linear) and long times (different tendencies). The high values of regression coefficients obtained, 
confirm the rightness of the hypothesis. 
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Table 40. Estimated parameters, long times (K2) and n values obtained from fitting drug release experimental data to 
Power Law (Eq. (1)). 
Fabric type T (ºC) 
Classification 
(Figure 8) 
Experimental 
medium 
K2 n2 R
2
 
Drug 
Delivery 
System 
CO 
37 B Deionized water 0.4729 0.1052 0.9321 
Fickian 
diffusion 
37 B 
Physiological 
saline 
0.7323 0.0490 0.9370 
Fickian 
diffusion 
PA 
37 B Deionized water  0.2313 0.2351 0.9877 
Fickian 
diffusion 
37 D 
Physiological 
saline 
0.6990 0.0568 0.9036 
Fickian 
diffusion 
PAC 
37 B/D Deionized water 0.2468 0.2256 0.9041 
Fickian 
diffusion 
37 B/D 
Physiological 
saline 
0.6877 0.0623 0.9274 
Fickian 
diffusion 
PET 
37 B/D Deionized water 0.2443 0.2273 0.9077 
Fickian 
diffusion 
37 B/D 
Physiological 
saline 
0.8553 0.0194 0.9528 
Fickian 
diffusion 
 
In long times, the mechanism of gallic acid delivery is governed by Fickian diffusion in all 
samples as shown table 40.  
 
At early stages, K values are higher in saline solution. CO and PA show significant differences 
that become smaller in the case of PAC and close to zero for PET. However, when long periods 
of time are taken, behavior converges to only one tendency. There are significant differences 
between K values in the two media of delivery and higher values for physiological saline 
solution. The important reason is the chemical structure of gallic acid, since the presence of the 
polar groups (3 hydroxyl and one carboxylic) can make it be more stable in a saline medium.   
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5.5 KORSENMEYER-PEPPAS EQUATION APPROXIMATION AND HIGUCHI MODEL 
 
Since the release mechanism of active compound follows a Fickian diffusion, both the Higuchi 
(Eq. (2)) governed by this mechanism and the approach of Korsenmeyer-Peppas (Eq. (3)) for 
plane surfaces, have been assumed. Parameters corresponding to these equations for different 
systems and according to the experimental medium are shown in the same table, due to the 
mathematical relation that exists between them. 
 
5.5.1 KORSENMEYER-PEPPAS EQUATION APPROXIMATION AND HIGUCHI MODEL – 
PLGA-MICROSPHERES WITH CAFFEINE 
 
Using Eq. (2) and Eq. (3), KH and D/δ
2parameters , respectively , (as apparent diffusion 
coefficients), are shown in Table 41. 
 
Table 41. Estimated parameters applying Higuchi Equation (2) and Korsenmeyer-Peppas equation approximation (3). 
 
  
 
 
 
 
 
 
 
 
From the results of Table 41, regression coefficients almost 1, which assures that the model is 
right for these experimental results.  
 
In the case of acrylic and polyester fabrics, the most conducive medium to the mass transport of 
caffeine is deionized water.  Acrylic and polyester samples have bigger mass transfer 
coefficients than cotton and polyamide. That fact could probably be attributed to the differences 
on hydrophility of fabrics and/or zeta potential values. Mass transfer coefficient  of polyamide in 
the deionized water medium,  is greater than in saline solution, and although values are much 
lower than in acrylic and polyester, cotton  almost behaves in quite the opposite way.  
 
The effect of media is important because kinetic parameters are different. The mass transfer 
coefficient is lower in deionized water than in physiological saline. The release of caffeine may 
be inhibited, due to some interactions between system carboxyl groups and ions of 
physiological saline [20]. Both PA and PET have this group in their structure, as well as the 
PLGA-microspheres and the active agent. However, CO and PAC have higher values than the 
others, since they do not have carbonyl groups in their chemical structures. 
Fabric type T (ºC) Experimental medium D/δ
2
 KH R
2
 
CO 
37 Deionized water 0.0116 0.2429 0.9193 
37 Physiological saline 0.0162 0.2875 0.9877 
PA 
37 Deionized water 0.0084 0.2072 0.9052 
37 Physiological saline 0.0070 0.1893 0.9848 
PAC 
37 Deionized water 0.0289 0.3836 0.9817 
37 Physiological saline 0.0137 0.2639 0.9439 
PET 
37 Deionized water 0.0264 0.3663 0.9072 
37 Physiological saline 0.0079 0.2004 0.9947 
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5.5.2 KORSENMEYER-PEPPAS EQUATION APPROXIMATION AND HIGUCHI MODEL – 
PCL-MICROSPHERES WITH IBUPROFEN 
 
Using Eq. (2) and Eq. (3), KH and D/δ2 parameters , respectively , (as apparent diffusion 
coefficients), are shown in Table 42. 
 
Table 42. Estimated parameters applying Higuchi Equation (2) and Korsenmeyer-Peppas equation approximation 
(Eq. (3)). 
Fabric type T (ºC) Experimental medium D/δ
2
 KH R
2
 
CO 
37 Deionized water 0.0002 0.0355 0.9053 
37 Physiological saline 0.0036 0.1346 0.9128 
PA 
37 Deionized water 0.0003 0.0383 0.8642 
37 Physiological saline 0.0030 0.1240 0.9392 
PAC 
37 Deionized water 0.1158 0.7678 0.8872 
37 Physiological saline 0.0042 0.1460 0.9082 
PET 
37 Deionized water 0.1031 0.7246 0.9384 
37 Physiological saline 0.0037 0.1373 0.9319 
 
Regression coefficients are good enough to consider that the model fits experimental results. 
 
It can be observed that in the case of cotton and polyamide the  tendency is similar: they both 
have almost the same apparent diffusion coefficient in two media. On the contrary, in the case of 
acrylic and polyester the results observed are quite far from cotton and polyamide but they are 
quite close one to each other. For this reason, it is important to take into account the properties 
of the fabrics, the hydrophilic fabrics (cotton and polyamide) retain more microspheres than 
hydrophobic fabrics (acrylic and polyester). Besides that, in saline medium [20], mass transfer 
coefficients are lower than in water in all cases. And, as above mentioned, the saline medium 
can interact with the system and inhibit the release of the active compound and hence, the 
values are low and release is slower than in water. 
 
However, it is not only a matter of microcapsules affinity in the different media, but an 
equilibrium between desorption of active compound, re-absorption by fabrics and the final 
release to corresponding medium.  
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5.5.3 KORSENMEYER-PEPPAS EQUATION APPROXIMATION AND HIGUCHI MODEL – 
PCL-MICROSPHERES WITH GALLIC ACID 
 
Using Eq. (2) and Eq. (3),  KH and D/δ
2parameters , respectively , (as apparent diffusion 
coefficients), are shown in Table 43. 
 
Table 43. Estimated parameters applying Higuchi Equation (2) and Korsenmeyer-Peppas equation approximation 
(Eq. (3)). 
Fabric type T (ºC) Experimental medium D/δ
2
 KH R
2
 
CO 
37 Deionized water 0.0004 0.0446 0.9976 
37 Physiological saline 0.0024 0.1101 0.9762 
PA 
37 Deionized water 0.0026 0.1143 0.9833 
37 Physiological saline 0.0014 0.0846 0.9741 
PAC 
37 Deionized water 0.0045 0.1507 0.9974 
37 Physiological saline 0.0160 0.2855 0.9435 
PET 
37 Deionized water 0.0088 0.2123 0.9774 
37 Physiological saline 0.0149 0.2754 0.9737 
 
 
Regression coefficients obtained show that Higuchi model is a accurate approach to fit the 
experimental results. 
 
In the case of gallic acid, the mass transfer coefficient shows the differences between saline 
medium and deionized water medium, stating that  the value obtained for physiological saline 
solution is higher, except for the case of polyamide fabric. This shows that the saline medium 
can be considered an important factor in these systems, since it allows interaction.  
 
In water deionized medium, the release of gallic acid is faster in polyester fabrics than in other 
sort of fabrics, where release is lower (depending on hydrophilicity/hydrophobicity). In 
physiological saline, the behaviour is totally different, because the lowest values correspond to 
acrylic and polyester while the highest correspond to cotton and polyamide.  
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5.6 CONCLUSIONS 
 
The kinetic study was determined assuming the release of active compound in two steps in the 
case of caffeine system and gallic acid system (short and long times) due to their different 
behaviours. However, Higuchi equation can be assumed for all systems in short times, because 
the release mechanism is governed by Fickian Diffusion in all cases (n<0.5).It can Also be 
demonstrated that the saline medium is an important factor, since it accelerates the degradation 
of the polymer, allowing ions to interact with the system and therefore, inhibit or accelerate the 
active compounds release. 
 
The main influence in these drug release systems is the affinity of active compound with the 
system. Different behaviours are shown, depending on the kind of fabrics. In the case of water 
medium, mass transport coefficients increase when hydrophobicity is higher. In saline medium, 
the tendency is different, because the saline ions can modify the of active compound release. 
 
Another important influence to be considered is the polymer one,  according to the behaviour of 
caffeine encapsulated with PLGA in comparison to the others (PCL-microspheres). The PCL as 
a crystalline polyester is degraded more slowly than PLGA, which is an amorphous and less 
hydrophobic polymer. Therefore, degradation will be faster in the case of the PLGA-
microspheres than the PCL-microspheres. Moreover, this factor increases in saline medium, 
therefore PLGA-microspheres release less amount of active compound in saline medium than 
in water. On the contrary, PCL-microspheres release more active compound in water than in 
saline solution [19,20,23]. 
 
To sum up, there are several factors influencing this sort of systems, both the affinity of 
microspheres with fabrics and the equilibrium between desorption of active agent, re-absorption 
by fabrics and final release to different media. Such processes are different depending on the 
type of active compound, the polymeric matrix and the substrate used, and as consequence, 
the results obtained will be different as per the trials carried out. 
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CHAPTER 6: MASS TRANSPORT MODEL THROUGH THE SKIN 
 
 
6.1 PERCUTANEOUS ABSORPTION ESSAY 
 
The skin permeability is measured by percutaneous absorption assay using Franz Diffusion 
Cells (in vitro technique).  
 
This study has only been carried out for ibuprofen system (applied on cotton fabric), because 
the experimental results from checked samples were good enough to discuss the percutaneous 
absorption essay. And also, because there is no literature for this type of study and it is of great 
interest to achieve improvements in the biotechnology field. The in vitro studies were carried out 
with pig skin on Franz static diffusion cells in order to know the evolution of the amount of the 
principle present in each of the different skin compartments (SC, epidermis and dermis) as well 
as in the receptor fluid, as a function of time by HPLC analysis. To determine the pig skin 
feasibility to use in absorption percutaneous experiments TEWL (transepidermal water loss) and 
skin thickness were measured, also the environmental conditions (T and HR) (Table 44). 
 
Table 44. Conditions of TEWL (TM210). All parameters are an average value. 
NUMBER OF CELLS 
SKIN 
THICKNESS (µm) 
TEWL ± SD T (ºC) % HR 
6 687.3 ± 20 8.77 ± 0.18 32.50 ± 0.5 50.77 ± 0.5 
LABORATORY CONDITIONS 
INITIAL PARAMETERS FINAL PARAMETERS 
T (ºC) % HR T (ºC) % HR 
27 ± 1.0 37 ± 1.0 27 ± 1.0 36 ± 1.0 
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The experimental conditions of in vitro experiments are detailed in Table 45. 
 
Table 45. Experimental conditions of Franz Cell apparatus. 
PENETRATION 
CELLS 
Area = 1.86 cm
2
 Volume = 3 mL - 
SKIN DISCS 
Thickness = 700 µm 
± 50 µm 
Inner diameter = 2.5 
cm 
Stored Temperature =  
-20 ºC 
RECEPTOR FLUID 
Phosphate – buffered 
saline 
pH = 7.4 
In Milli Q water (0.9% NaCl, 0.02% KCl and 
0.8% phosphate buffer) 
WATER BATH Temperature = 32 ºC 
Stirring  
700 rpm 
- 
TREATED 
FABRICS 
Area = 7.07 cm
2
 
Applied product = 
74.34 µg ± 5.77 
- 
 
Once finished the percutaneous absorption experiment for a given exposure time, the conditions 
to separate the different skin layers are detailed in Table 46. 
 
Table 46. Experimental for skin layers separation. 
SOLVENT OF EXTRACTION Methanol 
SEPARATION 
STRATUM CORNEUM 
8 strips Pressure = 80 g/cm
2
 
SEPARATION EPIDERMIS – DERMIS T = 80 ºC 
VOLUME EXTRACTION VTEXTILE 
10 mL 
VSC 
2 mL 
VE  = VD 
1 mL 
VRECEPTOR FLUID 
5 mL 
STIRRING 700 rpm 30 min Room Temperature 
SONICATION  15 min Room Temperature 
FILTRATION Nylon Filter Ø = 0.45 µm 
 
After skin layers separation and the corresponding Ibuprofen extraction (Table 46), HPLC 
analysis was performed, following the experimental conditions showed at Table 47. 
 
Table 47. Conditions of HPLC analysis. 
ELUENT 33 % A (H2O + 1.2 % H3PO4) 
67 % B Methanol 
FLOW 1 mL/min 
INJECTION VOLUME 40 µL 
RETENTION TIME 12 min 
WAVELENGTH (λ) 264 nm 
CALIBRATION CURVE y = 1124.1x + 416.38  
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6.2 RESULTS AND DISCUSSION - MASS TRANSPORT MODEL THROUGH THE SKIN 
 
Mass transport model through the skin was determined from the kinetic study of skin layers. For 
this study, the percutaneous absorption  essay was carried out repeatedly (3 repetitions) for 
several samples of treated cotton with ibuprofen PCL-microspheres at different times.  
 
The results of ibuprofen diffusion for PCL-microspheres system applied on cotton fabric  are  
expressed as μg/cm2, at different times. They are indicated in Table 48. 
 
Table 48. The amount of drug released in each part of the skin versus time. Exposure times: from 0 to 37 h. Values 
represent mean ± S.D (n = 3). 
TIME 
(h) 
Tex* 
(µg/cm
2
) 
SC* 
(µg/cm
2
) 
E* 
(µg/cm
2
) 
D* 
(µg/cm
2
) 
S* 
(µg/cm
2
) 
RF* 
(µg/cm
2
) 
Total 
(µg/cm
2
) 
0 15.07 ±3.94 nd** nd**  nd**  nd**  nd**  15.07 ±3.94 
1 9.08 ±0.36 
1.34 
±0.52 
0.32 
±0.10 
0 
1.70 
±0.87 
0 12.44 ±0.48 
3 8.97 ±0.78 
1.62 
±0.22 
0.91 
±0.38 
0.94 
±0.12 
2.40 
±2.05 
0 14.84 ±1.21 
6 9.59 ±0.35 
2.45 
±0.31 
1.79 
±0.14 
1.53 
±0.29 
0.97 
±0.22 
0 16.32 ±2.47 
24 8.36 ±1.90 
2.94 
±0.46 
2.89 
±0.09 
1.55 
±0.15 
2.15 
±0.87 
0.64 
±0.65 
17.88 ±2.31 
37 8.10 ±0.52 
1.07 
±0.42 
0.58 
±0.15 
1.26 
±0.45 
3.35 
±0.16 
5.11 
±0.86 
19.47 ±0.58 
*Abbreviations: Tex: Textile; SC: Stratum Corneum; E: Epidermis; D: Dermis; S: Surplus; RF: Receptor fluid; 
**nd: not detected 
 
The kinetic evolution of ibuprofen penetrated in each skin layer is shown in Figure 50. As it can 
be seen, the kinetic study shows that ibuprofen has penetrated through every layer of the skin, 
even it reaches the receptor fluid for a time longer than 24 hours.  
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Figure 50. Kinetic release of PCL-microspheres with ibuprofen applied on to cotton fabric through the skin layers. 
 
From the results obtained, it can be seen that at early times, the ibuprofen delivery to Stratum 
Corneum increases up to 6 hours approximately and then, it  gradually decreases over time. 
But, This is a normal tendency, since in the second layer of skin (epidermis), the release of 
ibuprofen is slower. However, taking the same time (6 hours) the amount of ibuprofen released 
increases more in this layer than in the dermis. This fact could be due to a saturation of the 
ibuprofen between the two first layers of the skin. Therefore, the close contact with the skin and 
the occlusion of the skin could be the main reasons for the active compound can cross the skin 
barrier located in the stratum corneum [14]. For this reason, in 24 hours, the release of 
ibuprofen has increased in the epidermis, but instead, has decreased in the stratum corneum 
and in the dermis. In contrast, in the receptor fluid is when it begins to increase. Therefore, one 
can observe that there is an equilibrium between one layer and another, up to 37 hours, when 
the ibuprofen release decreases in the epidermis and therefore, there is a considerable 
increase of ibuprofen release in the receptor fluid. It should also be taken into account the 
amount of hours for the study, as the degradation of the system can increase, either PCL-
microspheres or the experimental devices itself, in this case the pigskin. 
 
The model developed by Guy and Hadgraft has been used with the aim of investigating the 
ibuprofen released through the skin. In the equation (24), the relationship between the diffusion 
coefficient of the drug through the different skin layers (Ds) and the formulation thickness during 
a given period t (L0), is considered the apparent diffusion coefficient.  
 
When 
0
s
ap
L
D
D  , the equation (24) is transformed in the following expression (47): 
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Which has been used in our work taken into account the experimental parameters obtained for 
each skin layer. As regards to the partition  coefficient (K) of ibuprofen, Herkenne et al [104] 
determined that parameter in SC using propylene glycol as a solvent. The individual partition 
coefficients obtained as a function of ibuprofen concentration in the cosolvent are graphically 
plotted in Figure 51. Although the solvent used in our work has been methanol, the solubility of 
ibuprofen in both solvents is quite similar (ibuprofen solubility in propylenglycol: 140.00 mg/mL 
[105] whereas in methanol is: 144.50 mg/mL). Therefore, as it can be deduced from the values 
shown in Figure 51, the partition coefficient (K) of ibuprofen is about 1. 
 
 
Figure 51. Individual SC/PG partition coefficients measured in vivo as a function of ibuprofen concentration in the 
cosolvent [104] 
 
For the calculation of the apparent diffusion coefficients of ibuprofen, it must be considered the 
hydrophilic or lipophilic character of each skin compartment. The stratum corneum (SC) is a 
lipophilic layer whereas the epidermis and, in particular, dermis are the hydrophilic areas of the 
skin (viable skin). The results on apparent diffusion coefficients obtained for each layer are 
shown in Table 49. 
 
Table 49. Apparent diffusion coefficients for Stratum Corneum and Epidermis-Dermis. 
LAYERS THICKNESS (µm) Dap (cm/s) 
STRATUM CORNEUM 20 1.20 ·10
-7
 
VIABLE SKIN 
(EPIDERMIS-DERMIS) 
667.3 6.673 ·10
-6
 
 
It can  be seen that in the lipophilic area of skin (stratum corneum), the release of the active 
compound is the slowest, this is due to the properties of its barrier function. The diffusion 
through the SC is mainly a lipidic intercellular pathway, therefore it can be considered the rate-
limiting step for most compounds. However, once the active compound crosses through the 
epidermis and dermis (hydrophylic area of skin) the release rate increases significantly, even 
reaching to the receptor fluid. 
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As the ibuprofen penetrates into the skin, its solubility increases. According to the literature 
[104,106-108], the solubility of ibuprofen in a phosphate buffer solution (receptor fluid) at a 
temperature of 37 °C and pH = 7.4 is 6.02 mg/mL. However, ibuprofen has a very low water 
solubility (0.14 mg/mL), and in the lipophylic layer (SC) the ibuprofen release is slower than in 
the hydrophilic domain (epidermis-dermis).  
 
PCL-microspheres can reduce the diffusivity of active compound in the first layer of the skin due 
to a surface skin saturation and thus, driving to a slower delivery of ibuprofen versus time. 
Therefore, the phenomenas observed are either the drug release fully determined by the affinity 
of the active compound with the different layers of the skin, collapse on the surface of the skin  
together with a slower drug release. 
 
Once ibuprofen enters to the hydrophilic part of the skin, its solubility increases, release  to the 
receptor fluid is faster, while the solubility of the ibuprofen is very high (6.02 mg/mL). Moreover, 
in previous studies about the variation of solubility of the ibuprofen versus time [107] , it is 
demonstrated that its solubility increases exponentially in the time. Due to the hydrophobic 
nature of ibuprofen, the aggregation of ibuprofen powders is obtained during the dissolution 
testing  [107]. And, in this study, there is a good dispersion of the ibuprofen, because, basically, 
this takes part of a microencapsulation system, thus avoiding the aggregation of the active 
agent. 
 
As a conclusion, the model of mass transport of ibuprofen through the skin used in this study is 
illustrated in the scheme of Figure 52. As it can be seen, an specific equation is used for each 
skin layer considering the percutaneous absorption kinetics of ibuprofen. This simple and 
practical model allows the control of a drug delivery system consisting of PCL-microspheres 
applied on textile substrate as a method of controlled release of ibuprofen. 
 
 
Figure 52. Model of mass transport of ibuprofen through the skin. 
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6.3 CONCLUSIONS 
 
This study shows that the bioavailability of a model of ibuprofen microencapsulated in the skin 
can be evaluated by Franz-cells in vitro technique. This technique, combined with the 
appropriate analysis of the experimental data, provides kinetic parameters needed to design 
rationally a topical patch. Moreover, the role of PCL-microspheres, as a mass transport carrier in 
topical formulations of moderately lypophilic drugs as ibuprofen, has been examined carefully. 
The ibuprofen get in the SC slowly and seems to alter ibuprofen’s solubility in the barrier. 
However, the diffusivity of the drug across the epidermis-dermis (aqueous area) increases 
significantly, and the drug delivery is directly affected by the solubility of active compound. 
Quantitative characterization of the uptake of ibuprofen itself into the different layers of the skin 
from PCL-microspheres represents a logical research effort for future investigations.
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7.1 FINAL CONCLUSIONS 
 
The present study has shown that the main objective has been successfully achieved. 
According to that, microencapsulation applied on fabrics can be considered as a good controlled 
release system. As a result, the project reached to a general kinetic model using smart textiles 
as a mass transport system through the skin. 
 
For this main aim, each of the objectives has been satisfactorily completed.  
 
The microencapsulation of caffeine, ibuprofen and gallic acid has been achieved with success. 
Moreover, the encapsulation of ibuprofen has been carried out with great efficiency, as never 
before according to the available literature.  Besides that, encapsulation of caffeine and gallic 
acid have been also showed good results.  
 
Results from FTIR spectroscopy could give an idea of the possible interaction between PLGA - 
microspheres and caffeine (nitrogen bond), PCL – microspheres and ibuprofen (hydrogen 
bond), PCL – microspheres and gallic acid (hydrogen bond). 
 
The case of the application of microspheres on textiles,  shows that PLGA-microspheres with 
caffeine are the opposite of gallic acid and ibuprofen PCL-microspheres,  probably due to the 
factor clearly of affinity, since the first one are made of PLGA and the others are made of PCL. 
Therefore, it is demonstrated that the chemical structure of the polymers is one of the most 
important effects in the affinity of the system. 
 
The kinetic study shows a bimodal determined behaviour in the case of gallic acid and caffeine 
systems (short and long times). However, Higuchi equation can be assumed for all systems in 
short times, since the release mechanism governed by Fickian diffusion is applicable in all 
cases. The main influence in these drug release systems is the affinity of active agent with the 
system. It can be shown  that the behaviours are different depending on the kind of fabrics. In 
the case of water medium, the mass transport coefficients increase when the hydrophobicity is 
higher. In the saline medium, the tendency is different, because the ions saline can modify the 
release of active compound. 
Therefore, it can be deduced that the release mechanism will depend directly on the affinity 
between the different system components, textile-microspheres, microspheres-active principle 
and system (microspheres on textiles)-medium.  
 
To sum up, it has been demonstrated that the microencapsulation applied on textiles is a good 
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system of controlled drug release. As a result, the project has been completed with a general 
kinetic model by smart textiles as a transport system through the skin. 
 
7.2 FUTURE OUTLOOK 
 
Mainly, the future impact of the present study is the obtaining of a controlled drug delivery 
system  to release an active compound at the right time and on the right place.  
 
One of the first problems that should be solved in the future is the distribution of the particle size 
and therefore, to get a better homogeneity in order to have better control in the drug release. To 
that purpose, it would be necessary to modify the conditions of the preparation process of 
microspheres. 
 
A  general kinetic model by smart textiles as a mass transport system through the skin has been 
obtained. However, the "burst" problem persists, and so it suggests further studies to improve 
the stability and efficiency in this sort of systems.  
 
Furthermore, another important issue is the affinity between the microspheres and fabrics that 
affects the previous problem. Therefore, it would be recommended to study zeta potential of 
each fabric in different conditions and also, it could be possible using sandwich systems or 
some systems that keeps better the applied microspheres on the fabrics with the aim of 
decreasing the initial loss of the active agent. 
 
Besides that, one of the most relevant advantage of the present study is its potential application 
in different fields, such as the pharmaceutical one. In this particular field, the present work could 
provide a way to avoid pharmaceutical side effects, thanks to the polymeric base, which is 
biodegradable and therefore, respectful to both the human being and the environment. 
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8 STAY  ABROAD (GHENT UNIVERSITY) 
 
Collaboration in NO BUG Project. Novel release system and Bio-based Utilities for mosquito 
repellent textiles and Garments. Seventh Framework Programme; Theme 4; Ghent University.  
Faculty of Engineering. Department of Textiles. Technologic Park. 19/09/2011- 06/02/2012 
Ghent (Belgium). 
 
8.1 BACTERIAS INCORPORATED IN FIBERS BY ELECTROSPINNING TECHNIQUE 
 
The main aim of this work is to incorporate bioactive materials in textile fibers. The project aims  
to obtain an effective and long lasting mosquitoe repellent personal protective equipment  (PPE) 
using bio-repellents. My work consisted on preparing bioactive systems by microencapsulation 
methods and then, the incorporating of these substances on nanofibers through electrospinning 
technique.  
 
Therefore, my work could be divided by four steps: 
 
1. The spores were tested to prove that  they could survive the physical process 
parameters in the extruder, those are: , high temperature, high pressure and residence 
time. 
2. Incorporation of the spores in the nanofibers by electrospinning technique. 
3. Study of the microspheres preparation with spores by sonication technique.  
4. Obtaining of the nanofibres with incorporated microspheres by electrospinning 
technique.  
 
Due to the short time of the stay, that work was finished until third step, and the results obtained 
were not totally satisfactory. The basic problem was the optimization of the electrospinning 
process, since the compatibility between spores and nanofibers was not good and neither the 
stability of the system due to the existence of spores (partially soluble) [109-131]. 
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In recent years, new technologies have led to the production of biofunctional textiles. These biofunctional textiles
contain microscopic capsules of ingredients that break as the fabric rubs the skin, releasing the active agents.
Absorption and desorption behaviour of active agents embedded into the different biofunctional textiles should be
taken into account when determining the amount of active agents incorporated into these textiles and when following
the delivery mechanism as the fabric comes in contact with the skin. In this work, an encapsulated active agent (a sun
filter, ethyl hexyl methoxycinnamate [EHMC] into microcapsules or liposomes) was applied by foulard onto different
fabrics. The amount of capsules and active agents embedded into the fibres were quantified by (1) weight difference
between untreated and treated fabrics, (2) extraction with isopropanol in an ultrasound bath, or (3) extraction with
isopropanol/water 50/50 in a soxhlet device. Sun filter detection of the extraction baths was followed by HPLC and
by UV spectrophotometry. The results show that the real amount of the EHMC present in different textile substrates
depends on the way that the active agent is trapped, the ionic character of the fibres and on the vehicles used.
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Introduction
 
In recent years, the textile industry has initiated the
production of functional textiles. One such textile
constitutes the basis for the delivery system of cosmetic
or pharmaceutical substances when the textile gets in
contact with the skin. As most of the body is covered
with some sort of textile, the potential of biofunctional
textiles is considerable. Textiles that have functional
properties for the skin have been studied and patented
(Guarducci, 2006; Wachter, Weuthen, Panzer, & Paff,
2005).
Encapsulation is one of the techniques used to
apply the substances onto the textiles (Nelson, 2002).
Microcapsules have a diameter between 1 and 1000 
 
µ
 
m
(Aggarwal, Dayal, & Kumar, 1998). The capsule is a
kind of box that provides both a space for storing an
active agent and a protective shield from external agents
such as sunlight, heat and moisture; this shield may be
obtained by a natural or synthetic polymeric substance.
The encapsulated compound can be released by
mechanical means, temperature, diffusion, pH, biodeg-
radation and dissolution means.
Liposomes have been used as models for complex
biological membranes in biophysical and medical
research owing to their lipid bilayer structural similar-
ity. Moreover, liposomes have been the subject of
numerous studies because of their importance as
microencapsulation devices for drug delivery and their
applications in cosmetics (Betz, Aeppli, Menshutina,
& Leuenberger, 2005; Lian & Ho, 2001; Teschke &
Souza, 2002).
In recent years, liposomes have been used in the
textile industry as dyeing auxiliaries, mainly for wool
dyeing (Montazer, Validi, & Toliyat, 2006).
The sun filters applied on the skin are usually lipo-
philic molecules incorporated into oil/water (O/W)
emulsions containing surfactants. It is well known that
a large number of topical formulations contain emulsi-
fiers that can modify both the skin lipids and their barrier
function. One way to avoid the harmful effects of emul-
sifiers could be the use of biomolecules with similar
characteristics to those of the lipids in the stratum
corneum, i.e. liposomes prepared from internal wool
lipids and incorporated ethyl hexyl methoxycinnamate
(EHMC) as a sun filter (Ramón et al., 2005). When such
liposomes were used, the skin penetration was retarded,
suggesting a certain reinforcement of the stratum
corneum barrier. In this work the same sun filter was
used as a reference probe to study the preparation of
biofunctional textiles with liposomes or microcapsules.
Most studies on the incorporation of active agents
into textile substrates place more emphasis on the
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characterization of the entrapping system (Badulescu,
Vivod, Jausovec, & Voncina, 2008; Li, Boyter, & Qian,
2005), the type and amount of resin needed to improve
the microcapsule adhesion to fabrics (Monllor, Capa-
blanca, et al., 2009), and on their use in standard textile
machinery (Rodrigues et al., 2009). The release of
active agents from the microcapsule or from the textile
entails complicated mechanisms that include mass
transport through different media and layers in order to
reach the surface of the skin. This release depends on
the exact amount of active agents incorporated into the
fabric. The number of active molecules is responsible
for the concentration gradient that governs transport to
the inner layers of the skin.
This study seeks to establish a methodology to
quantify the amount of active agent, i.e. a sun filter,
incorporated into the fabric to develop a biofunctional
textile by a Pad-Dry process, using a well known
foulard machine. Attention should be focused on the
encapsulation process in which the active agent has
been trapped and on the chemical characteristics of the
textile substrates in which the sun filter is applied. The
sun filter encapsulated into microcapsules or liposomes
was applied onto different fabrics, cotton, polyamide,
acrylic and polyester. The amount of capsules and
active agent embedded into the fibres was assessed by
different methodologies to determine the most conve-
nient application procedure to be used by textile manu-
facturers.
No resin was used to promote the adhesion of
microcapsules to the fabrics because one of the main
factors in the preparation of a biofunctional textile is
the active agent delivery mechanism given that the use
of resins could interfere in this release. The results
from the extraction and detection have optimised meth-
odologies and demonstrated the different affinity of
microcapsules or liposomes with the different textiles
assayed.
 
Materials and methods
 
Materials
 
The following standard fabrics were used: plain cotton
fabric (bleached desized cotton print cloth, Style 400
ISO 105-F02), spun polyamide fabric (PAM) (Style
361, ISO 105-F03), polyester fabric (PES) (Style 777,
ISO 105-F04), acrylic fabric (PAC) (Style 864, ISO
105-F05). All chemicals used were of analytical grade.
For high-performance liquid chromatography (HPLC)
analysis, methanol (HPLC grade) and distilled water
were used.
Microcapsules (38% EHMC, 56.8% water) were
supplied by the Lipotec Group (Gavà, Spain) and were
constituted by an O/W emulsion with a shield of silica
acid and xanthan gum as an external wall. Formulations
of lecithin liposomes containing sun filter (1% EHMC,
3% lecithin, 25% cationic compound, Dehyquart L 80
from Henkel) were also prepared by the Lipotec Group.
 
Application process
 
All fabric samples were conditioned under standard
atmospheric pressure at 20
 
±
 
2
 
°
 
C and 60
 
±
 
5% relative
humidity for 24 hours prior to future application. The
application of the microcapsules or liposomes onto
the fabrics was performed by foulard process using a
Pad-Steam-Rame pilot plant of 30 cm width (ERNST
BENZ AG KLD-HT and KTF/m250), with the corre-
sponding pressure to obtain a pick-up of 80
 
±
 
5% [(mass
of bath solution taken by the textile/mass of dry textile)
 
×
 
 100] from the microencapsulation or liposome formu-
lations. Microcapsules were applied with a 20% of
solution (7.6% EHMC) at pH 4.1 onto fabrics samples
(25 
 
×
 
 40 cm
 
2
 
); liposomes were applied at 100% (1%
EHMC) at pH 3.9 onto pieces of fabric 25 
 
×
 
 35 cm
 
2
 
.
Due to their little size, the impregnation was carried on
in a beaker, where the fabric samples were completely
submerged into the treatment bath before passing
through pad cylinders. Thereafter, the impregnated
fabrics were put into a curing and heat-setting chamber
and maintained at 47
 
°
 
C for 10 minutes. The treated
fabric samples were finally conditioned at 20
 
±
 
2
 
°
 
C and
60
 
±
 
5% relative humidity for 24 hours before weighing
to determine the amount of product incorporated into
the fabrics. All treatments were made in duplicate and
the results were a medium of two values.
 
Biofunctional textile extraction
 
Textile samples, about 1 g of each fabric, were
extracted using two different methodologies: (1) with
100 ml isopropanol/water (50/50), 1/100 bath ratio for
one hour at its boiling point 82.3
 
°
 
C by a Soxhlet extrac-
tor, and (2) with isopropanol 100% twice with a 1/30
bath ratio at 35
 
°
 
C followed by a 15-minute sonication in
a vial by an ultrasound bath (100 W Labsonic 1510, B.
Braun, Melsungen, Germany). After extraction, the
samples were dried for 48 hours under the same room
conditions (20
 
±
 
2
 
°
 
C and 60
 
±
 
5% relative humidity)
before weighing.
 
EHMC detection
 
EHMC from the different extraction bath samples was
determined by HPLC equipped with an UV–Vis detec-
tor or by UV–Vis spectrophotometer.
The HPLC instrument used was a Hitachi-Merk
Elite LaChrom (Darmstadt, Germany). The apparatus is
20
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equipped with L-6000 Intelligent Pump, AS-4000 Auto
sampler and L-4250 UV–Vis detector working at
307 nm. The system was operated from the software
Merck EZChrom Elite v3.1.3. The column used was a
LiChrocart 125-4/Lichrosorb RP-18 (5 
 
µ
 
m) (Darmstadt,
Germany). The mobile phase was 12% water (0.5 ml
H
 
3
 
PO
 
4
 
 85%/L)/88% methanol at 1 ml/min flow rate.
The EHMC retention time was about 5.5 minutes. The
area under the peak was used to calculate the concentra-
tion of EHMC using external standards that
showed linearity over the concentration range of 0.05 to
140 
 
µ
 
g/ml. The intraday and interday variations of the
method were less than 5%.
A Cary 300 Bio spectrophotometer UV–Visible
(Varian, USA) was used to detect the EHMC in isopro-
panol/water (50/50 v/v) solution at a wavelength of
310 nm. Calibration curves were used, employing lipo-
somes or microcapsules as standards, and the curves
showed linearity over the concentration range of 0.05 g/
l to 0.5 g/l in both cases.
 
Results and discussion
 
The amount of the active principle (EHMC) incorpo-
rated into textiles was based on the weight of the fabrics
processed or on the extracts. It is therefore necessary to
determine the real amount of EHMC in the formulations
(microcapsules and liposomes) supplied by the Lipotec
Group. To this end, dried extracts were obtained by
prior water evaporation. The EHMC amount present in
these products was analysed by HPLC and the results
are indicated in Table 1.
As shown in Table 1, small differences were found
between the percentage of dry weight and EHMC anal-
ysed and the values indicated in the technical product
file provided by the company: liposomes, 29% of dry
product and 1% EHMC; and microcapsules, 43.2% of
dry product and 38% EHMC.
The performance of the release systems could be
affected by a number of factors such as biocompatibility,
biostability, biodegradability, the amount of efficient
drug delivery, and controllability (dosage control, rate
control and time control) in the development and design
of textile drug delivery systems (Nierstrasz, 2007).
For these reasons it is very important to know the
precise amount of active agents to be applied onto the
textile before its use as a textile drug delivery system.
In order to establish an accurate methodology to
quantify the amount of active agent incorporated into
the fabric, the sun filter encapsulated into microcap-
sules or liposomes was applied onto different fabrics,
cotton (CO), polyamide (PAM), acrylic (PAC), and
polyester (PES). Traditionally, the fixation of microcap-
sules onto textiles is achieved by applying a binder with
capsules as the fabric passes through a thermal curing
process (Monllor, Bonet, & Cases, 2007; Monllor,
Capablanca, et al., 2009; Rodrigues et al., 2009). In this
process the fabric is subjected to high temperatures
(130–170
 
°
 
C) between 1 and 10 minutes during which
the components in the binder are converted into a tough
polymer that forms a network on the fabric to retain the
capsules. However, it is possible that high temperatures
occasionally damage the active agents with the result
that their functionality is diminished. For this reason, no
binder was used in the present work when microcap-
sules were applied. Apart from acting as vehicles, lipo-
somes could also be beneficial to skin (Patravale &
Mandawgade, 2008; Wachter et al., 2005). Any binder
could interact with the liposomes, depriving them of
skin contact and impeding their passage to the outer-
most layers of skin. Bhatia, Mangat, Jain, Bhupinder,
and Katare (2008) studied the phospholipid-structured
as a possible solution in the formulation of coal tar
creams to help stain removal on textiles (cotton/polyes-
ter blends) due to its high desorption properties. More-
over, the fibre-care effect of liposome applied to textiles
has been patented given their more enduring effect on
the skin than conventional application methods
(Wachter et al., 2005).
The application of the active agent vehiculised in
liposomes (27.2% of dry product and 1.01% EHMC)
or  in a microencapsulated formulation 20% diluted
(8.3% of dry product and 7.5% EHMC) on the textile
substrates was performed by foulard in an attempt to
achieve an approximately 80% pick-up. The impregna-
tion technology used is the most efficient microcapsule
application methodology (Monllor et al., 2007). The
percentages of pick-up for the different textiles, the
percentage of theoretical product present in the fabric
taking into account the composition of liposomes
(27.2% product/72.8% water) (see Table 1) and micro-
capsules (8.3% product/91.7% water), and the percent-
age of dry product applied calculated by weight
difference between dry initial fabric and dry fabric after
Pad-Dry process are shown in Table 2.
When liposomes were applied onto the fabrics, there
were differences of about 4% between the calculated
amount of product impregnated (
 
≈
 
22%) and the product
found in the fabric after heating at the Stenter (
 
≈
 
18%).
This could mean that the liposomes showed a slightly
lower tendency to be incorporated into the fibres than
the water content in the formulation. It seems that cotton
 
Table 1. Percentage of dry extract weight and EHMC
content of the liposome and microcapsule formulations.
% Dry weight % EHMC 
 
± 
 
% CV
Liposomes 27.2 1.01 
 
± 
 
0.02
Microcapsules 41.5 37.32 
 
± 
 
2.37
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fabric incorporates a lower percentage of liposomes
whereas the other synthetic textiles (polyamide, acrylic
and polyester) have similar percentages of product
applied (on weight of fibres [o.w.f.]). Other authors
have shown that lecithin liposomes have a higher
affinity with polyamide than with cotton (Baptista,
Countinho, Real Oliveira, & Rocha Gomes, 2004). In
the case of microcapsule application, the differences
between the calculated amount of the impregnated prod-
uct (
 
≈
 
6.7%) and the product in the fabric after heating
at the Stenter (
 
≈
 
30–60%) were much higher and
depended on the textile material. The high affinity of
this microcapsule formulation with respect to water
with all the processed textiles should be noted. Both
microcapsules and liposomes were applied to the fabrics
at pH around 4.0 at which acrylic was anionic, cotton
and polyester were neutral and polyamide had a cationic
character. At pH 4.0, the liposomes applied had cationic
polar heads and the microcapsules applied had silicic
acid with an anionic character in their external wall. It
could therefore be inferred that cationic liposomes have
a slightly high affinity for PAC and the anionic micro-
capsules had a high tendency to be incorporated into the
cationic fibres, which is the special case of polyamide.
However, this would not explain the highest affinity for
the microcapsules to the PAC. A higher diffusion of the
microcapsules into the PAC fibre would explain this
highest absorption (Lis et al., 2008).
A number of works have been based on the
increased adhesion of microcapsules to the fabrics by
adding a binder or a resin which usually required a
thermal process to be fixed (Li et al., 2005; Li, Lewis,
Stewart, Qian, & Boyter, 2008; Monllor, Sánchez,
Cases, & Bonet, 2009; Nelson, 2002). As stated above,
this falls outside the scope of our study given that our
aim is to achieve a high EHMC textile desorption to
favour skin penetration. The different affinity of micro-
capsules with textiles used must be studied in depth. In
order to determine the amount of product incorporated
into the fibres, two extraction methodologies were
tested after several trials to optimise the solvent, the
time and the bath ratio.
The samples treated with liposomes or microcapsules
applied by foulard were extracted with isopropanol in an
ultrasound bath and with isopropanol/water, using a
soxhlet extractor (see section Materials and methods).
Figure 1 shows the results obtained by the weight
difference of the impregnated sample and the extracted
 
Table 2. Results of the finishing process of several textile fabrics: percentage pick-up and the theoretical percentage of product
present in the wet fabrics after impregnation; and percentage o.w.f. (on weight of fibres) of product applied, calculated by weight
difference between dry non-treated textile and dry textile after Pad-Dry process.
Liposomes Microcapsules
Textile
% Pick-up 
(% theoretical product)
% o.w.f. 
product applied
% Pick-up 
(% theoretical product)
% o.w.f. Dry 
product applied
CO 80.87 (21.99) 16.99 80.21 (6.65) 30.39
PAM 80.45 (21.88) 18.39 80.94 (6.72) 55.40
PAC 85.71 (23.31) 19.93 79.75 (6.62) 62.88
PES 84.31 (22.93) 18.76 81.17 (6.74) 37.73
Figure 1. Assessment of liposome application on textiles: percentage o.w.f. of liposomes obtained by weight difference
(a) initial and applied fabrics, (b) applied and ultrasound bath extracted fabrics, and (c) applied and soxhlet extracted fabrics.
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sample using both methodologies when liposomes were
applied onto several textiles. Figure 2 shows the results
obtained when microcapsules were applied onto differ-
ent textiles.
 
Figure 1. Assessment of liposome application on textiles: percentage o.w.f. of liposomes obtained by weight difference (a) initial and applied fabrics, (b) applied and ultrasound bath extracted fabrics and (c) applied and soxhlet extracted fabrics.2 micr capsules application on textiles: perc ntage o.w.f. f microencapsules obtained by weight difference (a) init al and applied fabr cs, (b) applied and ul rasound bath extracte fabrics an  (c) applied and soxhlet extracted fabrics.Similar results of the amount of product (liposomes
or microcapsules with EHMC) applied and extracted by
both methodologies were obtained in all cases although
the degree of microcapsule incorporation into the
textiles exceeded that of liposome application. These
results confirm the different degree of liposomes
(
 
≈
 
18%) and microcapsules (
 
≈
 
30–60%) to be incorpo-
rated into the different textiles. In order to determine the
efficiency of both extraction methodologies, the
percentage of extracted product related to the applied
product was calculated for the liposome and microcap-
sule-treated fabrics (Figure 3). As shown in the figure,
most of the fibres yielded a high percentage (between
90% and 105%) of the extracted product. Only the lipo-
some applied onto cotton fibre and extracted with ultra-
sound yielded a lower extraction percentage (
 
≈
 
83%). In
general, it can be deduced that the soxhlet extraction
with isopropanol/water at high temperatures is more
suitable for cotton and polyamide fabrics. However, the
ultrasound extraction with only isopropanol is more
appropriate for the more hydrophobic synthetic fibres
such as acrylic and polyester in which an extraction
percentage around 100% was obtained.
 
Figure 3. Percentages of extracted product (liposomes or microcapsules) related to the applied product.The EHMC content of the different extraction baths
was determined either by HPLC-UV when the ultra-
sound bath was used (see Figure 4) or by UV–Vis spec-
trophotometry when soxhlet was used. The results
obtained are shown in Figures 5 and 6 for liposome and
microcapsule-treated fabrics, respectively. The percent-
age of EHMC present in the treated fibres was first
calculated from the percentage o.w.f. of the product
applied (calculated by weight difference between dry
non-treated textile and dry textile after Pad-Dry
processes). For this calculation, liposomes were consid-
ered to have a 3.71% EHMC of their total dry weight
and microcapsules were considered to have a 90.58%
EHMC of their total dry weight. The results obtained
using both extraction and analysis methods of the differ-
ent treated fabrics were compared with the % EHMC
calculated from the total amount of applied product.
 
Figure 4. HPLC chromatogram of extract from cotton treated with EHMC microcapsules – (a) solvent peak and (b) EHMC peak.
Figure  2. Assessment of microcapsules application on textiles: percentage o.w.f. of microencapsules obtained by weight dif-
ference (a) initial and applied fabrics, (b) applied and ultrasound bath extracted fabrics, and (c) applied and soxhlet extracted fabrics.
Figure 3. Percentages of extracted product (liposomes or microcapsules) related to the applied product.
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Figure 5. Evaluation of EHMC present in textiles with liposomes: calculated from product applied, EHMC extracted by ultrasound bath and analysed by HPLC–UV–Vis and EHMC extracted by soxhlet and analysed by UV–Vis spectrophotometer.
 
In Figures 5 and 6, there was a mark difference
between the percentages of EHMC applied and
extracted, the latter being much lower in the extraction
baths. EHMC analysed by HPLC in the isopropanol
ultrasound extracted baths was markedly lower for all
applied fabrics. The efficiency of the methodologies
used (extraction + detection) was determined by calcu-
lating the percentage of extracted EHMC versus the
percentage of applied EHMC for the liposome and
microcapsule-treated fabrics (Figure 7).
 
Figure 6. Evaluation of EHMC present in textiles with microcapsules: calculated from product applied, EHMC extracted by ultrasound bath and analysed by HPLC–UV–Vis and EHMC extracted by soxhlet and analysed by UV–Vis spectrophotometer.7 Percen age extracted EHMC v rsus the percentage of applied EHMC.Comparison of the results plotted in Figures 3 and 7
shows that the percentages of EHMC extracted versus
the applied ones are not as high as the percentages
obtained for the total products absorbed using lipo-
somes or microcapsules. This could be due to low
extraction or some analytical detection problems of the
EHMC or to a difference in the absorption characteris-
tics of the products (liposomes or microcapsules). It
should be borne in mind that the amount of EHMC
present in the fibres is calculated by considering the
same availability of the product and the EHMC to be
incorporated onto the fibres.
In this case, the extraction and detection of EHMC
ranges between 70% and 105%. For all fibres, the
HPLC detection of EHMC in the isopropanol ultra-
sound extracted baths is lower than the UV detection
of EHMC in isopropanol/water soxhlet extracted
baths. Again this extraction methodology with soxhlet
seems to be more suitable than the one with the ultra-
sound bath. However, it should be pointed out that
whereas 100% of extraction can be achieved for
cotton or polyester, this should not be applied to
polyamide and acrylic. Moreover, the higher absorp-
tion of the total product obtained for these two fibres,
mainly in the case of microcapsule application, is not
reflected in the EHMC analysis. Samples subjected to
two different discharge mechanisms show differences
in the amount of EHCM released to the media.
Depending on the chemical characteristics of the
textile substrate, there is adhesion of certain amount of
the active agent that is more marked for microcapsules
than for liposomes.
In summary, the results obtained from the EHMC
extraction and analytical detection indicated that the
soxhlet extraction with isopropanol/water at high
temperatures followed by UV spectrophotometer detec-
tion is more suitable for all fibres than ultrasound
extraction with only isopropanol using HPLC-UV
Figure 4. HPLC chromatogram of extract from cotton treat-
ed with EHMC microcapsules – (a) solvent peak, and (b)
EHMC peak.
Figure 5. Evaluation of EHMC present in textiles with liposomes: calculated from product applied, EHMC extracted by
ultrasound bath and analysed by HPLC-UV–Vis and EHMC extracted by soxhlet and analysed by UV–Vis spectrophotometer.
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detection. Moreover, it can be confirmed that EHMC
has the highest tendency to be incorporated into the
fibre when microcapsules are applied, especially in the
case of acrylic and polyamide. Different methodologies
have been described in the literature to assess the pres-
ence of microcapsules in textiles (Monllor et al., 2007;
Monllor, Capablanca, et al., 2009; Monllor, Sánchez,
et al., 2009; Rodrigues et al., 2009; Sarier & Onder,
2007). These are based on the use of sophisticated and
expensive equipment, SEM, DSC, FTIR, etc., which
do not always yield quantitative results. This study
presents two extraction and detection procedures that
Figure 6. Evaluation of EHMC present in textiles with microcapsules: calculated from product applied, EHMC extracted by
ultrasound bath and analysed by HPLC-UV–Vis and EHMC extracted by soxhlet and analysed by UV–Vis spectrophotometer.
Figure 7. Percentage of extracted EHMC versus the percentage of applied EHMC.
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may be readily adopted by textile manufactures to quan-
tify microcapsules and active agents in textiles.
 
Conclusions
 
This study demonstrates that the amount of the EHMC
applied onto different textile substrates depends on the
way the active agent has been encapsulated, the ionic
character of the fibres and the vehicles. Liposomes with
cationic polar head groups have a lower absorption than
expected onto fibres, the lowest absorption being for
cotton. Microcapsules with an anionic character in their
external wall (because of silicic acid composition) have
higher amounts of product incorporated into textiles
than expected, the highest absorption being for polya-
mide (cationic fibre).
Two extraction methodologies were assayed: with
isopropanol in an ultrasound bath and with isopropanol/
water using a soxhlet extractor. Similar results of the
amount of product (liposomes or microcapsules with
EHMC) applied and extracted by the two methodolo-
gies were obtained in all cases. These results confirm
the absorption found for liposomes (
 
≈
 
18% pick-up) and
microcapsules (
 
≈
 
30–60% pick-up) in different textiles.
However, it can be deduced that the soxhlet extraction
with isopropanol/water at high temperatures is more
suitable for cotton and polyamide and that the ultra-
sound extraction with only isopropanol is the most
appropriate extraction for the more hydrophobic
synthetic fibres such as acrylic and polyester.
EHMC from the different extraction baths was
determined by HPLC-UV when the ultrasound bath was
used or by UV–Vis spectrophotometry when soxhlet
was used. There was a marked difference between the
EHMC applied and extracted percentages, the lowest
amount of this active agent being detected in the extrac-
tion baths. Again, the extraction methodology with
soxhlet is more suitable than the one with ultrasound
bath. However, it should be pointed out that a 100% of
extraction can be achieved for cotton or polyester,
whereas the extraction is lower than 100% for polya-
mide and acrylic fibres.
In the present work, a methodology to detect the
amount of active agent applied onto several fabrics was
established taking into account the influence of the
chemical characteristics of vehicles and fibres on
EHMC incorporation. Absorption and desorption
behaviour of EHMC embedded into different biofunc-
tional textiles must be considered in order to determine
the amount of active agents incorporated, and to under-
stand the delivery mechanism when the textile is in
contact with human skin. Thus, the methodology used
should be verified when an active agent is encapsulated
into a new device given that the chemical substances
employed in the preparation of capsules can exert a
marked influence on specific doses of active agents that
are released to the skin.
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ABSTRACT 
 
Today, the technology of microencapsulation of active principles is on top of biomedical 
advances, because through it we can solve many of the problems caused by current 
methods of taking medication. By  active principle microencapsulation not only solve 
the problems of drug intake but also controlled it’s dosage. 
 
In this study has carried out the development of a protocol for the microencapsulation 
of ibuprofen by solvent evaporation method. A subsequent application of those 
microencapsulates to biofunctional textile substrates (cotton, polyamide, acrylic and 
polyester) using a finishing process, and finally a study of the release of active principle 
in two different media (deionised water and physiological serum) has been carried out 
using samples of the treated fabrics that were submerged into thermostatized vessel at 
semi infinite bath conditions. The determination of active principles released to the bath 
was determined by UV-Spectrophotometer. These experimental results have been 
analyzed and evaluated, therefore have allowed to define a controlled drug release 
system by Fickian diffusion in different medias. 
 
Keywords: Microcapsules, biofunctional textile substrates, drug release, ibuprofen. 
 
1. INTRODUCTION 
 
Currently, biomedical advances are emerging faster and faster, one of these new 
methods is microencapsulation. Microencapsulation has become one of the best ways 
of taking medicines, because slow absorption through the skin prevents from the side 
effects that the medicine can cause. By the application on bio-textile substrates let us 
to get a support for the microspheres formed during the process and it also allows 
microspheres to be placed on the skin [1-7]. 
 
Due to its great versatility, the polymer's family is the most used in the 
microencapsulation of active principles. Within it are the natural, the semi-synthetic and 
the synthetic polymers. Natural polymers are mainly polysaccharide, animal and plant 
origin. The alginate, dextran, gum arabic and chitosan are highlighted. Semi-synthetic 
polymers comprise cellulose derivatives, of which there is a wide variety with different 
solubility characteristics. The most widely used synthetic polymers are the acrylic 
derivatives and polyesters. Among the acrylic derivatives are insoluble polymers with 
different degrees of permeability and also with different solubilities depending on pH. 
Polyesters are polymers with character biodegradable. Among them, the most known 
are poly-ε-caprolactone (PCL), the poly-lactic acid (PLA) and its derivatives such as L-
PLA, and the copolymers of lactic acid and glycolic acid (PLGA). 
 
Poly-ε-caprolactone (PCL) behaves as a biocompatible material and used as 
biodegradable sutures. Therefore, it is a suitable material for the transport of drugs, 
such as ibuprofen [2]. 
 
Ibuprofen is an anti-inflammatory steroid. It is used to relieve symptoms of arthritis, 
primary dysmenorrhoea, fever, and as an analgesic, especially where there is an 
inflammatory component. Ibuprofen appears to have the lowest incidence of 
gastrointestinal reactions adverse of all non-selective NSAIDs (Non-steroidal anti-
inflammatory drug). However, this only occurs at lower doses of ibuprofen, because it's 
usually advisable a maximum daily dose of 1,200 mg. Adverse effects include 
dyspepsia, nausea, ulcers / bleeding gastrointestinal, hepatic enzymes increased, 
diarrhea, constipation, epistaxis, headache, dizziness, priapism, rash, retention salt 
and fluid, and hypertension. A 2010 study has shown that the use regular NSAID was 
associated with increased hearing loss. Uncommon side effects include, oesophageal 
ulceration, heart failure, hyperkalemia, renal failure, confusion, and bronchospasm. 
Currently, it requires that drug delivery systems be precise in their control of drug 
distribution and reduce the side effects of the drug. Therefore, drug delivery systems 
based on a polymeric matrix can allow to have control of the drug release during a 
period of time until reaching the expected effect in the right target. [8]. 
Release of core material from a non-erodible microcapsule can happen in different 
ways. Four theoretical curves (A, B, C and D) that describe four types of diffusion 
kinetics are contained in Fig 1 [9]. 
 
Curve A represents the type of release of a seamless, non-erodible, spherical 
microsphere encapsulated material released by the state balance of diffusion through a 
coating of uniform thickness. Rate release remains constant as long as the 
concentrations inner and outer core material and the concentration gradient through 
the membrane are constant. If the beginning is to establish need a finite time, the 
concentration gradient is constant that is on the wall of the membrane, and then there 
is a delay release of the core material. Curve A of Fig 1 shows system without delay. If 
some of the encapsulated materials migrate through of the microsphere membrane 
during storage happens effect of "burst" (initial burst release), represented by curve B. 
If the microsphere acts as a matrix of inert particles in the core material is dispersed (a 
bead), the Higuchi model is valid up to 60% release. In this case, the percentage of 
drugs released according to the square root of time is linear, as indicated by curve C in 
Fig 1. The release of the first order is represented by curve D. The curve is linear if it 
represents the logarithm of the percentage of core material remaining in the capsule 
versus time [9]. 
 
 
Fig 1. Theoretical curves of release behaviour. A, Membrane reservoir-type free of lag 
time and burst effects; B, same as A, with burst effects; C, matrix or monolithic sphere 
with square root time-release; D, system with first-order release [7]. 
 
 
 
During the study various semi-empirical equations were used, such as the “power law” 
used to describe the release of the drug from the polymeric system [10-12]: 
 
nt t·k
M
M


   (1) 
 
where  
  
  
 , is the percentage of drug released at each interval of time relative to the 
percentage of release at the equilibrium, “K” is the constant of drug release, t is time 
measured and finally “n” is the diffusion exponent. 
 
The equation of power law, gives the diffusion exponents which are classified by this 
Table 1. 
 
 
Table 1. Drug delivery models based on the parameter n.   
Exponent n    
Plane surface Cylinder Sphere Drug Delivery Systems 
0,5 0,45 0,43 Fickian Diffusion Mechanism 
0,5 < n < 1,0 0,45 < n < 0,89 0,43 < n < 0,85 Anomalous Diffusion 
1,0 0,89 0,85 Non-Fickian Diffusion Mechanism 
 
From Equation 1, when the exponent “n” is set to 1, the rate of drug released is 
independent of time. This case corresponds to zero order kinetics. For films, the 
mechanism that creates zero-order release is known among experts such as case II 
transport. Here the relaxation of macromolecules process happens over the imbibitions 
of water in the system that is the stage of speed control. Water acts as a plasticizer and 
decreases the glass transition temperature (Tg) of the polymer. Once the Tg is equal to 
the set temperature, the polymer chains pass from the glassy state to rubbery state, 
with an increase of the mobility of macromolecules and volume expansion. 
 
Thus, Equation 1 has two different physical realistic meanings in the two special case 
of n = 0,5 (indicating the diffusion controlled release of active principles). The values of 
“n” between 0,5 and 1 can be considered as an indicator for the superposition of both 
phenomena (anomalous transport). It must always be clear that the two extreme values 
for the exponent n, 0,5 and 1, are only valid for flat sheet geometry. 
 
The transport in swelling systems can be described by Fick’s second Law, because of 
this, the diffusion of the active principle can be studied as a plane surface for short 
times of liberation, from the Korsenmeyer-Peppas equation approximation [10-12]. 
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where D is the diffusivity of the active principle in the polymeric system, and δ is 
the thickness of the lamina. 
 
The model to describe the release drug release from polymeric matrices is derived 
from the equation of Higuchi for planar films [10-12]: 
 
t·K
M
M t 

     (3) 
 
In this study, we have tried to apply those drug delivery models to the 
microencapsulation of ibuprofen and its subsequent applications on biofunctional 
textiles in order to know the pattern of drug release corresponding to ibuprofen. 
2. EXPERIMENTAL 
 
2.1. MATERIALS  
 
PCL (poly(ε-caprolactone)) with a molecular mass (Mn) of 60,000 from Aldrich. 
Ibuprofen in powder with a molecular mass (Mr) of 206.28, supplied by Sigma-Aldrich. 
PVA (Poly(vinyl alcohol)), 87-89% hydrolyzed,  with a (Mw) range of 31,000-50,000 
from Aldrich. Dichloromethane stabilized with 20 ppm of amylene, supplied by Panreac 
were used to prepare microspheres. 
The standard woven fabrics used were: Cotton fabric (COT) (Style, ISO 105 - F02) 
Polyamide fabric (PA) (Style 361, ISO 105-F03), Polyester fabric (PET) (Style 777, ISO 
105-F04), and Acrylic fabric (PAC) (Style 864, ISO 105-F05) from Test Fabrics Inc 
(USA). 
All chemicals used were of analytical grade. 
 
2.2 PREPARATION OF IBUPROFEN MICROSPHERES 
 
The solvent evaporation method is used to obtain the microspheres and by it form a 
microemulsion (o1/o2/w double emulsion). 
Briefly, the polymer (PCL) and the active principle (ibuprofen) were separately 
dissolved in methylene chloride and in isopropylic alcohol, respectively. 
 
The simple emulsion (o1/o2) was generated by mechanical agitation (Ultra-turrax T25, 
IKA) for several minutes. Afterwards, this simple emulsion was added to a continuous 
phase, constituted of 150 ml aqueous solution of PVA (dispersant) (2% w/w) and 
emulsified for several minutes resulting in a double emulsion (o1/o2/w). The mixture 
was maintained under constant agitation until total evaporation of the solvent in order 
to obtain the corresponding microsphere. The method used was carried out at room 
temperature. [13-17] 
 
2.3 CHARACTERIZATION 
 
For the characterization of the obtained microspheres, 4 tests were done: Scanning 
Electron Microscopy (SEM), Encapsulation Efficiency, Fourier Transform Infrared 
Spectroscopy (FTIR) and Particle Size Distribution. 
 
 
 
2.3.1 ENCAPSULATION EFFICIENCY 
 
The encapsulation efficiency (EE) of active compound in microspheres was detected 
indirectly in the liquid phase by UV/Vis Spectrophotometer (Shimadzu UV-2401 PC) 
after centrifugation of dissolution for several minutes. The percentage of caffeine 
entrapped in the dispersion was calculated by following equation: 
 
100
C
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t
dt 

  (4) 
 
where Ct is the theoretical concentration of microencapsulated drug, Cd is the drug 
concentration remaining in the bath solution corresponding to the amount of drug that 
has not been microencapsulated. 
 
2.3.2 FOURIER TRANSFORM INFRARED SPECTROSCOPY (FTIR) 
 
A Fourier-transform infrared spectrometer FTIR (Avatar System 320) was used to 
identify the chemical structure of the formulation of microspheres which were prepared 
by grinding the powder sample with KBr (wave-numbers 500-4000 cm-1, at a resolution 
of 4 cm-1 and by coadding 20 scans). The goal has been to investigate the possible 
interactions that can be produced between the polymer and the active agent [18-20]. 
 
2.3.3 PARTICLE SIZE DISTRIBUTION 
 
Particle size distribution of microspheres was carried out at Malvern Nanosizer (Model 
Nano-ZS Series, Malvern). Microspheres samples were introduced into a DTS1060C – 
Clear disposable zeta cell and water was used as a dispersant at 25ºC. The results 
were reported as intensity of size distribution. 
 
2.3.4 SCANNING ELECTRON MICROSCOPY (SEM) 
 
The treated fabrics were analyzed by SEM (model JSM-5610, JEOL, Tokyo, Japan) in 
order to detect the existence of microspheres as well as analyze their morphology 
(shape and surface). 
 
2.4 FINISHING PROCESS 
 
The application of microcapsules onto the fabrics was carried out by foulard process 
using a Pad-Dry technique of 30 cm width (ERNST BENZ AG KLD-HT and KTF/m250) 
and followed by a process of drying at room temperature, with the padding pressure to 
obtain a pick-up of 805%, from the microencapsulation formulations. The treated 
fabric samples were finally conditioned at 202ºC and 605% relative humidity for 24 
hours before weighting and proceeding to perform subsequent experiments. 
 
 
 
2.5 DRUG RELEASE 
 
To analyze the kinetic release of ibuprofen, samples of 1 g of the treated fabric were 
submerged into the thermostatized vessels filled with deionized water and physiological 
saline at semi-infinite bath conditions at a temperature of 37ºC. The semi-infinite bath 
is called to the system which has one limited direction and extends infinitely in the 
other, therefore it can be considered that the diffusion into the edges can be neglected. 
This analysis aims to study the environmental effects on the drug release systems, for 
instance the effect of saline medium (physiological saline), simulating the skin’s sweat. 
The amount of active principle released to the bath was determinate by UV/Vis 
Spectrophotometer at different times (from 0 to 200 hours).  
 
3 RESULTS AND DISCUSSION 
Microspheres of ibuprofen were prepared following the method of experimental part. 
Then, those microspheres were characterized using several techniques outlined in the 
experimental part. 
 
3.1 ENCAPSULATION EFFICIENCY 
 
After 20 hours of stirring the microspheres preparation at room temperature, the 
encapsulation efficiency was analyzed. 
Table 2 shows the ibuprofen encapsulation efficiencies obtained by triplicates, the 
overall average was about 84%. 
 
Table 2. Encapsulation efficiency of the ibuprofen microspheres. 
 
Sample Encapsulation efficiency 
(%) 
1 88.00 
2 82.00 
3 82.00 
 
According to the literature [21-23], the efficiency results obtained are very high. Thus, it 
may ensure us that the designed method for preparation of ibuprofen microspheres has 
been very efficient. 
 
3.2 FTIR - MICROSPHERES OF IBUPROFEN 
 
FTIR analysis were carried out to see structural changes between different 
microspheres components. 
Two types of FTIR spectra were obtained. The first one (Fig 2) corresponds to a 
comparison between the polymer and empty microspheres, and the second one (Fig 3) 
compares the structural changes detected between ibuprofen, microspheres of 
ibuprofen and empty microspheres. 
 
 
Figure 2. FTIR spectrum of (a) PCL-microspheres without ibuprofen and (b) PCL 
polymer. 
 
 
Movements of the characteristic groups in the formation of microspheres are 
discussed: 1725 cm-1 (carbonyl stretching) shows a shift of the peak corresponding to 
the movement of the carbonyl group to 1731,63 cm-1. The 1269,58 cm-1 is a shift due to 
an asymmetric movement to 1269,58 cm-1 of the asymmetric COC stretching. Also 
notes the displacement of the peaks 2944,23 and 2865,46 cm-1 corresponding to the 
CH2 group tension movement. 
These movements that occur during the process, may be crucial to justify optimal 
formation of the microspheres. As it can be seen, PCL polymer has changed from a 
linear chain to a polymeric matrix form. 
 
 Figure 3.  FTIR spectrum of (a) PCL-microspheres with ibuprofen and (b) ibuprofen. 
 
 
As shown in the image of the different spectra, it can be appreciated the disappearance 
of one of the characteristic peaks 1231,19 cm-1 corresponding to C-O stretching 
(COOH) and O-H bending. Also, it can observed an increased frequency range 
corresponding to the movement of carbonyl group (1731,63 cm-1 (carbonyl stretching)),  
in the case of microspheres corresponds to the structure of the polymer containing 
more carbonyl groups than the active principle. Moreover, ibuprofen presents a certain 
stearic hindrance due to its aromatic group.  This movement could give an idea about a 
possible interactions due to hydrogen bonds. 
 
3.3 PARTICLE SIZE DISTRIBUTION - MICROSPHERES OF IBUPROFEN 
 
Another parameter studied to characterize the ibuprofen microspheres was particle 
size. The size of microspheres could be easily affected by a variety of processing 
factors such as volume and viscosity of inner and external aqueous phase [24].  
The particle size distribution of microspheres in terms of intensity is shown in Fig 4. 
 
 Fig 4. Size distribution by intensity of ibuprofen microspheres. 
 
The average particle diameter is 846.9 ± 64,95 nm. As a consequence, the particles 
obtained can be considered as microspheres, because their particle sizes meaning that 
are about 1 µm. 
 
The polydispersity (PDI) value is about 1.000 meaning there are many microspheres 
with a very different sizes. The PDI values range from 0 to 1 and a higher value 
indicates a less homogeneous particles size distribution. Therefore, the results indicate 
that microparticles generated  have low homogeneity in size distribution. 
 
3.4 FINISHING PROCESS 
The application of the ibuprofen encapsulated on the textile substrates was performed 
by pad-dry. The percentages of pick up for the different textiles, and percentages of dry 
product applied calculated by weight difference between dry initial fabric and dry fabric 
after Pad-dry process are indicated in Table 3. 
 
Table 3. Results of the finishing process of several textile fabrics. 
 
Textile % Pick-up*  
(% theoretical product) 
% o.w.f.* 
 Dry product applied 
COT 76.13 4.30 
PA 80.20 35.06 
PAC 81.79 18.24 
PET 77.65 75.65 
* % pick-up and the theoretical percentage of product present in the wet fabrics after 
impregnation; and % o.w.f. (on weight of fibres) of product applied, calculated by 
weight difference between dry non-treated textile and dry textile after Pad-Dry process. 
 
It can be seen that depending on each fabric, the results obtained were quite different. 
Above all we must mention that the cotton has been reduced importantly dry 
impregnation on the wet; however the changes were observed in the case of polyester, 
had remained practically the same permeation rate in both dry and wet.  These results 
should be understood taking into account the efficiencies and the affinities of the fabric 
with the polymer in terms of hydrophilicity/hydrophobicity. 
 
3.5 SCANNING ELECTRON MICROSCOPY (SEM) 
 
Treated fabrics (only cotton fabric) with ibuprofen microspheres have been analyzed by 
SEM and the micrographs are shown bellow. 
 
 
         (i)          (ii)  
Fig 5. Scanning electron micrographs of microspheres on cotton fabric. (i) 
microspheres with ibuprofen (x400). (ii) microspheres without ibuprofen (x500). 
 
These two micrographs (Fig 5) show that microspheres were formed with a spherical 
shape smooth surface, composed of PVA, but internally are porous (although it is not 
appreciated in these micrographs). The surfaces layer of PVA acts as a binder 
between microspheres and fabric. It can be observed that all cases the microspheres 
maintain the same characteristics, thus the process may not be affected by active 
compound. 
 
3.6 DRUG RELEASE 
 
Afterwards, from the experimental results obtained, we proceed to apply two type of 
analysis, qualitative (Theoretical Mechanisms of Drug Release) and quantitative (Semi-
empirical Equations), in order to know the mechanism of drug release for each kind of 
fabric. 
 
  
3.6.1 DRUG RELEASE – THEORETICAL MECHANISMS OF DRUG RELEASE 
 
The ibuprofen release from PCL-microspheres of all treated fabric samples (COT, PA, 
PAC and PET) are characterized by a bimodal behaviour depending on the type of 
fabric as shown in the following Figures. 
 
 
 
Fig 6. Kinetic release of ibuprofen microspheres applied onto cotton fabric at 37ºC 
according to the experimental media used. Mt (g ibuprofen/ g fabric). 
 
 
 
Fig 7. Kinetic release of ibuprofen microspheres applied onto polyamide fabric at 37ºC 
according to the experimental media used. Mt (g ibuprofen/ g fabric). 
 
 
 Fig 8. Kinetic release of ibuprofen microspheres applied onto acrylic fabric at 37ºC 
according to the experimental media used. Mt (g ibuprofen/ g fabric). 
 
 
 
Fig 9. Kinetic release of ibuprofen microspheres applied onto polyester fabric at 37ºC 
according to the experimental media used. Mt (g ibuprofen / g fabric). 
 
Comparing the kinetic profiles obtained with the theoretical curves (A, B, C and D) 
illustrated in Fig 1 it can be deduced that the behaviour of the fabrics in water medium 
is similar to the theoretical curve D whereas in saline medium the fabrics behave like a 
theoretical curve between B/C. In general, burst effect happens, and it can be seen 
more differences in the case of cotton and polyester than in the others regarding to the 
type of medium. 
 
  
3.6.2 DRUG RELEASE – SEMIEMPIRICAL EQUATIONS 
 
Using Eq. (1), the value of the exponent n, indicative of mass transport mechanism was 
calculated and the results are shown below (Table 4). 
 
Table 4. Estimated parameters, (K) and n values obtained from fitting drug release 
experimental data to Power Law (Eq. (1)). 
 
Fabric 
type 
T (ºC) Classification 
(Fig 1) 
Experimental 
media 
K n Drug 
Delivery 
System 
COT 37 D 
Deionized 
water 0,0860 0,2948 
Fickian 
diffusion 
37 B 
Physiological 
saline 0,3313 0,1288 
Fickian 
diffusion 
PA 37 D 
Deionized 
water  0,0567 0,3805 
Fickian 
diffusion 
37 B/C 
Physiological 
saline 0,3159 0,1368 
Fickian 
diffusion 
PAC 37 D 
Deionized 
water 2,9424 0,3109 
Fickian 
diffusion 
37 B/C 
Physiological 
saline 0,3734 0,1258 
Fickian 
diffusion 
PET 37 D 
Deionized 
water 2,8987 0,3034 
Fickian 
diffusion 
37 B/C 
Physiological 
saline 0,3474 0,1335 
Fickian 
diffusion 
 
Considering the results obtained for all systems, it is very clear that the ibuprofen 
release is governed by a Fickian diffusion. 
 
As the release mechanism of active principle follows a Fickian diffusion, the Higuchi 
Equation (3) governed by this mechanism and the approach of Korsenmeyer-Peppas 
(2) for plane surfaces have been assumed.  
 
Using Eq. (2) and Eq. (3), it main parameters (expressed as apparent diffusion 
coefficients), KH and D/δ
2, respectively , have been calculated and are shown in Table 
5. 
 
 
Table 5. Estimated parameters applying Higuchi Equation (Eq. (3)) and Korsenmeyer-
Peppas equation approximation (Eq. (2)). 
Fabric type T (ºC) Experimental 
media 
D/δ2 KH 
COT 
37 Deionized water 0.0002 0.0355 
37 
Physiological 
saline 
0.0036 0.1346 
PA 
37 Deionized water 0.0003 0.0383 
37 
Physiological 
saline 
0.0030 0.1240 
PAC 
37 Deionized water 0.1158 0.7678 
37 
Physiological 
saline 
0.0042 0.1460 
PET 
37 Deionized water 0.1031 0.7246 
37 
Physiological 
saline 
0.0037 0.1373 
 
It can be observed that cotton and polyamide have a similar trend, because in both 
cases the apparent diffusion coefficient and the constant KH have similar values in 
deionized water. In contrast, in the case of acrylic and polyester the results observed 
were quite distant from cotton and polyamide but being similar to each other. It seems 
that saline medium has not an influence in the different systems, because the results 
obtained were similar in all cases. 
 
4. CONCLUSIONS 
 
It has been demonstrated that the microencapsulation of ibuprofen it’s possible, and it 
can be done by a procedure with a high percentage of efficiency, which had never 
been reported before. 
Frequencies movements detected by FTIR could give an idea on the possible 
interactions between microspheres and ibuprofen by hydrogen bonds. 
It can be demonstrated that the system has low homogeneity in particle size 
distribution and with the particle size average of 846,9 nm therefore they are 
microspheres. 
The use of a Pad – dry technique promoted a desired permeation. However, in different 
fabrics, the pick-up obtained in dry conditions were different; it seems that the chemical 
affinity there is an important factor to be considered. The kinetic study carried out has 
allowed to determine the same drug delivery behaviour for all systems in each medium.  
All samples are governed by Fickian diffusion. In the case of cotton and polyamide 
have a similar trend, the mass transport has resulted similar in deionized water for 
both. In contrast, in the case of acrylic and polyester the results observed were quite 
distant from cotton and polyamide but being similar to each other. As a result, it has 
been demonstrated that there is no influence of saline medium in the different systems 
because it was obtained similar results in all cases. 
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ABSTRACT 
At the present time, there is a great interest in pharmaceutical technology focused on 
the development of biodegradable microparticles as a controlled release system. In this 
study, PLGA-microspheres containing caffeine were prepared using a water-in-oil-in-
water (w/o/w) solvent evaporation procedure with poly(vinyl alcohol) as surfactant in 
the external aqueous phase. The microspheres obtained were characterized by the 
measure of encapsulation efficiency. The surface morphology and chemical structure 
of the microparticles were investigated using scanning electron microscopy (SEM) and  
Fourier transform infrared spectroscopy (FT-IR). For particle size distribution Zetasizer 
was used. The drug release system was analyzed, through samples of the treated 
textile fabric (cotton, polyamide, acrylic and polyester) by Pad-Dry technique. The 
fibers were submerged into thermostatized vessels filled with two different mediums: 
deionized water and physiological saline. Release data were examined kinetically and 
the ideal kinetic models were estimated for caffeine release.  The results showed a 
bimodal behavior by comparing the different media (water and saline) . It could only be 
assumed a Fickian Diffusion for short times.  
 
Keywords: Microspheres; PLGA; caffeine; Drug release; Biomaterials. 
 
1. INTRODUCTION 
Poly(lactide-co-glycolide) (PLGA) is a biodegradable, biocompatible, non-toxic polymer 
that can be used as a functional material in studies in the field of life sciences. PLGA 
particles have been used commercially in the preparation of drug delivery system 
formulations [1,2]. 
In the last 20 years, biodegradable microspheres of biocompatible polymers as delivery 
systems for active agent have been studied. Generally, the drug is distributed in the 
polymer matrix and is released by two fundamental mechanisms: by diffusion through 
matrix, and polymer degradation, which leads to erosion of the particles. This has been 
used natural and synthetic polymers, among the latter highlights the copolymers of 
lactic acid and glycolic acid (PLGA) [3,4]. 
The term biomaterial includes all materials introduced into the body tissues for specific 
therapeutic purposes, diagnostic purposes or prevention. These materials must be 
biocompatible, which means that they should not cause any significant adverse 
response from physiological media that damage the biomaterial; after interaction with 
tissues and body fluids should biodegrade to nontoxic components, chemically and 
physically, or a combination of both [5,6]. 
The design and implementation of systems for controlled drug dosing and management 
systems located in the activity of a given drug is currently one of the most important 
aspects in the development of news forms o medication [7]. The main objective of the 
controlled release is simple: get the right amount of active agent, at the right time and 
right place. This release method is commonly used to prolong the therapeutic dose of 
effectively using a single dose, and to eliminate or minimize the concentrations 
exceeding the therapeutic requirements [8]. 
Release of core material from a non-erodible microparticle can occur in several ways. 
Fig 1 contains four theoretical curves (A, B, C and D) that describe four types of 
release behavior. All curves are plotted as percent drug released versus time. 
Curve A represents the release behaviour of a perfect, non-erodible, spherical 
microcapsule which releases the encapsulated material by steady-state diffusion 
through a coating of uniform thickness. The rate of release remains constant as long as 
the internal and external concentrations of core material and the concentration gradient 
through the membrane are constant. If a finite time is needed to establish the initial, 
constant concentration gradient in the capsule wall membrane then there is a time lag 
in core material release. Curve A in Fig 1 displays a system with no time lag. If some of 
the encapsulated material migrates through the microcapsule membrane during 
storage, a burst effect occurs, as represented by Curve B. If the microcapsule acts as 
an inert matrix particle in which core material is dispersed (a microsphere), the Higuchi 
model is valid up to 60% release (3). In this case, a plot of percent drug released 
versus square-root time is linear, as shown by Curve C in Fig 1. First-order release is 
represented by Curve D. The curve is linear if log percent core material left in the 
capsule is plotted versus time [9]. 
 
 Fig 1. Theoretical release curves expected for different types of non-erodible delivery 
systems. A, Membrane reservoir-type free of lag time and burst effects; B, same as A, 
with burst effect; C, matrix or monolithic sphere with square root time-release; D, 
system with first-order release.  
 
To predict the kinetics of release of a drug, it is necessary to know the exact 
mechanism of mass transport involving this release. Thus, several semi-empirical 
equations to describe the controlled release rate of a drug in a matrix system have 
been formulated. Power Law (1) combines two apparently independent processes, one 
due to the transport of the drug that obeys Fick’s laws and the other to the swelling of 
the fibber, which involves the transition from a state semi-rigid (glass) to a more flexible 
(rubber), 
 
nt t·k
M
M

    
(1) 
 
where Mt amount of drug released at time t, M∞ the maximal amount of the released 
drug at infinite time, k is a constant incorporating structural and geometric 
characteristics of the device, and n is the release exponent, indicative of the 
mechanism of drug release, as can be seen in the table below: 
 
Table I. Drug delivery models based on the parameter n   
Exponent n    
Plane surface Cylinder Sphere Drug Delivery Systems 
0,5 0,45 0,43 Fickian Diffusion Mechanism 
0,5 < n < 1,0 0,45 < n < 0,89 0,43 < n < 0,85 Anomalous Diffusion 
1,0 0,89 0,85 Non-Fickian Diffusion Mechanism 
 
 
Higuchi published the probably most famous and most often used mathematical 
equation (2) to describe the release rate of a drug in a planar system for short periods 
of release time:  
 
t·K
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The mass transport in swelling systems can be described by Fick’s second Law, so the 
diffusion of the active principle can be studied as a plane surface for short time of 
liberation; through the Korsenmeyer-Peppas equation approximation (3), where D is 
the diffusion coefficient of drug release, and δ is the diffusional distance [10,11,12]. 
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2. EXPERIMENTAL 
 
2.1. Materials 
PLGA had a copolymer ratio (lactic acid/glycolic acid) of 75/25 and a molecular mass 
(Mr) range of 5,000-15,000 from Aldrich. Caffeine anhydrous in powder with (Mr) 
194.20 from Fluka. PVA (Poly(vinyl alcohol)), 87-89% hydrolyzed,  with a (Mw) range of 
31,000-50,000 from Aldrich. Dichloromethane stabilized with 20 ppm of amylene, 
supplied by Panreac. 
 
Standard woven fabrics were used: Cotton fabric (COT) (Style 400, ISO 105-F02), 
polyamide fabric (PA) (Style 361, ISO 105-F03), acrylic fabric (PAC) (Style 864, ISO 
105-F05) and polyester fabric (PET) (Style 777, ISO 105-F04). 
All chemicals used were of analytical grade. 
 
2.2. Preparation of microspheres 
The microspheres were performed by a w1/o/w2 emulsion using the conventional 
solvent evaporation method. Briefly, PLGA and caffeine (3:1) were separately 
dissolved in methylene chloride and water, respectively. The simple emulsion (w/o) 
was generated by mechanical agitation (Ultra-turrax T25, IKA) for several minutes at 
24000 rpm. Afterwards, this simple emulsion was added to a continuous phase, 
constituted of 150 ml aqueous solution of PVA (2% w/w) and emulsified for several 
minutes at 24000 rpm, resulting in a double emulsion (w/o/w). The mixture was 
maintained under agitation at 400 rpm (8h) leading to the solvent evaporation and 
consequently the microsphere formation. The method used was carried out at 4ºC 
[13,14,15]. 
 
 
 
 
2.3. Characterization of caffeine loaded-microspheres 
 
For the characterization of the obtained microspheres, 4 tests were done: Scanning 
Electron Microscopy (SEM), Encapsulation Efficiency, Fourier Transform Infrared 
Spectroscopy (FTIR) and Particle Size Distribution. 
 
2.3.1. Encapsulation efficiency 
The encapsulation efficiency of caffeine in PLGA-microspheres was detected indirectly 
in the liquid phase by UV/Vis Spectrophotometer (Shimadzu UV-2401 PC) after 
centrifugation for several minutes. The ratio of amount of caffeine entrapped in the 
dispersion was calculated. 
 
2.3.2. Fourier transform infrared spectroscopy (FTIR) 
FTIR spectra were collected on a FTIR Avatar System 320 by preparing KBr pellets 
using a sample concentration of 1% (w/w). Spectra were recorded between 500 and 
4000 cm-1 at a resolution of 4 cm-1 and by coadding 20 scans. 
 
2.3.3. Scanning electron microscopy (SEM) 
The analyzed samples correspond to the treated fibers. The morphology of 
microspheres was investigated using a SEM (Model JSM-5610 Series, JEOL, Tokyo, 
Japan). Samples were coated with a thin layer of sputtered gold prior to examination. 
 
2.3.4. Particle size distribution 
The size distribution of microspheres was measured using a Zetasizer (Model Nano-ZS 
Series, Malvern). Microsphere samples were introduced into a DTS1060C – Clear 
disposable zeta cell and water was used as a dispersant at 25ºC. The results were 
reported as an intensity size distribution. 
 
2.4. Impregnation of microspheres on textile substrates 
Microspheres were applied onto fabrics 25x40cm2 using Pad-Dry technique (ERNST 
BENZ AG KLD-HT and KTF/m250) and followed by a process of drying at room 
temperature, with the padding pressure to obtain a pick-up of 805%, from the 
microencapsulation formulations.The treated fabric samples were finally conditioned at 
20±2ºC and 60±5% relative humidity for 24 hours. The conditions required for this 
procedure are shown in the table below: 
 
Table II. Conditions of textile impregnation process 
FINISHING CONDITIONS  
SUBSTRATE Fabric Cotton/Polyamide/Acrylic/Polyester 
FABRIC DIMENSIONS 25 x 40 cm2 
LIQUOR RATIO 3 – 5 L/Kg 
PICK-UP 80-90% 
DRYING CONDITIONS Room temperature 
 
 
2.5. Drug Release study 
To analyze the kinetic release of active compounds, samples of 1 g of the treated fabric 
were submerged into the thermostatized vessels filled with deionized water and 
physiological saline at infinite bath conditions at a temperature of 37ºC. This analysis 
aims to study the environmental effects on the drug release systems, for instance the 
effect of saline medium (physiological saline), simulating the skin’s sweat. The amount 
of active principle realized to the bath was determinate by UV/Vis Spectrophotometer 
at different times. 
 
3. RESULTS AND DISCUSSION 
After loaded-microspheres preparation with caffeine, different parameters were 
analyzed to characterize the microspheres. 
 
3.1. Scanning Electron Microscopy (SEM) 
Treated fabrics with microspheres have been analyzed by SEM. SEM micrographs 
confirmed that the adhesion between fabrics and, either caffeine microspheres or 
empty microspheres was effective, as can be observed in Fig 2. Both kind of 
microspheres have a spherical shape with a smooth surface composed of polyvinyl 
alcohol (PVA).  
The cross-sectional picture as shown in Fig 2, it is clear that although internally the 
microspheres are all highly porous, thus causing an increase in the control of the 
dosage of the active principle, there are no distinct hollow cores. Porosity of 
microspheres is known to vary with numerous factors such as polymer molecular mass, 
co-solvent concentration, dispersed phase to continuous phase (DP/CP) ratio, active 
principle concentration, solvent removal rate as well as method. The absence of core 
formation could be due to the presence of emulsifier in the inner aqueous phase, which 
prevents coalescence of the internal water droplets [16]. 
 
There is variety of sizes of microparticles because is not possible to control, over the 
experimental procedure, the drop size at the time of the addition of an emulsion in 
another. This causes the particle size obtained is random and not get a uniform size.  
 
The non-presence of caffeine crystals attached to fabric, leading to consider that the 
methodology used to encapsulate caffeine is perfect. 
 Fig 2. Scanning electron micrographs of microspheres on cotton fabric. (i) 
microspheres with caffeine (x50) (ii) microspheres with caffeine (x50). (iii) cross-
sectional picture of caffeine microspheres (x600). (iv) microspheres without caffeine 
(x500). 
 
3.2. Encapsulation efficiency 
 
Table III shows the results of caffeine encapsulation efficiencies after centrifugation 
and the overall average is about 28%. Encapsulation efficiencies achieved are 
remarkably low [15,17,18] and there is no literature to compare them with other 
encapsulation efficiencies and to establish whether methodology followed is optimal or 
not.  
 
Table III. Encapsulation efficiency of the microspheres 
Sample Encapsulation efficiency (%) 
1 27,97 
2 27,89 
3 27,97 
 
Therefore, further studies are needed to achieve stabilization of the caffeine in the 
polymer matrix, because of the greater affinity of this with the medium than with the 
polymer. 
 
 
 
 
3.3. FTIR Analysis 
FTIR analysis was carried out to verify the microsphere formation, to see if structural 
changes occur in these microspheres and to justify the possible interactions that can 
be to inside of them. 
 
Fig 3 shows the FTIR spectrum of (a) PLGA polymer and (b) microspheres without 
caffeine. Several structural differences are apparent both characteristic frequencies 
movements of the components as defined in the characteristic peaks. The frequency of 
1758.54 cm-1 belonging to the strain carbonyl group (C=O stretching) is part of PLGA, 
have a displacement and an increase in the bandwidth of the frequency (1736.53 cm-1) 
in the spectrum of microspheres without caffeine. Similarly, the frequencies of the 
methyl group (1456.10 cm-1) of PLGA moves and increases the bandwidth in the 
frequency of 1438.86 cm-1 for microspheres without caffeine. Also, note the minimum 
frequency shift of 1090.64 cm-1 (C-O-C asymmetric stretching) and 1272.84 cm-1 (C-H) 
belonging to the PLGA regarding frequencies of 1092.54 cm-1 (C-O-C asymmetric 
stretching) and 1273.84 cm-1 (C-H) microspheres without caffeine. Finally, the 
disappearance of the frequency of 1420.30 cm-1 (C-H deformation caused by the link -
O-CH2) of PLGA in the spectrum of the microspheres without caffeine.  
 
These structural changes suggest that the PLGA polymer goes being a linear chain to 
close and thus form a polymer matrix. 
 
 
Fig 3.  FTIR spectrum of (a) PLGA polymer and (b) microspheres without caffeine. 
 
Fig 4 shows the FTIR spectrum of (a) caffeine microspheres and (b) caffeine. 
Comparing the spectrum of caffeine with caffeine microspheres encapsulated in PLGA, 
many structural differences represented by the displacements of the characteristic 
frequencies of the components can be seen. In the frequency of 1701.53 cm-1, 
belonging to the tension of the carbonyl group (C=O stretching) as part of caffeine, 
there is a movement and an increased bandwidth of the frequency (1736.28 cm-1) in 
the spectrum microspheres containing caffeine. Another import peak to note is 1661.58 
cm-1 (C = N stretching) in the spectrum of caffeine is very significant on the 
microspheres with caffeine. Moreover, the latter suffers a slight shift to a frequency of 
1654.67 cm-1. This move could give an idea of the possible interaction in the form of 
bridges between the oxygen atoms of carbonyl groups and nitrogen that has caffeine. 
Most important frequencies to emphasize that are part of the structure of caffeine and, 
as in previous cases, identify the peaks corresponding displacements, such as: CH3 
asymmetric bend (1456.4 cm-1, 1431. 23 cm-1 and 1359.64 cm-1), the C-N stretching 
(1286.53 cm-1) and cyclic C = N tension (1550.29 cm-1). 
 
 
Fig 4.  FTIR spectrum of (a) caffeine microspheres and (b) caffeine. 
 
3.4. Particle size distribution 
The size of microparticles can be easily affected by a variety of processing factors, 
such as volume of inner and external aqueous phase and the viscosity of inner and 
external aqueous phase. Increase in the molecular mass of polymer also leads to the 
size of microspheres increases [16]. 
 
Fig 5 shows three different size distributions belonging to caffeine microspheres. The 
most important of them is about 87.5% intensity and the average particle diameter is 
159.1 nm. 
 
 
Fig 5. Size distribution by intensity of caffeine microspheres.  
 
About microspheres without caffeine (Fig 6), two similar intensities were obtained, 47.8 
and 43.6%. The average particle diameter is 760.4 nm. 
 Fig 6. Size distribution by intensity of microspheres without caffeine. 
 
These results show that both of them are less than 1 μm, this implies that the achieved 
microspheres are not microspheres, but nanospheres. 
 
3.5. Impregnation of microspheres on textile substrate 
Microspheres solution was applied onto fabrics 25x40 cm2 using Pad-Dry technique. 
The results belonging to % by weight (dry) of various treated fabrics differ significantly 
compared with the % permeation of these in the solution of microspheres, as shown in 
Table IV.  
 
Table IV. Results of the finishing process of several textile fabrics: % pick-up and the 
theoretical percentage of product present in the wet fabrics after impregnation; and % 
o.w.f. (on weight of fibres) of product applied, calculated by weight difference between 
dry non-treated textile and dry textile after Pad-Dry process. 
Textile % Pick-up*  
(% theoretical product) 
% o.w.f.* 
 Dry product applied 
COT 83.37 2.37 
PA 80.94 1.75 
PAC 82.49 1.98 
PET 81.21 1.26 
 
This implies that the fabrics absorb the solution of microspheres. However, in dry, few 
microspheres remain attached to them, probably caused by a lack of affinity in the 
system. Another important fact can be the influence of medium due to such low 
encapsulation efficiencies obtained.  
 
Fabric has a higher percentage by weight (dry) is the cotton. Cotton is a hydrophilic 
fiber with the same ability as to absorb as to desorb. The polyester fabric is the 
contrary of cotton because is the most hydrophobic synthetic fabric. Lastly, there are 
the fabrics of polyamide and acrylic, although the last has a higher weight percent (dry) 
than the polyamide fabric, it is the most hydrophobic of each other. 
 
 
3.6. Theoretical mechanisms of Drug Release 
 
The results obtained on the kinetic release profiles for all treated fabric samples (PA 
COT, PA, PAC and PET) in deionized water and physiological saline are graphically 
plotted in Figures 7 to 10. 
 
The caffeine release from PLGA-microspheres of all treated fabric samples (COT, PA, 
PAC and PET) are characterized by a bimodal behavior depending on the medias as 
shown in following figures. 
 
 
Fig 7. Kinetic release of caffeine microspheres applied onto cotton fabric at 37ºC 
according the experimental media. Mt (g caffeine/ g fabric). 
 
 
Fig 8. Kinetic release of caffeine microspheres applied onto polyamide fabric at 37ºC 
according the experimental media. Mt (g caffeine/ g fabric). 
 
 Fig 9. Kinetic release of caffeine microspheres applied onto acrylic fabric at 37ºC 
according the experimental media. Mt (g caffeine/ g fabric). 
 
 
Fig 10. Kinetic release of caffeine microspheres applied onto polyester fabric at 37ºC 
according the experimental media. Mt (g caffeine/ g fabric). 
 
It can be demonstrated that there are big differences in the amount of active principle 
released. In the case of cotton the released active principle was higher than in the 
other fabrics, in both mediums. However, synthetic fabrics showed released amounts 
of active principle  were similar between each other, therefore it can be considered that 
the nature of fabrics may influence on the delivery system. 
 
In all different textiles the caffeine release to deionized water are faster than to 
physiological saline. This may be due to saline ions that interact with the system 
causing it to behave differently in each case. 
 
Comparing the kinetic profiles from the theoretical curves (A, B, C and D) illustrated in 
Fig 1. The behavior of the different fabrics, regardless the mediums were similar to the 
theoretical curve B/D. This bimodal kinetic profile could be explained by a burst effect 
and a part of the drug entrapped in the polymeric matrix, which requires a longer time 
for degradation [17,19]. 
 
Several semi-empirical equations to describe the controlled release rate of caffeine in 
deionized water and physiological saline were analyzed. 
 
3.7. Power Law 
 
As mentioned in the Introduction, fabrics have two behaviors and were treated in two 
steps, short times (K1) and long times (K2). Using Eq. (1), the value of the exponent n, 
indicative of mass transport mechanism was calculated. Therefore, the most release 
mechanism of caffeine from PLGA-microspheres of all samples was governed by 
Fickian diffusion, as shown in Table V. Except for acrylic that is an anomalous delivery 
in physiological saline medium. 
 
Table V. Estimated parameters, short times (K1) and n values obtained from fitting drug 
release experimental data to Power Law (Eq. (1)). 
Fabric 
type 
T (ºC) Classification 
(Fig 1) 
Experimental 
media 
K1 n1 Drug 
Delivery 
System 
COT 
37 B/D 
Deionized 
water 
0.4676 0.2273 
Fickian 
diffusion 
37 B/D 
Physiological 
saline 
0.2371 0.4909 
Fickian 
diffusion 
PA 
37 B/D 
Deionized 
water 
0.5981 0.0881 
Fickian 
diffusion 
37 B/D 
Physiological 
saline 
0.4826 0.0913 
Fickian 
diffusion 
PAC 
37 B/D 
Deionized 
water 
0.5064 0.2588 
Fickian 
diffusion 
37 B/D 
Physiological 
saline 
0.1467 0.6825 
Anomalous 
diffusion 
PET 
37 B/D 
Deionized 
water 
0.6786 0.0265 
Fickian 
diffusion 
37 B/D 
Physiological 
saline 
0.3929 0.1070 
Fickian 
diffusion 
 
 
  
Table VI. Estimated parameters, long times (K2) and n values obtained from fitting drug 
release experimental data to Power Law (Eq. (1)). 
 
Fabric 
type 
T (ºC) Classification 
(Fig 1) 
Experimental 
media 
K2 n2 Drug 
Delivery 
System 
COT 
37 B/D 
Deionized 
water 
0,7276 0,0382 
Fickian 
diffusion 
37 B/D 
Physiological 
saline 
0,5487 0,0620 
Fickian 
diffusion 
PA 
37 B/D 
Deionized 
water  
0,6979 0,0390 
Fickian 
diffusion 
37 B/D 
Physiological 
saline 
- - - 
PAC 
37 B/D 
Deionized 
water 
0,8270 0,0142 
Fickian 
diffusion 
37 B/D 
Physiological 
saline 
0,4953 0,0642 
Anomalous 
diffusion 
PET 
37 B/D 
Deionized 
water 
- - - 
37 B/D 
Physiological 
saline 
0,1902 0,4714 
Fickian 
diffusion 
 
 
In long times, the mechanism of caffeine delivery is governed by Fickian diffusion as 
shown Table VI. And again, except for acrylic that is an anomalous delivery in 
physiological saline medium. 
 
 
3.8. Korsenmeyer-Peppas equation approximation and Higuchi model for a 
planar matrix 
As the release mechanism of active principle follows a Fickian diffusion, the Higuchi 
equation governed by this mechanism and the approach of Korsenmeyer-Peppas for 
plane surfaces have been proposed. The parameters were obtained from these 
equations for each treated fabric, and according to the experimental media are shown 
in Table VII. 
 
 
 
 
Table VII. Estimated parameters applying Higuchi’s equation (Eq. (2)) and 
Korsenmeyer-Peppas equation approximation (Eq. (3)). 
Fabric type T (ºC) Experimental 
media 
D/δ2 KH 
COT 
37 Deionized water 0.0116 0.2429 
37 
Physiological 
saline 
0.0162 0.2875 
PA 
37 Deionized water 0.0084 0.2072 
37 
Physiological 
saline 
0.0070 0.1893 
PAC 
37 Deionized water 0.0289 0.3836 
37 
Physiological 
saline 
0.0137 0.2639 
PET 
37 Deionized water 0.0264 0.3663 
37 
Physiological 
saline 
0.0079 0.2004 
 
 
The results from Table VII show that in the case of PAC and PET fabrics, the 
experimental medium most conducive to the mass transport of caffeine, and the 
constant K, is deionized water. The PAC fabric has the high mass transfer coefficient, 
closely followed by PET fabric. Therefore, one can say who have a behavior and a 
similar trend as seen in the qualitative analysis of the same, being the two most 
hydrophobic tissue while COT and PA the most hydrophilic. COT and PA do not follow 
the same trend as those of PAC and PES. As PA deionized water medium in the 
middle of the mass transfer coefficient and the constant K is greater than in saline, 
although much lower values than those of PAC and PES for COT is quite the opposite.  
The effect of mediums is important because the kinetic parameters are different. The 
mass transfer coefficient is lower in deionized water than physiological saline. The 
release of caffeine may be inhibited, due to some interactions between fiber carboxyl 
groups and ions of physiological saline [20], like is the case of PA and PET. This 
makes sense in COT and PAC have higher values than others, because do not have 
carbonyl groups in their chemical structures. 
 
4. CONCLUSIONS 
PLGA microspheres containing caffeine were obtained by a w/o/w double-emulsion 
solvent evaporation technique. The encapsulation efficiency of caffeine was low, 
leading to further studies to improve these efficiencies. Frequencies movements could 
give an idea of the possible interaction in form of bridges between the oxygen atoms of 
carbonyl groups and nitrogen that has caffeine. Microspheres have a spherical shape, 
a smooth surface produced by polyvinyl alcohol (PVA) and are internally highly porous, 
thus causing an increase in the control of the dosage of the active principle. It is 
necessary to get a relative homogeneity in the size distribution of particles and so, to 
achieve efficient results. Pad-dry technique causes a desired permeation control and, 
therefore, is a simple technique that allows the application of the desired amount of 
fabric products. The kinetic study determined a bimodal behavior and the medium 
significantly affects to drug release system. 
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ABSTRACT 
 
Current technology of microencapsulation has enabled the production of biofunctional 
textiles. These textiles are able to release drugs or cosmetics to the skin. This 
technology is based on empirical procedure that are limited to applications high value-
added, such as medicine field for drug delivery. A quantitative analysis based on 
physico-chemical principles can allow the generation of new technologies. 
In this work, after the foulard application of a microencapsulated active principle, a sun 
filter, ethyl hexyl methoxycinnamate (EHMC), into microcapsules, onto different fabrics 
(polyamide, acrylic, and polyester), the drug delivery system was analyzed, through 
samples of the treated fiber that were submerged into a thermostatized vessels with 
deionised water at semi infinite bath conditions. The amount of active principle 
delivered to the bath was determined by UV-Visible Spectrophotometry. The 
determination of the exact amount of active principle present in the fabric samples was 
assessed by a previous ultrasound bath extractions and an analytical sun filter 
detection from the extracted baths by HPLC. 
From the results obtained, it can be concluded that the sun filter delivery is clearly 
related with the existing gradient of concentration in the sample following a mechanism 
of Fickiag diffusion. 
 
Keywords: Microcapsules; Ethyl hexyl methoxycinnamate (EHMC); Biofunctional 
textiles; Drug release; 
 
INTRODUCTION 
The science of drug release may be described as the application of chemical and 
biological principles to control the in vivo temporal and spatial location of drug 
molecules for clinical benefit. When drugs are administered, only a very small fraction 
of the dose actually hits the relevant receptors or sites of action, and most of the dose 
is actually wasted either by being taken up into the “wrong” tissue, removed from the 
“right” tissue too quickly, or destroyed en route before arrival. [1, 2] 
Today's world requires that drug delivery systems be precise in their control of drug 
distribution. Moreover, many drugs are difficult to taking because they must be 
delivered slowly over a prolonged period to have a beneficial effect. 
The design and implementation of systems for controlled drug dosing and management 
systems located in the activity of a given drug is currently one of the most important 
aspects in the development of news forms o medication [3]. The main objective of the 
controlled release is simple: get the right amount of active agent, at the right time and 
right place. This release method is commonly used to prolong the therapeutic dose of 
effectively using a single dose, and to eliminate or minimize the concentrations 
exceeding the therapeutic requirements [4]. 
Actual capsule release data have been plotted for all of the described ways and 
analyzed in terms of the appropriate model. Good agreement between actual results 
and assorted model release curves may exist for some portion of the release curve, but 
significant deviations occur often. Release of core material from a non-erodible 
microcapsule can occur in several ways. Figure 1 contains four theoretical curves (A, 
B, C, and D) that describe four types of release behaviour. All curves are plotted as 
percent drug released versus time. 
Curve A represents the release behaviour of a perfect, non-erodible, spherical 
microcapsule which releases the encapsulated material by steady-state diffusion 
through a coating of uniform thickness. The rate of release remains constant as long as 
the internal and external concentrations of core material and the concentration gradient 
through the membrane are constant. If a finite time is needed to establish the initial, 
constant concentration gradient in the capsule wall membrane then there is a time lag 
in core material release. Curve A in Figure 1 displays a system with no time lag. If 
some of the encapsulated material migrates through the microcapsule membrane 
during storage, a burst effect occurs, as represented by Curve B. If the microcapsule 
acts as an inert matrix particle in which core material is dispersed (a microsphere), the 
Higuchi model is valid up to 60% release (3). In this case, a plot of percent drug 
released versus square-root time is linear, as shown by Curve C in Figure 1. First-order 
release is represented by Curve D. The curve is linear if log percent core material left in 
the capsule is plotted versus time. [5] 
 Figure 1. Theoretical release curves expected for different types of nonerodible 
delivery systems. A, Membrane reservoir-type free of lag time and burst effects; B, 
same as A, with burst effects; C, matrix or monolithic sphere with square root time-
release; D, system with first-order release. 
 
The Korsenmeyer-Peppas equation (1) is used to account for the coupled effects of 
Fickian diffusion and viscoelastic relaxation in polymer systems, including both 
processes, 
 
nt tk
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·

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where Mt amount of drug released at time t, M∞ the maximal amount of the released 
drug at infinite time, k is the rate constant of drug release, n is a diffusional exponent 
that depends on the system geometry and its value is indicative of the release 
mechanism of the active principle. 
 
Eq (1) has been used frequently in the literature to describe the relative importance of 
transport mechanisms as shown in Table I. [5][6][7][8] 
 
Table 1. Drug delivery models based on the parameter n. 
N Drug Delivery Systems 
n ≤ 0,5 Fickian Diffusion Mechanism 
0,5 < n < 1 Anomalous Diffusion 
n ≥ 1 Non-fickian Diffusion Mechanism (zero-
order model) 
 
 
Higuchi published the probably most famous and most often used mathematical 
equation to describe the release rate of drugs from matrix systems. Initially valid only 
for planar matrix was later modified and extended to consider different geometries and 
matrix characteristics. The classical Higuchi equation was derived under pseudo-
steady state assumptions and generally cannot be applied to real controlled release 
systems. This equation can be expressed as: 
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In addition, a proportionality between the fractional amount of drug released and the 
square root of time can as well be derived from an exact solution of Fick’s second Law. 
So the diffusion of the active principle can be estudied as a plane surface for short 
times of liberation, where D is the diffusion coefficient of drug release, and δ is the 
thickness of thin films under perfect sink conditions, can be expressed as follows [10-
12]: 
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Thus, a proportionality between the fraction of drug released and the square root of 
time can also be based on these physical circumstances which are substantially 
different from those studied by Higuchi for the derivation of his classical equation. 
The main objective of this study has been to evaluate the diffusion system with 
mathematical kinetic models, for the drug release from textiles treated with 
microcapsules systems which contains an active agent such as Ethyl Hexyl 
Methoxycinnamate (EHMC). 
 
2. EXPERIMENTAL 
 
2.1 Materials 
Standard woven fabrics were used: Polyamide fabric (PA) (Style 361, ISO 105-F03), 
polyester fabric (PET) (Style 777, ISO 105-F04), and acrylic fabric (PAC) (Style 864, 
ISO 105-F05) from Test Fabrics Inc (USA). 
Microcapsules (38% EHMC, 56.8% water) from Lipotec Group (Gavà, Spain) were 
prepared by o/w emulsion with a shield of silicic acid and xanthan gum for an external 
wall. Principal parameters of the microcapsules were determined by a Zeta-sizer Nano-
ZS (Malvern, U.K.), obtaining an average diameter of them of 936.7 nm (Standard 
deviation 7.3 nm) and an average zeta potential of -37.8 mV (standard deviation 9.2 
mV) 
All chemicals used were of analytical grade.  
 
2.2 Treatment of the fabrics with microcapsules 
All fabrics samples (PA, PAC and PET) were conditioned under standard atmospheric 
pressure at 202ºC and 605% relative humidity for 24 hours prior to application. 
Microcapsules were applied onto fabrics 25 x 40 cm2 at 20% of solution (7.6 % EHMC) 
and pH 4.1.  
The application of microcapsules onto the fabrics was carried out by a pad-dry 
technique that consists on foulard with diffusion and fixation by dry. It was followed by a 
process of drying in the Laboratory Stenter (ERNST BENZ AG KLD-HT and 
KTF/m250), with the padding pressure to obtain a pick-up of 805%, from the 
microencapsulation formulations. Then the impregnated and squeezed fabrics were put 
into an air curing and heat –setting chamber and maintained at 47ºC for 10 minutes. 
The treated fabric samples were finally conditioned at 202ºC and 605% relative 
humidity for 24 hours before weighting and proceeding to other experiments. 
 
2.3 Extraction methodology 
Fabric samples about 1g were extracted by a Soxhlet using 100ml isopropanol/water 
(50/50), using a 1/100 liquor ratio for 1h at its boiling point (82.3ºC). After the extraction 
textile samples were dried 48 hours in the same conditions (20ºC and 60% RH) before 
weighted. 
A Cary 300 Bio spectrophotometer (Varian, USA) was used to detect EHMC in an 
isopropanol/water (50/50 v/v) solution at the wavelength of 310 nm. 
Calibration curves were used, employing microcapsules as standards, and the curves 
showed linearity over the concentration range of 0.05g/l to 0.5g/l in all cases. 
 
2.4 Drug Release 
To analyze the kinetic release of EHMC, samples of 1 g of the treated fabric were 
submerged into thermostatized vessels filled with deionized water at semi-infinite bath 
conditions at a temperature of 37ºC. The semi-infinite bath is called to the system 
which has one limited direction and extends infinitely in the other; therefore it can be 
considered that the diffusion into the edges can be neglected. The amount of active 
principle delivered to the bath was determined by UV-Vis Spectrophotometery at 
different times (from 0 to 200 hours).  
 
3. RESULTS AND DISCUSSION 
 
3.1. Treatment of the fabrics with microcapsules 
The application of the active agent vehiculized in a microencapsulated formulation 20% 
diluted (8.3% of dry product and 7.5% EHMC) on the textile substrates was performed 
by foulard in an attempt to achieve an approximately 80% pick-up (Product percentage 
collected in the fabrics after the Pad-Dry stage). The percentages of pick-up for the 
different fabric treated, the percentages of theoretical product present in each fabric 
taking into account the composition of microcapsules (8.3% product/91.7% water), as 
well as the percentages of dry product applied calculated by weight difference between 
dry fabric after Pad-Dry process and dry initial fabric are shown in Table 2, according to 
the conclusions of a previous paper [13]. 
 
Table 2. Results of the finishing process of several textile fabrics: % pick-up and the 
theoretical percentage of product present in the wet fabrics after impregnation; and % 
o.w.f. (on weight of fibres) of product applied, calculated by weight difference between 
dry non-treated textile and dry textile after Pad-Dry process. 
 
 
 
 
 
 
 
 
 
When comparing the experimental results obtained for the different fibers studied, 
some comments have to be done: 
The amount of bath absorbed by the different samples is very similar (very close to the 
expected 80%). 
Dry matter content determined differs slightly. PET fibre shows less content, probably 
due to its hydrophobic nature and to the non-existence of ionic groups in its structure 
PA, at the impregnation conditions (pH=4.1) must have bigger percentage of terminal 
amine groups in its ionized (-NH3
+) form than carboxylic groups. That can suggest the 
existence of an electrostatic attraction between polymer chains of PA and 
microcapsules. This can explain the higher content of dry matter detected for PA in 
respect to PET. 
In the case of PAC fibres, at the experimental conditions used, Sulphate groups should 
be in its ionic form and carboxylic in the neutral one. That is just the contrary than in PA 
fibres, although PAC shows a higher dry matter content than PA. 
Textile 
MICROCAPSULES 
% Pick-up  (% 
theoretical 
product) 
% o.w.f. Dry 
product applied 
PA 80,94 (6.72) 55,40 
PAC 79,75 (6.62) 62,88 
PET 81,17 (6.74) 37,73 
Nevertheless, what is common to the three types of fibres is the existence of zeta 
potential values in each one (PET: -64 to – 78 mV, PA: - 42 mV and PAC: -47 mV) [14], 
which are similar between PA and PAC, but not with PET that shows a higher negative 
zeta potential. 
As it can be seen in Table 2, results on dry product applied show a similar amount  for  
PA and PAC (55.40 and 62.88 % owf) and low amount for PET (37.73% owf). We can 
deduce that zeta potential has a relevant influence on the process of microcapsules 
retention and, with certain probability, that it is responsible of those experimental 
results. Nevertheless this phenomenon must be studied much deeper to establish the 
extent of this influence. 
No resin was used to promote the adhesion of microcapsules to the fabrics because 
one of the main factors in the preparation of a biofunctional textile is the active agent 
delivery mechanism given that the use of resins could interfere in this release. 
 
3.2 Theoretical mechanisms of Drug Release 
The results obtained on the kinetic release profiles for all treated fabric samples (PA, 
PAC and PET) are graphically plotted in Figure 2 and Table 3. Comparing the kinetic 
profiles obtained with the theoretical curves (A, B, C and D) indicated in Figure 1, it can 
be clearly deduced that the behaviour of the different fabrics was similar to the 
theoretical curve D. This behaviour represents a First-order release system that it 
corresponds to a controlled release [15, 16]. 
 
 
 
Figure 2. Release of microencapsulated sun filter (EHMC) applied onto polyamide, 
acrylic and polyester fabrics at 37ºC. Mt (g EHC/g fabric) 
 
 
3.3 Power law 
Using Eq. (1), the value of the exponent n, indicative of drug transport mechanism, was 
calculated. As Table 3 shows, values about 0.25 were obtained, so the transport 
mechanism observed may be considered as a Fickian diffusion according to the drug 
delivery models based on the parameter n. [17, 18] 
 
Table 3. Estimated parameters, K and n values obtained from fitting drug release 
experimental data to Korsenmeyer-Peppas model (Eq. (1)).  
Fabric 
type 
Temperature 
(ºC) 
Classification 
(Figure I) 
K N Drug 
Delivery 
System 
Polyamide 37 D 0,3176 0,24 Fickian 
Acrylic 37 D 0,3608 0,23 Fickian 
Polyester 37 D 0,3088 0,26 Fickian 
 
 
3.4 Higuchi equation 
As the release mechanism of active principle in our research follows Fickian diffusion 
and the transport in swelling systems can be described by Fick’s second Law, this 
system can be studied like a plane surface for short times of active principle release. 
Therefore, parameters were obtained from the Higuchi equation and the solution of 
Fick’s second law for thin films, which are shown in the Table 4. 
The results were calculated using release profiles, i.e. percentage of drug release 
(Mt/M∞) versus time , and were plotted for each treated fabric (Fig. 3, Fig. 4 and Fig. 
5) [19, 20]. 
 
 
 
Figure 3. Release percentage of microencapsulated sun filter (EHMC) applied onto 
polyamide fabric at 37ºC. 
 
 Figure 4. Release percentage of microencapsulated sun filter (EHMC) applied onto 
acrylic fabric at 37ºC. 
 
 
 
Figure 5. Release percentage of microencapsulated sun filter (EHMC) applied onto 
polyester fabric at 37ºC. 
 
Table 4. Parameters measured and estimated applying the mathematical models (Eq. 
(2) and Eq. (3)). 
Fabric type Temperature 
(ºC) 
D/δ2 K (Higuchi) 
Polyamide 37 0,0460 0,2420 
Acrylic 37 0,0513 0,2555 
Polyester 37 0,0372 0,2177 
 
 
Results from Table 4, show the same tendency than the observed from Table 2. The 
increasing order on diffusion magnitudes detected for PET, PA and PAC indicates that 
the rate of EHMC delivering is absolutely related with the existent gradient of 
concentration (dry matter) in the fiber. That behavior is according with the proposed 
mechanism of Fickian diffusion.  
From the results obtained, it seems that the main factor for kinetic delivery rate is the 
behavior and capacity of fabrics to absorb more or less microcapsules from the bath. 
Therefore, when trying to apply to industry, regulation of the delivery rate will depend 
mainly on the impregnation percentage and on the initial concentration of the 
microcapsules present in to the pad-liquor bath. 
 
4. CONCLUSIONS 
In this study it has been demonstrated that the controlled release dosage of active 
principle can be possible. The characterization of the mechanism of drug release can 
be defined using equations of Power Law, when Fickian diffusion is assumed. Higuchi 
model and the solution of Fick’s second law for thin films can be also used to determine 
the diffusion coefficient of drug release. 
For each polymer-based fibre, the delivery action is similar, so the chemical structure of 
the fabric is not an important parameter in this system. Although, the kinetic models 
have certain limits on their applicability in different systems, it has been demonstrated 
that the behaviour of the synthetic fabrics studied, considering their own absorption 
capacity, follows the same release mechanism, that is a Fickian diffusion.  
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